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Abstract
Lipopolysaccharides (LPS) released from the outer membrane (OM) of Gram neg-
ative bacteria form aggregates which trigger an inflammatory response in humans
and can result in severe septic shock. LPS molecules are heterogenic, macro-
amphiphilic oligosaccharides with a pro-inflammatory activity strictly related to
the colloidal structures formed in solution; the morphology of the colloids formed
by LPS is dependent upon the molecular conformation of the LPS monomers.
The intact LPS molecule (smooth chemotype) forms elongated micelles in solution
whereas truncated LPS molecules (rough chemotypes) form lamellar aggregates.
Biological toxicity tests revealed that the different chemotypes have different toxic
activities on cultured macrophage cells. It is believed that the micellar aggre-
gates are responsible for the toxic effect of LPS, while the lamellar phase should
not trigger an inflammatory response. The data presented in this thesis revealed
that there might be a more complex connection between the toxicity of LPS and
the aggregate structures. The amphiphilic cationic antimicrobial peptides (CAPs)
LL37 and LFb possess putative anti-endotoxic activities and were therefore stud-
ied using small-angle neutron scattering (SANS) and cryo transmission electron
microscopy (cryo-TEM) to assess any modification induced to the colloidal struc-
ture of LPS, ideally from a high toxic state to a lower toxic morphology of the
aggregates. The peptides LL37 and LFb are able to induce changes to the ag-
gregates from different LPS chemotypes in relation to their conformation and the
LPS molecular structure. Neutron reflectivity experiments on monolayer and bi-
layer membrane models containing different chemotypes of LPS were performed
in the presence of the peptides; the data revealed that the two peptides have dif-
ferent mechanisms of interaction with membrane models containing LPS. These
investigations provide new insight into the structure-activity of LPS in conditions
which are more biologically-relevant than previously published data. Additionally
the activity of CAPs on membrane models of the Gram negative bacteria OM was
investigated to elucidate the different mechanisms of interaction and their possible
anti-inflammatory role.
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1.1 Gram negative bacterial infections.
Amongst all the principal diagnosis which required the patient hospitalization reg-
istered in the US in the years 1997-2009, septicemia is the seventh most common
diagnosis and grew by 78% over the decade, the second highest diagnosis increase
after osteoarthritis ; septicemia represented an additional financial burden in the
light of the fact that it was the most expensive condition in 2009 and it showed
a striking increase by 11.3% average annual growth in aggregate costs of hospi-
talization from the year 1997 to 2009, the highest amongst all the diagnosis [1].
In the period from September 2006 to October 2007, 89% of the nosocomial in-
fections registered in US hospitals where caused by strains of only ten common
pathogens of which 10% were Escherichia coli (E. coli) [2]. According to the UK
Public Health England (PHE), E. coli was the most frequent pathogen associated
with healthcare associated infection (HAI) in the UK in 2011 [3] and the UK PHE
periodic report on the surgical site infection (SSI) surveillance over the years 2004
and 2011 collected by NHS hospitals, established that Enterobacteriaceae (the
family of E. coli and other Gram negative bacteria) were the predominant micro-
organisms causing almost 30% of the SSI cases [4]. In addition to that, between the
years 2001 and 2006, one-fifth of all bacteriemias cases in the UK were provoked
by E. coli strains with an increased drug resistance [5]. Surgery and other invasive
techniques such as the application of catheters, mechanical ventilation, vascular
access and physiological status monitoring, are the most common ways to con-
tract nosocomial infections amongst intensive care unit (ICU) patients and have
1
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been strictly surveilled [6, 7] in the light of the increasing bacterial drug resistance
and its epidemiological and economic consequences. The most critical resistance
trends are those observed for Enterobacteriaceae [8] and the latest survey of the
European Centre for Disease Prevention and Control (ECDC) [9, 10], shows how
bacterial resistance towards common antibiotics in Europe continues to increase
amongst Gram negative bacteria. The data released by the European Antimi-
crobial Resistance Surveillance Network (EARS-net) [10] reported in Figure 1.1
shows the prevalence of resistant E. coli strains toward several antibiotics with
different mechanism of action. It is clear from the maps how both cephalosphorin
and fluorquinolone resistance have increased over the last few years in Europe.
The data report a high percentage of resistance to aminopenicillins already at the
beginning of this study starting in the late 1990’s. In general the data show how
the development of resistance has been a continuous process which does not seem
to affect the carbapenem family yet. Recent evidence in the 2013 [11] from the
US Centre for Disease Control and Prevention (CDC), and supported by the 2012
ECDC survey [9], report the discovery of carbapenem-resistant Enterobacteriaceae
isolates with an astonishingly high mortality rate, resulting in the death of half of
the patients whose bacteriemia was caused by these resistant strains.
The increase of antimicrobial resistance is sometimes described as ’catastrophic’
because of the limited amount of new antimicrobial drugs introduced onto the
market to counter this trend [12]. The paucity of new antimicrobial agents has an
economical explanation since the investment and effort that the pharmaceutical
industry has to input in order to get new drugs onto the market are unlikely to
have a good return [13]. An antimicrobial drug is meant to treat mostly acute
diseases but still requires the same regulatory approval of long-term drugs, there-
fore it is economically unfavorable when compared to the profit obtained from
the commercialization of a long-term drug developed for the treatment of chronic
diseases [13]. The antimicrobial drug market is of course dependent on large and
small biotechnology companies which need to be encouraged to support R&D and
probably the issues found during the development of new drugs are political rather
then scientific [14, 15] suggesting that a different approval route or greater financial
support may be needed. In the light of the obvious increased incidence of antibiotic
resistance in Gram negative bacteria and the necessity for obtaining more active
drugs, these efforts should be probably focused towards developing new classes of
compounds from the improvement of the well known class of peptide antibiotics
[16, 17].
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Figure 1.1: Resistance to fluorquinolones, cephalosporines, aminopenicillins
and carbapenems of E. coli isolates to. Data collected from states that partic-
ipate in the EARS-net study over the years 2003 and 2011. The survey and
data were updated in 2012. In the legend: “No Data” refers to an insufficient
amount of isolates. Figure adapted from [10]
In this thesis the attention to the rising threat generated by Gram negative bac-
teria has been engaged through the analysis of two processes occurring during a
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bacterial infection. One research focus of this investigation aims to understand the
role of the bacterial outer membrane (OM) component lipopolysaccharide (LPS) in
protecting against the membrane perturbing activity of specific peptide antibiotics.
The second research focus aims to study the efficacy of these potential antibiotics
as effective molecules against the toxic activity of the same LPS component.
1.2 The lipopolysaccharides of Gram negative
bacteria.
In common with other types of microorganisms, Gram negative bacteria have
evolved several mechanisms to resist the action of antibiotic molecules. These
mechanisms include enzymatic degradation, enzymatic modification and inactiva-
tion of the antibiotic molecule, alteration of the molecule’s target in the bacteria,
active transport that reduces the intake of the drug and reduced access of the drug
into the cell due to the presence of a physical barrier, which is a non-specific, broad-
spectrum, intrinsic mechanism against several type of antibiotics drugs [18, 19].
The cell envelope of Gram negative bacteria depicted in Figure 1.2 is composed of
an inner membrane consisting of a lipidic bilayer with intrinsic proteins surrounded
by a thin peptidoglycan layer, further enclosed within the asymmetric bilayer that
constitutes the outer membrane (OM). The OM, on its outer leaflet, is composed
of the amphiphilic macromolecule LPS which confers a negative charge to the cell
envelope, covers up to 75% of the outer membrane surface area [20, 21] and is an
essential component for the viability of the bacterial cell [22].
An OM containing LPS is an effective barrier against hydrophobic molecules which
would potentially interact with the bacterial plasma membrane, destroy it and kill
the bacteria [19, 23]. The low permeability of the outer membrane seems to be
due to the rigidity of the acyl chains induced by the intact structure of LPS, in
fact truncation of the oligosaccharide moiety of LPS results in a more disordered
bilayer of the membrane and a higher susceptibility to hydrophobic antibiotics
[24–26]. Hence the outer membrane permeability is strongly dependent on the
structure of the oligosaccharide headgroup of LPS.
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Figure 1.2: Representation of the cell envelope of Gram negative bacteria.
1.2.1 Structure of Lipopolysaccharides.
An intact LPS molecule is defined as being a smooth chemotype and consists of
a high-molecular-weight heterogeneous macroamphiphile composed of three do-
mains: the lipid A, the oligosaccharide core region (sub-divided into the inner and
outer core) and the polysaccharide O-antigen (Figure 1.3).The lipid A region is
a highly conserved moiety of LPS which anchors the whole molecule to the OM
of the bacterium via its hydrophobic chains. It is covalently linked with the core
oligosaccharide which has several lateral substitutions and it is bound by a glyco-
sidic bond to the highly polydisperse O-antigen moiety, which consists of repeating
short oligosaccharide units (up to 40 times).
The absence of the O-antigen due to mutations in the bacterial genome produces
so-called rough chemotypes of LPS (Figure 1.3). Within the rough chemotype
group, specific mutations can lead to the expression of LPS with even shorter core
regions. Rough chemotypes of LPS are designated as Ra, Rb, Rc, Rd and Re
according to the length of their core region (Figure 1.3).
Inter-species variation exists in each of the three structural domains of LPS and is
characterized by differences in length of the poly-oligosaccharide chains, the num-
ber and type of constituent sugars, the number and type of substituent groups,
and the number and length of the acyl chains found on the lipid A moiety. The
heterogeneity of the LPS structures also occurs between different strains of the
same species [27–31]. In this thesis attention has been focused on the well studied
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Figure 1.3: Schematic representation of the structure of smooth and rough
chemotypes of LPS. The labels Ra to Re depend upon the length of the oligosac-
charidic core region.
LPS from E. coli [29, 32–35] and in particular from the mutants of the strain K12
[31, 36], and the strains 0111B4, EH100 and J5 [37–41].
1.2.1.1 Structure of the lipid-A from E. coli.
The lipid A region of LPS is the hydrophobic anchor to the OM and the centre of
its endotoxic activity. The most conserved structure of lipid A from enterobacteria
such as E. coli consists of a bisphosphorylated Glucosamine (GlcN) di-saccharide,
whose monomers are connected β − 1, 6 by a O-glycosidic bond [42]. The dis-
accharide is acylated by four residues of (R)-3-hydroxytetradecanoic acid (14:0)
in positions two and three of each GlcN monomer [43], a basic structure which
is highly conserved amongst many genera of Gram negative bacteria [44]. Fur-
ther non-stoichiometric acylation may be present by the formation of ester bonds
with the acyl chains of the basic structure, as shown in Figure 1.4, and other
specific variations on the appendages X and Y of the phosphate groups and phos-
phoethanolamine (PEtn) or phospho-phosphoethanolamine (PPEtn) groups, may
vary between different species [29]. The lipid A from E. coli possesses a hexa-
acylated hydrophobic region with the possibility of a further phosphorylation in
position Y (Figure 1.4). The lipid A region is connected to the core oligosacharide
moiety by a β O-glycosidic bond in position 6 of the distal GlcN with the first
3-deoxy-D-mannooctulosonic acid (Kdo) residue of the inner core.
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Figure 1.4: Conserved structure of the lipid A moiety of LPS from E. coli and
other enterobacteriae. X and Y refer to possible substitutions on the phosphate
groups.
1.2.1.2 Structure of the core oligosaccharide of LPS from the Rough
E. coli K12, D21 mutants.
E. coli K12 is a rough strain of the bacterium which does not express an O-antigen
region, but possesses an intact core oligosaccharide [45]. E. coli K12 produces sev-
eral glycoforms of lipopolysaccharide with minor differences on the number and
type of carbohydrates and phosphate substitutions [35, 42]. The D21 mutant of
K12, whose core structure is described by Banoub et al. [46], is an ampicillin-
resistant mutant [47–49] of the wild type E. coli K12 which produces an identical
core region to the parental strain [50]. The LPS produced by this mutant is a full
core Ra chemotype which is named LPS D21 in this thesis (see Table 1.1). The
mutant D21 is quite distinctive from other strains of E. coli , as it expresses a
L-rhamnose (Rha) substitution on the second Kdo residue of the inner core of its
LPS [47]. The mutant D21e19 carries a mutation on the lpsB gene and produces a
Rb cemotype of LPS which retains some of the Rha substituents of the chemotype
D21 and has very little galactose (Gal) residues linked to the first outer core D-
glucose (Glc) I [47]. The Rc mutant D21e7, also defined as LPS E7 in this thesis
(see Table 1.1), possesses a mutation at the rfaP gene which gives no phosphory-
lation at the heptose (Hep) I and II, coupled with absence of the lateral Hep III
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[51] (Figure 1.5). A mutation, presumably involving the rfaY gene, gives noRha
at the Kdo II level and seems to be coupled with the modification at the level of
the heptoses as well[52]. Additionally the LPS E7 does not possess phosphates,
PEtns or other lateral substituents at Kdo II level [45, 47, 49]. The mutant D21e7
is the parental strain of the glucose-deficient mutant D21f1 and heptose-deficient
mutant D21f2 which produce a Rd and Re LPS chemotypes respectively [48, 51].
Both these strains lack phosphate substituents on their inner core region and do
not possess Rha or PEtn substituents in the Kdo II [50].
The LPS chemotypes of interest in this thesis will be those produced by the mu-
tants D21 and D21e7 (together with those described in the next Section 1.2.1.3)
whose structures are depicted in Figure 1.5 . For the sake of clarity the codes used
in this thesis to refer to these two LPS chemotypes are respectively D21 and E7,
as reported in Table1.1.
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Figure 1.5: The core structures of LPS D21 and D21e7. The dashed lines
refer to non-stoichiometric substitutions.
1.2.1.3 Structure of the core oligosaccharide and O-antigen of LPS
from E. coli 0111B4,EH100 and J5
The lipopolysaccharide from the smooth E. coli 0111B4 and the rough chemotypes
from E. coli Eh100 and E. coli J5 were investigated and their structures reported
in Figure 1.6. The smooth LPS [41] produced by the E. coli 0111B4 has an in-
tact O-antigen and core regions which differ from the LPS D21 and EH100. The
core region of the smooth LPS 0111B4 possesses a Gal in the place of the Glc II,
further substituted by a N-acetyl-D-glucosamine (GlcNac), and the replacement
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of the lateral GlcNac with a Glc at the Glc III level. The J5 mutant is derived
from the parental strain 0111B4 and is an Rc chemotype, named LPS J5, which
possesses different core species, the main product of which is reported in Figure
1.6 [39, 40]. The LPS J5 has a similar core region to the LPS E7 but retains all the
phosphate substitutions at the heptose level and it has the Hep III group which
is further substituted with a GlcN. The core of the lipopolysaccharide expressed
by E. coli EH100 is described by different authors [37, 38, 41] and its structure is
similar to the LPS D21 with the additional presence of a PEtn and a Gal substi-
tutions at the Kdo II level. For the sake of clarity the codes used in this thesis
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Figure 1.6: The core and O-antigen structures of LPS 0111B4, Eh100 and J5.
The dashed lines refer to non-stoichiometric substitutions.
1.2.2 The role of LPS in the packing of the outer mem-
brane.
The low permeability of the outer membrane to hydrophobic molecules may be due
to the structure-dependent ordering effect of LPS molecules on the outer leaflet.
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Table 1.1: Nomenclature of lipopolysaccharide chemotypes used in this thesis.







i phosphate-free in the heptose region
The intact structure of the smooth LPS has a high gel to liquid phase transi-
tion temperature for the acyl chains (above 37◦C ) [53] in the presence of divalent
cations such as Mg2+ . This means that the smooth LPS at physiological human
body temperature increases the ordering and the rigidity of the membrane [54] thus
reducing the permeation of hydrophobic molecules and preventing their insertion
into the bilayer [55]. The modified rough LPS from the Ra to the Re chemotypes
exhibit, in the presence of divalent cations, transition temperatures which decrease
from 37◦C to 30◦C with the reduction of the length of the oligosaccharide chain
[53, 56], hence at physiological human body temperature the acyl chains of these
LPS chemotypes are likely to be in their fluid phase increasing the likelihood of
permeation of hydrophobic molecules [24, 26]. LPS has a high affinity for divalent
cations such as Mg2+ and Ca2+ [57] the presence of which increases the order state
of all the LPS increasing the rigidity of the acyl chains [53, 56, 58, 59]. The diva-
lent cations may act as bridges between the negative charges of the LPS headgroup
explaining the importance of such ions to the stability of the OM [20, 60].
1.2.3 The toxic activity of LPS from Gram negative bac-
teria in humans.
LPS is released from bacteria during cell multiplication, death and lysis [22] and is
responsible for the major toxic manifestations of serious Gram negative infections
[61], giving rise to its alternative name endotoxin. The pathological effects of a
severe Gram negative bacterial infection are, in reality, the result of an unregu-
lated physiological response to endotoxins. Endotoxins stimulate the mammalian
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immune system which reacts, in a balanced physiological immunoreaction, produc-
ing several inflammatory mediators and small molecules in order to promote the
antimicrobial defence mechanisms designed to eliminate the cause of the infection
(e.g. increase of the body temperature, reduced oxygen species, etc.). Elevated
concentrations of LPS in the body, as in the case of severe sepsis, over-stimulates
the immune system and the unbalanced levels of inflammatory mediators may lead
to septic shock syndrome resulting in high fever, hypotension, thrombosis, organ
failure and other pathological life, threatening conditions [61].
Macrophages/monocytes and neutrophils cell types are of particular interest be-
cause they are the primary target cells that react towards LPS due their constitu-
tive expression of the membrane protein CD14 (mCD14) and toll-like receptor 4
(TLR4) , and are sensitive to picomolar quantities of endotoxin (i.e. 1-10 pg/mL)
[61]. Nevertheless many other host cell types such as endothelial and muscle cells,
fibroblasts and dendritic cells, are responsive to LPS thanks to the activation of






Figure 1.7: Activation of a macrophage cell by a LPS aggregate. The Single
LPS monomer is transferred from the aggregate to the CD14 by the LBP protein.
CD14 associates with the TLR/MD-2 receptor which triggers the cell signaling.
first step for the cellular activation is the recognition of LPS aggregates by the
serum circulating lipopolysaccharide binding protein (LBP) [63] which, at low con-
centrations, acts as carrier of a single LPS monomer taken from an LPS aggregate
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and presented to the CD receptor on the immune system cells membrane [64] .
Only aggregates of LPS exert toxic activity whereas monomers of rough LPS and
lipid A have proved to be inefficient in stimulating the release of tumor necrosis
factor alpha (TNF-α) from human monocytes in vitro in the presence of LBP [65].
LBP is essential for an efficient immune system activation against LPS and muta-
tions of this protein increase the mortality of patients with sepsis [66]. LBP binds
specifically the negative charges of the lipid A portion of LPS by electrostatic
interaction with three cationic amino acid residues (Arg 94,Lys 95 and Lys 99)
at the N-terminal of the protein [67] and site mutations in this region result in
loss of binding with the LPS monomer [67]. Recent experiments [68] suggest that
LBP may also partition into cell membrane models thus suggesting the aid of the
fusion of LPS with the lipid bilayers, which when occurring in macrophages, would
enhance the activation of the cells [69]. On the other hand a high concentration
of circulating LBP neutralizes LPS reducing the cellular activation [69], possibly
due to a modification of the LPS aggregates’ morphology (Section 1.2.3.1). More
recent investigations suggest that LBP could be already present in the membrane
of cultured human macrophages even after washing of the culture media [70].
LBP interacts by its C-terminal region [71] with mCD14 and sCD14 forming a
ternary LPS/LBP/CD14 complex with an ideal 1:1:2 stoichiometry, and transfers
the LPS monomer allowing the formation of a CD14/LPS complex [72, 73]. The
CD14 receptors seem to form a hydrophobic region with a β-sheet conformation
able to accommodate the acyl chains of lipid A and possess cationic residues which
would interact with the negative charges on LPS as well [63] and possibly also with
the carbohydrates of the core and O-antigen region [74]. CD14 presents the LPS
monomer to the essential TLR4 associated protein (MD-2) associated to the final
TLR4 receptor, which is responsible for the intracellular signaling cascade [62, 63]
(Figure 1.7). The receptor MD-2 , as monomer, binds directly monomers of LPS
[75, 76] by a delimited amphiphilic region which seems to recognize the amphiphilic
properties of LPS. The structure of MD-2 contains a hydrophobic region [77] and
hydrophillyc lysines [78] which could interact respectively with the acyl chains and
the negative charges of LPS. Moreover the number of acyl chains of LPS influences
the activity of MD-2 as signal transducer, in fact the hexa-acylated LPS/MD-2
complex activates more TLR4 than the tetra- or penta-acylated LPS/MD-2 com-
plex [75].
The signal transduction pathway that is initiated by the activation of the TLR4
receptor leading to the release of inflammatory mediators is described in detail
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elsewhere [79]. The ultimate purpose of such signal amplification is the release
of prostaglandins, cytokines and other small molecules such as the anion super-
oxide (O−2 ), radicals (
•OH) and nitric oxide (NO) [61]. A central role in the
inflammatory response of the macrophages is played by the mediators TNF-α
and interleukin 1 (IL-1) which facilitates many of the pathological features of the
LPS-induced shock [80].
1.2.3.1 Structure-activity relationship of LPS aggregates.
LPS is an amphiphilic glycolipid which forms (like phospholipids) colloidal aggre-
gates in an aqueous environment above its critical micellar concentration (CMC).
The CMCs of different LPS have not been precisely determined due to their poly-
dispersity and the complexity of their structures. However it is reasonable to
assume that the CMC of smooth and rough LPS chemotypes is in the picomolar
range of concentration, in consideration of atomic force microspcopy data from the
literature which showed the formation of aggregates already in the pM range [81].
The type of aggregate that any amphphiles can form in solution has been described
by Israelachvili [82, 83] by a geometric model which relates a dimensionless shape
parameter S to the ratio of the effective hydrophile hydrophile cross-sectional area






ao · lc (1.1)
where the other parameters are the molecular volume of the hydrocarbon’s region
V and the hydrophobe chain length (lc). The shape parameter S is an indicator
of the possible supramolecular aggregate structure formed by various amphiphiles
dependent upon the state of order of the acyl chains. The order parameter is a
physico-chemical property inversely correlated to the fluidity of the chains, which
can adopt two type of states, or phases: the highly ordered gel phase (Lβ) and the
disordered liquid-crystalline phase (Lα). The transition between the two phases
takes place at the so-called phase transition temperature (Tm). The shape pa-
rameter, state of order and phase transition temperature depend on molecular
properties, such as the length of the acyl chains, degree of saturation, headgroup
conformation, charge density and charge distribution, but they are also influenced
by the environmental conditions, i.e. ionic strength of the solution, type of ions
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present, temperature and pH .
The morphology of the aggregates of LPS in solution, which is related to the
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Figure 1.8: Amphiphile molecular structure shape parameter and related ag-
gregate structures.
shape parameter of each single monomer, is thought to be related to its toxic ac-
tivity as proposed in the “conformational concept of endotoxicity” [84]. Previous
investigations on synthetic phospholipid-like compounds provided an understand-
ing of the structure-activity relationship of LPS [85]. The toxic synthetic analog
of lipid A , compound 506, studied by FT-IR at a minimal concentration of 40
mg/mL, possesses a disordered acyl chains state and a Tm of 44
◦C [53], forms non-
lamellar cubic/inverted hexagonal structures (S>1) similarly to the lipid A from
E. coli [86]. Whereas the non-toxic synthetic tetraacylated compound 406, an an-
tagonist of lipid A possessing more ordered acyl chains and a Tm of 20
◦C , was
found to form micellar or lamellar structures (S<1) [86]. When the compound 406
is mixed in a defined ratio with compound 506, it loses its antagonistic effect and
the mixed aggregates showed even higher capacity to stimulate the production of
TNF-α by human mononuclear cells than aggregates composed of pure compound
506 [65]. This suggests that the toxic/non-toxic feature of lipid A derivatives de-
pend on the morphology, or shape parameter, of the molecule within the aggregate
rather than the value of Tm.
Many investigations have been performed by means of X-ray diffraction in the
presence of Mg2+ with different chemotypes of rough LPSs and with lipid A with
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a water content above 90% to resolve the structural polymorphism of different
endotoxin chemotypes [56, 58, 59, 87, 88]. Ra, Rc, Rd, Re LPS and lipid A from
Salmonella minnesota (S. minnesota) at a minimal concentration of 18 mg/mL
formed lamellar structures below 37◦C and non-lamellar structures above the phase
transition temperature, whereas the addition of Mg2+ induced the coexistence of
lamellar and non-lamellar strucutres and reduced the fluidity of the acyl chains
[56, 59, 89]. The ordering effect of Mg2+ is most expressed in lipid A and the Re
LPS and to a lesser extent in rough chemotypes with a more complete oligosaccha-
ride core, suggesting that the negatively charged phosphates at the heptose level
might reduce the effect of divalent ions which otherwise would interact with the
phosphates at the glucosamine level of lipid A inducing a stronger ordering effect
upon the acyl chains [53]. The divalent cation Mg2+ reduced the chain mobility
of LPS and produced a decrease in the toxicity levels due to the favoring of a
lamellar state [90]. The biological role of LPS is also connected to the interdepen-
dence of the molecular conformation and the molecular charge of the lipid A [91].
To summarise LPSs in the lamellar state with a cylindrical shape parameter and
absent or reduced negative charges seem to be non-toxic whilst LPS aggregates in
the non-lamellar state whose monomers possess an inverted cone shape parameter
(S>1) and have four negative charges exert the highest toxic activity [84, 91, 92].
A B 
Figure 1.9: Model of cell activation by LPS adapted from [70]. (A) Recog-
nition of non-lamellar structures of LPS by membrane bound LBP and cell
activation. (B) Aggregates of LPS in the lamellar state pre-treated with LBP
do not stimulate the cells.
The proposed mechanism of endotoxic activity suggested by the group of Klaus
Brandenburg can be summarized as follows (Figure 1.9). The LBP associated
to the membrane of the immune cells such as human mono-nuclear cells [68, 69]
recognizes the aggregates of LPS in the non-lamellar state and facilitates the in-
corporation of endotoxin in the membrane of the host cell [93]. The incorporated
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LPS molecule is allowed to interact with the membrane-bound acceptors and ini-
tiate the immunostimulatory signal [69]. The presence of LPS in the lamellar
state would not allow the recognition of the aggregates and the stimulation of the
immune system would not occur [84].
1.3 Cationic antimicrobial peptides (CAP).
The increasing prevalence of multi-drug resistant Gram negative bacteria and the
lack of new antimicrobial drugs on the market (Section 1.1), necessitates the need
for the investigation of feasible alternatives to the use of classical antibiotics. The
support for cationic antimicrobial peptides as possible replacements or adjuvants
to common treatments for bacterial infections has been extensively discussed [94–
97]. Currently the number of recognized cationic antimicrobial peptides (CAPs)
in the literature amount to almost two thousand peptides [98, 99] which can be
divided in the following classes (a) α-helical, (B) β-sheet, (c) cysteine-rich, (d)
unusual composition and (e) unusual amino acids [100].
Several CAPs of diverse natural origin with different structures and physico-
chemical features have been investigated [101, 102] and despite their structural
diversity, most of them share some important features required for their activity
including a net positive charge and an amphiphilic character [103]. The cen-
tral mechanism of antimicrobial activity of CAP is the selective interaction of
the peptides with the negatively charged envelopes of Gram negative bacteria
[94, 100, 104, 105]. The initial electrostatic interaction of CAPs with biological
membranes is followed by the permeabilization of the membrane [105]. The most
plausible mechanisms of membrane disruption involve the formation of pore-like
structures such as the ’barrel-stave model’ or the ’toroidal model’ [106], or the
so-called ’carpet model’ by which the lipid bilayer is destroyed in a detergent-like
manner [107]. All these mechanisms of action rely on the achievement of a co-
operative threshold peptide concentration on the surface of the membrane. Once
that the bacterial physical barrier has been compromised, the peptides may be
internalized into the cytoplasm of the cells and interact with intracellular targets
such as nucleic acids and proteins, strongly affecting the bacterial viability [108–
110]. The function of CAPs may not be confined to bactericidal activity, in fact
human cathelicidins and defensins showed additional activities in processes such
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as chemotaxis and wound repairing [111–113]. In addition to these latter activi-
ties, an emerging interest is arising for the anti-inflammatory role of antimicrobial
peptides of synthetic [114] and natural origin [115, 116].
This thesis investigates the functions of the two CAPs, LL37 anf LFb , as mem-
brane active compounds against models of Gram negative bacterial membranes
containing different chemotypes of LPS and as potential anti-endotoxic molecules











Figure 1.10: Structures of LL37 and LFb with the hydrophobicity scale on the
left. LFb (A) hydrophilic side, (B) hydrophobic side and (c) the diagram of the
axial view of the peptide that shows the hydrophobic and hydrophilic regions.
LL37 with the (d) hydrophilic side, (e) hydrophobic side and (f) diagram of the
axial view of the peptide and the relative helical diagram. Image generated
from the PDB structures of LL37 (PDB code 2k60) and LFb (PDB code 1lfc).
1.3.1 Bovine lactoferricin (LFb).
Lactoferricin B (LFb ) is a 25-residue antimicrobial peptide derived from the
bovine lactoferrin protein by pepsin cleavage [117] with a positive net charge of
+8 at neutral pH. LFb consists of an amphiphilic β-sheet conformation with one
disulfide bond between the Cys 3 and Cys 20 residues, which does not seem to
be necessary for its antimicrobial activity [118], and it forms a loop which bares
two distorted anti-parallel β-sheets domains [119]. The peptide presents one hy-
drophobic strip surrounded by the side chains of hydrophilic or positively charged
residues [120, 121]. The structure of LFb depicted in Figure 1.10 shows different
views of the peptide with the side chains of the hydrophobic residues Phe 1, Cys
3, Trp 6, Trp 8, Leu 13, Ala 15, Pro 16, Ile 18 and Cys 20, which form the apolar
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face of the peptide. From the figure it is possible to note the amphiphilic charac-
ter of the peptide with the identification of the hydrophobic (red) and hydrophilic
(blue) regions (Figure 1.10 C). Bovine lactoferricin’s structure differs from that of
human lactoferricin, which possesses a partial α-helical conformation, [122] and its
antimicrobial activity is more potent than its human analog against a wide range
of bacteria [123]. Sequence and details of the peptide are provided in Appendix
B.
LFb interacts with the outer membrane of E. coli causing blebbing and it is pos-
sibly internalized increasing the cytoplasmic debris [124, 125]. The possible in-
tracellular targets of LFb have been little investigated, however Yu et al. [126]
revealed that LFb affects several metabolic processes of E. coli . LFb interacts
with phosphatidylglycerol (PG) mono- and bilayers through the electrostatic in-
teraction with the negative charges, adsorbing parallel to the plane of the interface
below the lipid layer. The depth of the insertion is related to the order state of
the acyl chains, in fact the more ordered acyl chains of dipalmitoylphosphatidyl-
glycerol (DPPG) prevent the insertion of the peptide compared to the more fluid
chains of palmitoyl-oleoylphosphatidylglycerol (POPG) lipids [127]. Umeyama et
al. supported, by NMR investigations, the evidence that LFb is attracted by neg-
atively charged lipids and they also suggest that it possibly forms pores in bilayers
containing acidic lipids [128].
The susceptibility of E. coli to the minimal active sequence RRWQWR at the
N-terminal of LFb , necessary to build up an amphiphilic structure, is highly de-
pendent on the structure of LPS [129]. The presence of negative charges in the core
of LPS allows for a strong electrostatic interaction of the minimal sequence, re-
ducing the minimal bactericidal concentration (MBC) of the peptide, whereas the
removal of part of LPS’s core containing the negative charges, despite a reduced
shielding effect, decreases the electrostatic attraction with a consequent increase
in the MBC; exception is made for the case of the deep rough LPS which allows
a direct hydrophobic interaction of the peptide with the acyl chains, increasing
the bacteria’s susceptibility [129] . This suggests a two-step mechanism where
the initial electrostatic interaction with the core of LPS disorganizes the mem-
brane structure [127, 130] allowing the interaction of the hydrophobic residues
of LFb with the acyl chains and subsequent membrane disruption. Despite such
relevant evidence of the dependency on the LPS’s structure of the antibacterial
activity of LFb , interaction studies in the presence of different chemotypes of en-
dotoxin are absent from the literature.
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A sequence similarity investigation by means of the RCSB PDB protein com-
parison tool [131] which applies two sequence alignment algorithms, the Smith-
Waterman (SM) and Needleman-Wunsch (NW), has been carried out matching
the sequence of LFb with the whole sequence of LBP (PDB identification code
4M4D). The algorithms produced a high degree of similarity with only one mis-
matched residue (G and W) between the minimal LFb sequence 5RWQWRMKK
12 and the LBP’s sequence 92RGKWKVRK 99 which is the best docking sequence
for LPS [132]. The competition of antimicrobial peptides with LBP for the binding
to the endotoxin may be a very specialized and effective way to reduce or impede
the LPS-induced inflammatory response, as suggested by the investigation of Scott
et al. on several CAPs [133]. Moreover LFb presents a stronger affinity for LPS
than its human analog [134] and the LPS-binding activity has been established
for other similar peptides such as the cyclic β-sheet peptide tachyplesin I [135].
The interaction of a specific sequence in the loop of LFb with LPS molecules is the
basis of the anti-endotoxic role of the bovine lactoferrin protein [136] and may ex-
plain the in vitro anti-inflammatory effect of LFb on disc tissues from humans and
other mammals [116]. All this evidence supports the rationale for the investiga-
tions carried out in this thesis on the mechanism of anti-endotoxic activity of LFb .
1.3.2 Human cathelicidin LL-37 (LL37).
The LL37 peptide, sometimes called Cap-18, is a 37-residue antimicrobial pep-
tide derived from the proprotein hCAP-18 stored in neutrophils and epithelial
cells [137]. It is unfolded at low concentration in an aqueous environment [138]
whereas it adopts an α-helical conformation in the presence of sodium dodecyl sul-
phate (SDS) micelles and lipid membranes [139] with a bend between the residues
14 and 16 and a disordered C-terminus from the residue 32 to 37. The peptide
also folds up at higher peptide concentrations (over 0.1 µM) due to the formation
of oligomers which protect the peptide from proteolytic degradation [140, 141] .
LL37 possesses a positive net charge of +6 at pH 7.4 and an amphiphilic nature
produced by the defined hydrophobic and hydrophilic facets formed in the folded
state, shown in Figure 1.10. Sequence and details of the peptide are provided in
Appendix B.
LL37 has a wide range of antimicrobial and immunomodulatory bioactivities such
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as binding and transport activity of DNA, a complex role in carcinogenesis, chemo-
taxis and cell signaling [142–147]. In this thesis the attention is focused on the
interaction of LL37 with Gram negative model bacterial membranes and LPS ag-
gregates. LL37 binds LPS and reduces its toxic activity in vitro and in vivo
[148] decreasing the production of the inflammatory mediators TNF-α and NO
by macrophages [149].
The mechanism of action of LL37 against Gram negative bacteria involves the
interaction of the peptide with the outer membrane and its permeabilization.
LL37 interacts with negatively charged lipids covering the surface of the bilayer in
a carpet-like mode and, upon the achievement of a threshold concentration, the
peptide penetrates the bilayer as an oligomer forming a toroidal pore and crossing
the outer membrane [138, 145, 150, 151]. Oren et al. suggested that upon disrup-
tion of the outer membrane of the bacteria, LL37 dissociates into monomers and
disintegrate the inner membrane through a similar carpet-like action [140]. The
disruption of the Gram negative envelope induces leakage of the cell contents and
possible interaction of the peptide with intracellular targets [138, 145]. The mech-
anism of detoxification of LL37 has been investigated by Rosenfeld et al. [115] who
tested the peptide in cultures of murine macrophages in the presence of smooth
LPS 0111B4. The peptide strongly dissociates LPS aggregates in a linear dose-
dependent manner, inhibiting the binding of the endotoxin to the macrophages;
the peptide also binds LPS molecules already bound to the macrophages’ mem-
brane and competes with the receptor CD14 to the binding of LPS. The result of
all these bioactivities is a reduction of the secretion of cytokines and TNF-α by
the macrophages. In the same study the bioactivity of LL37 with other α-helical
peptides is compared and they suggested that the binding of the peptides to LPS
is not related to their detoxification capacity.
LL37 diminishes the pro-inflammatory response of mouse bone marrow macrophages
stimulated with smooth LPS 0111B4 by reducing the level and transcription of
TNF-α and NO in a time-dependent manner; the peptide has a greater anti-
inflammatory effect when it is pre-mixed with LPS before the addition to the cells.
The inhibition of NO production by LL37 is dose-dependent and 20 µg/mL of pep-
tide reduced the NO concentration by almost 90% [149]. The anti-inflammatory
effect of LL37 is probably due to a combination of the binding capacity for LPS
and its immunomodulatory role. It is evident the importance of the affinity of
LL37 for the endotoxin molecules, which modulates the anti-sepsis activity of the
pepetide; in fact the detoxification activity of LL37 (i.e. reduction of TNF-α and
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NO in macrophages) can be improved by substituting with Leu and Lys specific
residues within sequence 15 to 32, increasing the affinity for LPS by tuning the
cationic and hydrophobic features of the peptide [152].
In the light of the capacity of both peptides to interact with LPS molecules and
their anti-endotoxic role, certain for LL37 and partially unresolved for LFb , the
work described in this thesis aims to determine if the mechanism of interaction
with aggregates of several chemotypes of LPS follows the rationale described in
the ’conformational concept of endotoxicity’ (Section 1.2.3.1).
1.4 Techniques used for characterizing aggregates,
monolayers and bilayers of LPS.
1.4.1 Neutron scattering techniques.
Diffraction techniques involving photons (light, electrons, X-ray and neutrons) are
used in spectroscopy to analyse, to different extents, the structure of soft matter.
The different electromagnetic incident beams have diverse properties (i.e. wave-
length and energy, magnetic field, charge) and therefore may be selected according
to the nature of the sample under investigation and the information required from
it. In principle, all the photons are scattered by matter, but some of them are more
penetrating than others (Figure 1.11) and give detailed dimensional and structural
information about molecules and their assemblies within the matter itself. Elec-
trons are negatively charged particles that are repelled electrostatically by the
cloud of electrons around the atoms that compose the first layers of matter. This
probing method is therefore used to study the surface of solids in techniques such
as transmission electron microscopy and scanning electron microscopy; the result
is a very detailed image of the matter at nano-scale resolution. X-ray photons
penetrate matter more deeply than electrons and interact with its inner atoms.
X-rays are uncharged high energy electromagnetic waves (with an approximate
wavelength of 1 A˚) influenced by the electromagnetic field of the orbital of the
atoms. The bigger the atomic number (Z) of the atoms constituting the material,
the higher its scattering properties; therefore X-rays are sensitive to heavy nuclei
that compose the molecules and selective atomic substitution in the molecules
can aid the investigation and highlight particular groups within the structure.
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Neutrons are neutral particles which are not affected by the atomic orbital and
penetrate deeply into the matter. They interact directly with the nuclei of the
molecule that constitute the sample and are scattered due to the presence of the
strong nuclear forces within the atoms (Figure 1.11). All these techniques share
Figure 1.11: Schematic illustration of the diffraction of different photons and
neutrons by a material.
some theoretical aspects but in this section the attention is focused on the ba-
sic theory behind neutron scattering. In particular the application of small-angle
neutron scattering (SANS) and neutron reflectivity (neutron reflectivity (NR) )
techniques is discussed as analytical tools used to probe the properties of aggre-
gates, monolayer and bilayers of amphiphlies (i.e. lipopolysaccharide molecules
and lipids) and their interaction with small CAPs.
The neutron scattering techniques described in this chapter will be additionally
used in this thesis to carry preliminary investigations on the interaction of CAPs
and LPS. The LPS systems under study may be composed of aggregates of pure
LPS in solution (Chapter 3), monolayers of LPS at the air/liquid interface or
asymmetric bilayer of DPPC/LPS supported by silicon blocks (Chapter 4).
1.4.1.1 The properties of neutrons and elastic neutron scattering.
The neutron is an uncharged particle with a spin and a mass mn that behaves
according to the quantum mechanic rule of wave-particle duality of photons de-
scribed by Planck and de Broglie [153, 154]. According to Planck’s hypothesis, an
oscillating wave of frequency ν is associated with a defined packet (’quantum’) of
energy E shown in the Equation 1.2 and proportional to the Planck’s constant h.
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For periodic waves the frequency ν is related to the wavelength λ and the velocity
v of the wave by λ ν = v, therefore Planck’s equation becomes the Equation 1.3




The hypothesis of De Broglie associates a particle-like behaviour to an oscillating








where p is the momentum of the particle defined by the vectorial factor between
the mass mn and velocity v of the neutron. Taking into account the equation 1.4,










The kinetic energy of a beam of neutrons is thus related to the wavelength of the
periodic neutron wave. The energy of the neutron is also dependent upon the
temperature T by a simplified relationship
E = kB T (1.6)
in which kB is the Boltzmann’s constant.
1.4.1.2 Elastic neutron scattering and differential cross section.
The scattering of a neutron by a material, as depicted in Figure 1.12, is charac-
terized by a modification of the momentum p and the energy E of the neutron.







and by the energy transfer





in which Ki and Kf are the wavevectors, ωi and ωs are the angular frequencies of
respectively the incident and the scattered neutron. In an ideal simple scattering
experiment, the scattering is elastic and therefore there is no energy transfer to
be considered. The scattering event is restricted to the wavevector transfer Q =
Ki−Ks. The condition of “no energy exchange” (Ei = Es) between the neutron
and the sample implies that there is no modification of the λ of the neutron
(according to Equation 1.3) and in consideration of the relation of K with the
speed of the neutron v and the frequency ω as K · v = ω, the energy transfer is








which, according to the Equations 1.3 and 1.4, is simplified as relation between
the vectors
|Ki| = |Ki| = 2pi
λ
(1.10)
In consideration of the Equations 1.9 and 1.10, the wavevector transfer Q is sim-
plified by the equation [153–156]
|Q| = 4 pi sinθ
λ
(1.11)
Making it dependent only on the scattering angle θ and the wavelength λ of the
incident beam.
The scattering of a neutron occurs in a three dimensional system therefore the
position of the scattered wavevector Ks is defined by a second angle φ, as reported
in Figure 1.13. As a consequence of this implementation, the Q value is also
expanded to a three dimensional system described by the equation [153]
|Q| = 4 pi sinθ
λ
(−cosθcosφ,−cosθsinφ, sinθ) (1.12)
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Figure 1.12: Scattering of a neutron beam from a single point material. For
each scattering angle θ, the neutrons are collected by the solid angle dΩ, partial
areas (in white) that compose the detector.
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Figure 1.13: Scattering geometry of the neutrons’ wavevectors with three
dimensional coordinates. The position of the solid angle dΩ is now described
by the two angles θ and φ.
Differential cross section. The number of scattered neutrons by an atom is
defined by the scattering cross section (σ) which is directly proportional to the
scattering length (b) of the atom, or more precisely of the isotope. The number
of scattered neutrons in all directions per second divided by the incident flux of
neutrons (I0) that hits the scattering center is defined as the total cross section
σtot. The scattered neutrons are collected by a detector which is divided in areas
called solid angles dΩ (Figure 1.12). In a neutron diffraction experiment the
actual intensity recorded by the instrument taking into account the spherical polar




number of neutron per sec in dΩ (2θ, φ)
I0 dΩN
(1.13)
where N is generic term to define the number of scattering units of interest [153].
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Scattering from assemblies of atoms. In a sample containing several scat-
tering centers, the total differential cross section for the coherent elastic scattering







bj exp(iQ · rj)
∣∣∣∣∣ (1.14)
where bj is the scattering length of the isotope in the position rj of the space
defined by the coordinates x, y, z, which produces a wave scattered in the direction
Kf [155]. The atom in position rj is referred to an arbitrary center rj = 0, 0, 0.
1.4.1.3 Nuclear scattering length and contrast matching.
The strength of the neutron scattering induced by a particular isotope depends
upon the value of its b [154, 156, 157]. The b value is isotope-specific, does not
vary simply with Z of the atom and depends upon the spin of the nuclei. In
Table 1.2 the scattering lengths of the H and D atoms are reported [158]; these
atoms have two b values because of their non-zero atomic spin [153, 157]. The two
scattering lengths are then combined to determine the average scattering length
(〈b〉) [153]. The rate of neutrons scattered by an atom or molecule is defined by
Table 1.2: Neutron scattering lengths of H and D according to their spin
quantum number (b+ and b-). Averaged values of the scattering length 〈b〉 and
their standard deviation ∆b.
b+ b- 〈b〉 ∆bi σcoh σincoh
(x10-14m) (x10-14m) (x10-14 m) (barns) (barns)
H 1.085 -4.75 -0.374 2.527 1.76 80.27
D 0.953 0.098 0.668 0.403 5.59 2.05
i standard deviation of b calculated as ∆b =
√
〈b2〉 − 〈b〉2 [157]
the scattering cross section σ, as mentioned in the previous section. The value
of sigma is proportional to the scattering length b of each atom, taken b as if
it was the radius of the nucleus as seen by the neutron. Using H and D atoms
as an example, they present two values of σ each defined as coherent (σcoh) and
incoherent (σincoh) scattering cross section. The σcoh and σincoh are defined by the
equations
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σcoh = 4pi 〈b〉2 (1.15) σincoh = 4pi (∆b)2 (1.16)
The coherent scattering is the scattering that carries most of the information about
the matter, whilst the incoherent scattering is a sort of variance of the σcoh and
adds a featureless background signal [153, 157]. The difference of the scattering
cross sections between H, D and other atoms (e.g. N, O, P,C) is at the basis of
the contrast matching variations applied in neutron experiments.
From the 〈b〉 it is possible to calculate the parameter scattering length density
(ρ), for a particle or material, which is the sum of the scattering lengths of the





of which the parameters are the atomic mass of the material m, the density (δ)
and NA is Avogadro’s number.
1.4.1.4 Contrast variation.
One of the key advantages of using neutrons for the analysis of complex structures
is the possibility to selectively label a molecule, or part of it, with isotopes that
have different ρ (also referred with the acronym SLD) and thus allow the neutron
beam to highlight or block specific regions of the molecules. One of the most
used contrast variations is between H and D, and it is extensively used to aid
the investigation of biological samples such as DNA, lipids and proteins [159–161].
The substitution of H with D within a molecule introduces limited chemical mod-
ifications but the scattering length densities of these two isotopes are markedly
different (see Table 1.2). Other naturally occurring isotopes such as 14N,16O,P,32S
and 12C have a positive 〈b〉 and can be exploited in neutron scattering experiments.
As an example, if fully hydrogenated lipid liposomes are dispersed in pure D2O ,
which has an scattering length density (SLD) of 6.35×10−6 A˚−2 , the total scatter-
ing intensity is given by the liposomes whereas the solvent has very low scattering
properties (Figure1.14) [157]. The different simplified contrast variation examples
reported in Figure1.14 are implemented by the possibility to match the SLD of
a mixture of H2O andD2O to the scattering length density of specific biological
molecules. For instance a mixture of approximately 40-45% D2O in H2O (v/v)
matches the SLD of proteins whereas a mixture of 13% D2O in H2O (v/v) would
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match the SLD of hydrogenated lipids. The matched molecules would not con-
tribute to the neutron scattering and the scattering profile contains no information
regarding these molecules. In some experiments (see Section 1.4.2) it is convenient
to use a 8% D2O in H2O (v/v) solution which has no scattering (SLD=zero) [162].




Low or no scattering 
(a) (b) (c) 
(d) 
(a) Fully hydrogenated lipids in D2O 
(b) Fully deuterated lipids in D2O 
(c) Chain hydrogenated with   
headgroup deuterated lipids in 
D2O 
(d) Fully deuterated lipids with 
hydrogenated membrane 
proteins in D2O 
Figure 1.14: Schematic illustration of simplified contrast variation options in
a neutron scattering experiment carried out on lipid liposomes and membrane
proteins.
1.4.2 Neutron reflectivity (NR).
A reflectivity curve defined as R(Q) vs Q is obtained from the specular reflection
of an incident neutron beam with a wavevector Ki that occurs at the angle θ,
or above, on a planar sample (Figure1.15). The planar samples of interest in
this thesis can be either monolayers of lipids at the air/water interface or bilayers
supported on a silicon block. The neutron SLDs of the layers are invariant on the
x and y plane but they change through the z axis, due to the presence of layers of
different materials. Specifically the neutron refractive indices in a NR experiment
are defined by the scattering length density SLD of each layer [153, 157]. The
neutron beam hits the layers and is reflected to different extents (i.e. intensity or
R(Q)) according to the specific scattering length density of the material that is
crossing. The reflectivity value R(Q) is obtained from the relation [153, 162]
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Figure 1.15: Schematic illustration of the specular reflectivity of a neutron
beam from the surface of layered samples at an angle θ respect to the x plane.
R(Q) ∝ 16 pi
2
Q2
∣∣∣∣∫ ∞−∞ ρz e−i z Q dz
∣∣∣∣2 (1.18)
where ρz is the ρ of the layer in the z position along the z axis. The reflectivity
is a function of the wavevector transfer Qz which is described in Equation 1.11.
According to the geometry of the instrument and the type of neutron source, the
value of Qz varies modifying the angle of incidence of the beam or its wavelength
(as it occurs on pulsed sources [156]).
As an example, Figure 1.16 reports a simulation of the reflectivity profile of an
arbitrary lipid bilayer on a silicon block. Most of the interfacial information can
be obtained by the fitting of the reflectivity profile to obtain an SLD profile of the
layers (Figure 1.16 b). The SLD profile is directly related to the distance (A˚) along
the z axis and gives information about the thickness, roughness and solvation of
a particular layer. The use of contrast variation is essential in NR experiments
in order to obtain as much information as possible for each layer, and produce a
more reliable mathematical fit which would provide a more accurate interpretation
of the SLD profile. The material from which the layer is composed can be either
hydrogenated or deuterated, or a mixture of the two. In this thesis partially
deuterated lipids will aid the investigation of the monolayers or bilayers formed by
the amphiphile LPS in conjunction with the contrast matching (Section 1.4.1.4)
in order to gain an insight into the structure and interaction of specific regions of
the LPS layer.
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Figure 1.16: Neutron reflectivity simulation of a lipid bilayer on a silicon
block: (A) the reflectivity profile, (B) the SLD profile divided according to the
different layers, (B) schematic representation of the layers.
1.4.3 Small-angle neutron scattering (SANS).
The SANS technique is one of the most popular neutron scattering methods to
study a wide range of materials, including biological structures, [157] with a reso-
lution in real space from 10 to 1000 A˚. The main advantages of the neutron small
angle scattering technique over that of X-rays reside in its lower beam energy (for
an equivalent wavelength) which reduces the radiative damage given to the sample,
and the possibility of isotope contrast matching. A simplified scheme illustrating
the set-up of a SANS experiment is shown in Figure 1.12.
The SANS technique allows one to ascertain the dimension, the shape and the
orientation of an ensemble of particles in solution through the measurement of
the intensity of the coherent radiation scattered in an elastic way by the atoms
constituting the aggregates. The intensity of the scatter is dependent only upon
the Q value and is described by the generalized expressions
I(Q) ∝ dσ
dΩ
= N V 2 ∆ρ2 P (Q) S(Q) (1.19)
∆ρ = ρp − ρs (1.20)
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where N is defined as the number of particles of volume V , the form factor (P (Q))
and the structure factor (S(Q)), whereas the ∆ρ is the contrast defined as the
difference between the scattering length of the particle and the solvent, respectively
ρp and ρs [154, 155, 157]. The term P (Q) describes the shape of the particles
and its mathematical expressions exist for many different shapes (rods, spheres,
ellipsoids) which will be described in more detail in Section 3.2.4. The term
S(Q) takes into consideration the inter-particle interactions and distances. In the
case of very dilute systems the structure factor is often considered equal to one
and therefore is neglected during the analysis of the SANS data [155, 159]. The
scattered radiation is collected by the two dimensional detector and its intensity
is radially averaged and processed through a Fourier transform method to obtain
the classical small angle scattering profile I(Q) vs Q. The scattering curve can
be mathematically described by fitting appropriate models and approximations
(see Section 3.2.4) to obtain structural information on the particles or aggregates
in dispersion. At small values of Q the scattering pattern retains information
on the large scale dimensions such as tens of hundreds of nanometers, whilst at
higher values the information pertains to small scale dimensions in the order of
angstroms.
1.4.4 Neutron sources and instruments.
The neutron scattering experiments described in this thesis have made use of a
reactor source and a pulsed accelerator source [155, 156]. The reactor source used
for the reflectivity experiments under description is the high-flux reactor at the
Institut Laue-Langevine (ILL) in Grenoble (France) which produces a continuous
flux of neutrons. The pulsed accelerator source used for the small-angle neutron
scattering and neutron reflectivity experiments is the synchrotron accelerated ISIS
source at the Rutherford Appleton laboratory in Oxfordshire (United Kingdom)
in which, due to the initial pulsed nature of the colliding proton beam, the flux
of neutrons is pulsed as well. In both cases the outgoing high energy neutron flux
is moderated by passing through a medium (water, heavy-water, liquid hydrogen,
methane, graphite) which modifies its initial kinetic energy and determines the
wavelength of the flux according to the Equation 1.5. These neutrons referred
to as cold neutrons [154] are useful in studying biological materials due to their
wavelength, low energy and a subsequent reduced radiation damage inferred to
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the sample.
1.4.5 Monolayer at the air/liquid interface formed by lipids
and amphiphiles.
The physical properties of lipids and other amphiphiles have been extensively char-
acterized using monomolecular films formed at the interface between air and an
aqueous subphase. This study is ordinarily achieved with the use of a Langmuir-
Blodgett (LB) trough. A standard LB trough consists of a trough made of a
hydrophobic material such as polytetrafluoroethylene (PTFE), which contains the
aqueous subphase. Two movable barriers made of polyoxymethylene (POM) are
controlled by the instrument’s software via a computer interface and move across
the surface of the subphase and can be closed at a controlled speed. The am-
phiphiles are deposited at the interface after first being dissolved in an organic
solvent, such as chloroform, and spread onto the clean subphase with the barri-
ers open at their maximum area. The evaporation of the solvent leaves the lipid
molecules arranged far apart from each other on the surface with the hydrophilic
region in contact with the aqueous phase and the hydrophobic region directed
upward to the air (Figure 1.17). A microbalance allows the measurement of the
surface pressure (Π) through the suspension of a Wilhelmy plate made of chro-
matographic paper into the subphase, so that any surface active agent present
on the surface will modify the Π. The barriers are closed at a constant speed
expressed in cm2/min, forcing the lipid molecules to get closer and closer (Figure
1.17); this results in an increase of Π which is recorded by the microbalance as a
downward force (F ) expressed in mN/m2, which acts on the Wilhelmy plate. The
F is determined by the equation
F = (δP g l w t) + 2 γ (t+ w) cosθ − (δS g l w t h) (1.21)
.
where the Wilhelmy plate’s dimension are given by w (width), l (length) and t
(thickness). The density δP of the material used to prepare the plate (in this case
absorbant filter paper) and the density δS of the subphase are included. The depth
of the immersion of the plate is represented by h and the surface tension is γ, g
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is the gravitational constant and θ is the contact angle between the plate and the
subphase’s surface [163]. The surface pressure of the monolayer is generated by
the increasing pressure of the monolayer on the surface γm opposed to the pressure
of the clean surface γ0 according to
Π = ∆γ = γ0 − γm (1.22)
.
Considering that the dimensions and the depth of the plate remain constant and
that the plate is completely wetted by the subphase (cosθ = 1) [163], the rela-
tionship between the change in force ∆F and the change in surface tension ∆γ
derived from Equation 1.21 is now simplified as
∆F = 2Π (1.23)
.
thus the change in force, in m/mN, is equal to twice the change in surface pressure
[163].
The LB trough is used to compress a monolayer of lipids at a constant temperature
while the surface pressure is monitored, producing what is called a P − Area
(Figure 1.17). The number of molecules spread onto the surface must be known
in order to associate the surface area of the trough with the area per molecule (Λ)
giving the plot P − Area.
When the barriers of the LB trough are fully open the molecules are separated by
large distances and they behave like a two dimensional gas, hence this phase is
called the gas phase. The compression of the barriers forces the molecules together
reducing their intermolecular distances and the interaction becomes stronger, in-
creasing Π: the molecules pack tighter and tighter until they reach the liquid phase.
Further compression leads to the formation of a condensed or solid phase in which
the amphphiles are highly organized, oriented normal to the subphase and the area
per molecule is reduced as they are compressed together. A compression over the
solid phase causes the collapse of the monolayer due to mechanical destabilization
[164] and its organization is lost, resulting in the loss of material into the subphase
and a sudden drop of surface pressure. During the condensed phase it is possible
to determine the limiting area per molecule through the interpolation (dotted line
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Figure 1.17: Surface pressure - area isotherms of a phospholipid film and
molecules in different phases. Dotted line: interpolation for the calculation of
the limiting area per molecule.
in Figure 1.17) of the P−Area graph at a constant pressure within the range 30-35
mN/m, which has been chosen as it is the approximate lateral pressure of a lipid
bilayer [165]. The limiting area per molecule of different amphiphiles varies widely
and results from steric factors as well as attractive and repulsive forces between
adjacent molecules and the molecules and the subphase [163]. Salts and counter
ions present in the subphase affect the intermolacular interactions in addition to
the intrinsic properties of the amphiphiles (headgroup charge and steric proper-
ties, saturation and number of the hydrophillic chains, particular groups present
in the molecule) [166–168]. Monolayers formed on the Langmuir trough provide a
good model for the behaviour of bilayers, since the surface pressure and the area
per molecule are comparable between the monomolecular film and the membranes
[169, 170]. Lipid monolayers at the air-water interface are an invaluable tool for
the characterization of films of amphphiles and the interaction with antimicro-
bial peptides, especially in combination with other biophysical techniques such as
neutron reflectivity and Brewster angle microscopy [164, 171–173]. Limited in-
formation are available regarding the characterization of monolayers composed of
LPS [21, 174] despite its central role as permeability barrier on the OM of Gram
negative bacteria (see Section1.2.2). Previous studies determined the role of in-
creasing concentrations of rough Re and smooth chemotypes of LPS in monolayer
composed of DPPC [175, 176] suggesting a fluidizing effect on the lipid at 25◦C and
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and an attractive interaction between the two molecules. Recently this technique
has been used in connection with other biophysical techniques (X-ray and neutron
reflectivity) in order to investigate the properties of LPS within a monolayer model
of the Gram negative bacterial outer membrane [21, 177].
1.5 Techniques used for studying the interaction
between LPS and CAPs.
1.5.1 Tryptophan fluorescence
The amino acid tryptophan (Trp) possess the strongest fluorescence intensity and
highest quantum yield compared to the other two aromatic amino acids pheny-
lalanine (Phe) and tyrosine (Tyr) [178]. The emission spectrum of Trp reaches its
maximum when the amino acid is excited at 295 nm. The wavelength of the max-
imum emission of Trp and its intensity are strongly influenced by the polarity of
the surrounding environment (Figure 1.18). In a non-polar environment (i.e. the
hydrophobic chains within a lipid membrane or the hydrophobic core of a protein)
the peak fluorescence intensity increases and it undergoes a hypsochromic shifts
towards a wavelength of approximately 300 nm.
If the Trp residues are exposed to a highly polar environment such as aqueous
buffers (Figure 1.18 B case 3), the emission spectrum possesses a lower maximum
intensity peak at longer wavelength (Figure 1.18 A) at approximately 350nm. The
alteration in the emission peak is due to the presence of the indole group in the side
chain of the amino acid. The indole presents two electronic emission states (T1
and T2) which contribute to the overall emission anisotropy of Trp. In a non-polar
environment the transition T2 is dominant because has a lower energy state and
contributes for the most of the emission, which occurs at shorter wavelength and
high intensity (blue shift). The presence of polar solvents induces the formation of
hydrogen bonding with the imino group of the cyclic molecule, reducing the emis-
sion energy state of the transition T1, which now will contribute the most to the
emission; this results in red shifts (higher wavelength) of the emission spectrum.
The sensitivity of tryptophan towards the polarity of the environment has been
extensively used in order to study the interaction between lipid membranes and
peptides [179]. More interestingly the interaction between CAPs and models
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Figure 1.18: (A) Emission spectra of indole in different environments: red in a
nonpolar, blue at the interface and black in a polar environment. (B) Transitions
T1 and T2 involved in the indole emission in different environments, example
with a micelle.
of bacterial membranes has been investigated to understand the depth of in-
sertion of the peptides into the bilayers [180–182]. The environment polarity
- dependent emission of Trp amino acids within the primary structure of pep-
tides and proteins is used to study the interaction between the antimicrobial pep-
tides LL37 and LFb and liposomes composed of mixtures of hydrogenated dipalmi-
toylphosphatidylcholine (hDPPC) and LPS . It is possible to relate the shift of the
fluorescence spectra of the Trp residues with the penetration of the peptides into
the bilayer as described above. The modified LL37 peptide used in this experi-
ment has a substitution of the original amino acid phenylalanine in position 17
with a tryptophan residue; this substitution has negligible effects on the struc-
ture and potency of the peptide relative its wild type [182] therefore it is a good
representative of the original peptide. The multifunctional antimicrobial peptide
LL37 interacts and disrupts natural and model bilayers driven by the electrostatic
interaction with negatively charged lipids [183, 184]. The wild type antimicro-
bial peptide LFb possesses two tryptophans in its primary structure [117] located
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within the six residues that comprise its active antimicrobial center and which are
located in the loop formed by the disulphide bridge [120]. Fluorescence studies
on the whole LFb peptide and the active hexapeptide, suggest that they prefer-
entially disrupt vesicles composed of negatively charged lipids upon insertion into
the bilayer [181]. Considering the LPS binding activity of LL37 and LFb (Section
1.3), this technique may aid the investigation of the insertion process of these two
peptides and its modulation in the presence of different chemotypes of LPS which
present a different core structure. Hence some information could be obtained on
the modulation of the LPS’s shielding role by the diverse oligosaccharidic compo-
sitions.
1.5.2 Solid state 2H NMR.
The 2H NMR technique is well suited to acquire information about the dynamic
(i.e. the degree of order of the lipid chains) of the lipid bilayer and the influence on
the lipid organization due to the interaction of membrane perturbating peptides
[185]. The selective isotopic modification, as in the case of lipid tail deuterated
D62DPPC , allows one to study the deuterium energy and resonance spectrum
and its perturbation induced by the surrounding carbon atoms in the acyl chains.
The 2H-C bond orientation is derived from the analysis of the 2H signal splitting
due to the intensity of the quadrupolar interaction with Carbon [186]. The lipid
dynamics are important in the case of membrane lipid hence the spectra are mostly
recorded for bilayers above the lipid Tm, when they are in the fluid phase [186]
and their mobility is maximized. The signal from the randomly oriented bilayers,
such in the case of multilamellar vesicles, is deconvoluted into a signal from an
oriented bilayers through a procedure called depakeing of the 2H NMR powder
spectra [187].
Figure 1.19 A shows a 2H NMR spectrum for a mixture of D62DPPC /hDPPC in
Tris HCl 10 mM pH 7,4, 1 mM MgCl2 at 45
◦C and the deconvoluted (or dePaked)
spectrum of the D62DPPC acyl chains allowing for the resolution of the signal
into well defined splittings; the splittings from the 2H of the carbons close to the
headgroup presents the largest value of residual quadrupolar splitting ∆νQ, with
a progressive reduction of frequence width along the chains towards to the bilayer
centre. The 2H NMR signal for D62DPPC containing bilayers below the Tm would
provide a powder spectra with no visible doublet splitting whereas the increase in
temperature over the Tm results in higher mobility of the acyl chains and more
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defined doublet splitting in the powder spectrum, as shown in Figure 1.19 A [188].
The increase in order of the acyl chains reduces the degree of freedom of the flexible
lipids producing the broadening of the dePaked spectrum, i.e. an increase in the
∆νQ frequency (Figure 1.19 A) [189]. The ∆νQ is directly related to a SCD in a













3 cos2θ − 1)〉 (1.25)
where e2qQ/h is the quadrupole coupling constant (167 kHz for 2H in a 2H-C
bond), h is Planck’s constant and θ is the angle between the D-C bond and the
bilayer normal [185, 190]. The calculation of the SCD allows us to obtain the profile
reported in Figure 1.19 B which expresses the order parameter as a function of the
acyl position for D62DPPC . The SCD profile provides a straightforward interpre-
tation of the acyl chain order within the bilayer, and the increase in SCD indicates
an increase in their order [186]. This technique is ideal to study the perturbation
induced on membrane mimetic multilamellar liposomes by peptides with different
function, origin and structure which can either increase [191] or reduce [192] the
order parameter SCD of the bilayers. In this thesis, specifically, the solid state
2H NMR technique is used to resolve the effect of antimicrobial peptides on a
liposome model of the Gram negative bacterial membrane [193–195]. Previous
investigations did not consider the presence of the LPS in the composition of the
membrane models hence these preliminary studies aim to address this issue.
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Figure 1.19: d62DPPC-hDPPC in Tris HCl pH 7.4, 1 mM MgCl2 at 45
◦C .
(A) Deuterium powder spectrum with the relative dePaked and the residual
spectra. (B) Example of the smoothed order parameter profile obtained from
the dePaked 2H NMR powder spectra.
1.6 Aims of the project.
In the light of the theoretical background, employing the methods described in
this Chapter, the aims of the project can be summarised thus:
• To test the inflammatory activation of cultured murine macrophages in the
presence of different concentrations of several LPS chemotypes to determine
the changes in bioactivity according to the structure of the endotoxins.
• To ascertain the possible anti-endotoxic role of LL37 and LFb in biological
experiments by stimulation of the cultured murine macrophages with pre-
mixed solutions of different LPS chemotypes and peptides, either LL37 or
LFb , at different concentrations.
• To study the colloidal structures formed by several LPS chemotypes in aque-
ous suspension by cryo-transmission electron microscopy (cryo-TEM) and
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SANS and investigate the effect of the addition of either LL37 or LFb on the
morphology of the LPS aggregates. These results will be examined in the
context of the theories of the conformational concept of endotoxicity and the
preliminary biological studies carried out on cultured murine macrophages.
• To study, at the molecular level, the interaction of LL37 and LFb with LPS-
containing membrane models by the use of fluorescence spectroscopy, solid
state NMR and neutron reflectivity. The study will focus on the understand-
ing of the kinetics and the mechanism of peptide/LPS interaction. These
data will provide insight into the effect of the physico-chemical features of
the diverse LPS chemotypes and peptides on the binding with the models.
• The combination of all the biophysical data to elucidate the mechanisms of
the respective peptide/LPS interaction.
Chapter 2
Preliminary study of cell
activation by endotoxins and the
effect of LL37 and LFb peptides.
2.1 Introduction.
LPS released from Gram negative bacteria stimulates a strong inflammatory re-
sponse in mammals by the activation of cells of the immune system such as mono-
cytes, macrophages and neutrophils, in addition to tissue cells such as endothelial
cells and fibroblasts [62]. The cell activation induces the release of inflammatory
mediators such as citokines, chemokines, prostaglandins and small molecules e.g.
anion superoxide (O−2 ), radicals (
•OH) and NO [62], all of them aimed at the
eradication of infection. The result of a severe Gram negative infection may lead
to an extensive release of LPS in the body fluids which would over-stimulate the
immune system above the limits of a normal physiological response, causing a life-
threatening pathological condition called septic shock which exacerbates into high
fever, hypotension and eventual organ failure [61] (Section 1.2.3).
Both smooth and rough chemotypes of LPS stimulate the expression of surface
receptors on neutrophils and monocytes in whole human blood [196] and induce
the release of citokines (TNF-α, interleukines) [197] escalating the inflammatory
state. The degree of inflammatory stimulation may be related to the structure
of LPS in the light of the fact that whole and partial structures of LPS exhibit
different toxicities in terms of cytokine release from cultured human peripheral
41
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blood mononuclear cells [198]. Different LPSs of synthetic and natural origin have
also exhibited either agonistic or antagonistic toxic activities on cultured J774.1
murine macrophages, depending on the structure of the endotoxin [22, 199]. With
the introduction of the “conformational concept of endotoxicity” (Section 1.2.3.1),
additional evidence has accumulated to support the structure-activity relationship
of lipid A , the endotoxic principle of LPS [84]. The molecular conformation of lipid
A determines the toxic or non-toxic effect of LPS, with a lamellar conformation
eliciting less toxicity than inverted cubic or hexagonal conformations (see Section
1.2.3.1). Naturally occurring endotoxins (rough or smooth chemotypes) contain,
in addition to the lipid A , the core oligosaccharide and the O-antigen regions,
which modulate the toxicity of the whole LPS molecule in vitro [200]. Although a
number of studies have concentrated on the immunostimulatory effects of natural
lipid A and synthetic derivatives [53, 86], very few investigations have focused on
the comparison of the biological activity of rough and smooth chemotypes of LPS
[196].
Nitric oxide (NO) is a multifunctional modulator of the inflammation, produced by
macrophages, which is involved in the antimicrobial response of the immune sys-
tem [201–203]. As a consequence of the role of NO as an immuno-modulator, the
in vitro inflammatory activation of J774.1 murine macrophages cells by LPS can be
quantified by the dose-dependent production of NO [204, 205]. The same biologi-
cal model can also be used to measure the inhibitory effects of diverse molecules
on the LPS-induced activation of the macrophages [204, 206]. Thus measuring NO
production by cultured macrophages can be employed as a screening method for
investigating natural and synthetic CAPs with possible combined antimicrobial
and anti-endotoxic roles, by determining their ability to reduce the inflammatory
response of immune cells in vitro [114, 152, 207].
In this study the release of nitric oxide from J774.1 cells was investigated in
the presence of different concentrations of several chemotypes of LPS, specifically
smooth 0111B4, rough Ra EH100, rough Rc J5 and deep rough Re lipid A-2Kdo ,
in order to determine any difference in the inflammatory response in relation to
their relative structure. The same LPS chemotypes were challenged with differ-
ent concentrations of the cationic antimicrobial peptides (CAP) LL37 and LFb to
determine their potential anti-endotoxic activity (see Section 1.3).
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2.2 Materials and methods
2.2.1 Materials
Rc LPS from E. coli J5 (purity: protein 1.4%, nucleic acid 0.340%, phosphate
7.3%, Kdo 5.9%), smooth LPS from E. coli 0111B4 (purity: protein 1.6%, nu-
cleic acid 1.7%, phosphate 2.8%, Kdo 1.5%) were obtained from Merck KGaA
(Darmstadt, Germany) and used without further purification. Ra LPS from E.
coli EH100 was obtained from Sigma-Aldrich Ltd. (Dorset, UK) and used after
purification following the method described in Section 3.2.2. Re LPS lipid A-2Kdo
was obtained from Avanti Polar Lipids (Alabaster, USA) and was used without
further purification. Phenol red free Dulbecco modified eagle medium (DMEM),
fetal bovine serum (FBS), L-glutamine, antibiotic formulation containing 5 mg/mL
streptomycin and 5000 unit/mL penicillin, 75 cm2 Cellstar R© polystyrene culture
flasks, Trypan Blue dye, 96-well polystyrene plate Cellstar R© either transparent
or black suitable for fluorescence measurement, 3-(4-5-dimethylthiazol-2-yl)-2-5
diphenyltetrazolium bromide (MTT), SDS and dimethyl formamide were all pur-
chased from Sigma-Aldrich Ltd. (Dorset, UK). Interferon gamma (IFN-γ) was pur-
chased from PepproTech (London, UK). Phosphate buffered saline (PBS) was pur-
chased from Gibco life technologies (Paisley, UK). Details of the peptides LL37 and
LFb are reported in Appendix B.
2.2.1.1 Culturing of J774.1 macrophages.
Murine macrophages of the semi-adherent cell line J774.1 were maintained in a hu-
midified incubator at 37◦C in a 5% CO2/95% air atmosphere. The culture medium
consisted of phenol red-free DMEM, supplemented with 10% heat inactivated FBS,
2 mM of L-glutamine and antibiotic formulation at a final concentration of 100
µg/mL streptomycin and 100 unit/mL penicillin. All the cell culture experiments
were carried out in phenol red free cell culture medium to avoid any interference
with the nitric oxide fluorescence assay (Section 2.2.1.3).
The cells were cultured in 75 cm2 flasks and the confluent cell monolayer (90%
viability) was removed for passages and for experiments by scraping. Cell via-
bility was evaluated with Trypan Blue exclusion dye which selectively traverses
the membranes of dead cells, resulting in a blue colour, whereas it does not pass
through the membrane of viable cells, which are not coloured. With the use of a
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microscope it is therefore possible to count the ratio of viable and dead cells and
evaluate the confluence of the cell monolayer [208]. In order to perform the MTT
or the NO experiments, the cells were seeded in transparent 96-well tissue culture
plates with 200 µL of cell culture medium, at a density of 5 × 104 cells per well
and incubated for 24 hours to allow for cell attachment. The cells were pretreated
with IFN-γ at a final concentration of 500 unit/mL for a further 24 hours before
further experimentation, in the light of the evidence that IFN-γ primes the cells
by causing over-expression of mCD14 and TLR4 receptors [198, 209].
2.2.1.2 MTT cell viability assay.
The MTT assay was performed to assess the percentage cell viability upon treat-
ment with different LPS chemotypes or peptides (either LL37 or LFb ). This test
is based on the reduction of the soluble yellow MTT compound to an insoluble
purple formazan dye by the NAD(P)H-dependent oxidoreductase enzymes, allow-
ing the quantification of viable cells. The formazan crystals, collected from the
supernatant of the cell culture, were then solubilized by the addition of SDS; the
intensity of the absorption at 570 nm of the resulting purple solution is correlated
to the cell viability [210]. For the proliferation assays, after the initial stimulation
with IFN-γ, the cells were treated either with each LPS chemotype at concentra-
tions of 1, 10, 100 and 1000 ng/mL, or with the peptides, either LL37 or LFb ,
at concentrations of 0.01, 0.1, 1, 10 and 50 µM. After 24 hours of incubation,
the old media was removed and replaced by serum-free media containing 12,5%
(V/V) of MTT obtained from a 5 mg/mL sterile stock solution in PBS. The plates
were incubated for a further two hours before the addition of 100 µL of 10% SDS
solution in 50% dimethyl formamide and incubated for 4 hours to dissolve the
dark-blue formazan crystals. Finally the absorbance at 570 nm was measured
with a plate reader spectrophotometer SpectraMax 190 (Molecular devices, Sun-
nyvale, Ca, USA), recording the absorbance at 630 nm as a reference wavelength.
All the tests were carried out in at least triplicate and compared with control
wells in which untreated cells were cultured. The percentage of viable cells was
calculated using the equation:
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where the numerator is the average absorbance of the experimental groups and
the denominator is the average absorbance of the control group.
2.2.1.3 Cell inflammatory activation: nitric oxide assay.
The stimulation of the production of NO induced by the LPS chemotypes 0111B4,
EH100, J5 and lipid A-2Kdo was investigated. The J774.1 macrophages were cul-
tured in the same conditions as described above (Section 2.2.1.1) and, after stimu-
lation with IFN-γ for 24 hours and removal of the stimulus, each LPS chemotype
was added in fresh cell culture medium at the final concentration of 1, 10, 100 and
1000 ng/mL of LPS.
The possible anti-endotoxic role of the peptides LL37 and LFb was assessed by
the measurement of NO production from J774.1 cells stimulated by LPS. The
cells were treated with 100 ng/mL of each LPS chemotype pre-mixed in the cell
culture medium with either LL37 or LFb at increasing final peptide concentrations
of 0, 0.01, 0.1, 1, 10 and 50 µM. The LPS/peptide mixtures were incubated at
room temperature for at least one hour prior to their addition to the plates. After
24 hours incubation at 37◦C , the 96-well plates were spun down at 1500 rpm for
5 min and the supernatants were collected and stored at -80◦C before the analysis
of the nitrite concentration.
NO levels were determined using a fluorimetric assay performed in black 96-well
plates suitable for fluorescence measurements. Aliquots of 100 µL of each sample
supernatant were transferred into the black plates, mixed with 10 µL of a 0.3 mM
solution of 2-3 diaminonaphthalene (DAN) in 0.62 M HCl and incubated at room
temperature with continuous mild shaking for 15 minutes. Post incubation, 20 µL
of a 3 M NaOH stop solution was added and the plate was read in a plate reader
fluorimeter using an excitation wavelength of 365 nm and an emission wavelength
of 410 nm. The amount of nitrite in each sample was calculated from a linear
calibration curve of known nitrite concentrations, made up in the same medium
used for the test samples.
Statistical analysis All the data were collected from at least three independent
experiments. The values are presented as means±SD (standard deviation) and
were analyzed using two-way ANOVA test and T-test by the use of the software
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Graph Pad Prism (version 5) . Values with P <0.05 were considered statistically
different compared to untreated cells.
2.3 Results
2.3.1 MTT assay.
The first analysis performed on J774.1 macrophages concerned the cell viability
upon addition of the different LPS chemotypes or peptides (Figure 2.1A and B).
The most cytotoxic activity was exerted by the LPS chemotype EH100 which
produced a reduction of cell viability to 84% at 100 ng/mL and the lowest viability
value amongst all the LPS chemotypes tested with a value of 61.7% at the 1000
ng/mL concentration. The second most cytotoxic LPS seemed to be LPS J5 with
a value of cell viability of 82.9% at the highest concentration of 1000 ng/mL.
The LPS 0111B4 and the lipid A-2Kdo had a cell viability above 89 % for all
the concentration tested. The LPS EH100 only showed a significant cytotoxicity
compared to the control (P<0.05) at 1000 ng/mL.
The MTT assay was also performed on the macrophages in the presence of the
peptides alone, either LL37 or LFb (Figure 2.1 B). LL37 is clearly more cytotoxic
than LFb , with a reduction of cell viability to 55.3% and 10.3% respectively at
the concentrations of 50 and 100 µM; whereas LFb showed the largest reduction
of cell viability to 59.8% at the highest concentration of 100 µM. Apart from the
LL37 case at the concentration of 50 µM , the cell viability below the concentration
of 50 µM was above 88% for both peptides. Only LL37 at 50 and 100 µM and
LFb at 100 µM were significantly cytotoxic compared to the control (P<0.001).
2.3.2 Nitric oxide assay.
The production of NO induced by LPS is related to the inflammatory activation of
J774.1 cells. In the same way the production of NO was measured in the presence
of the peptides alone to assess any inflammatory stimulation they might elicit. The
chemotype EH100 is possibly the most endotoxic LPS amongst all, showing the
highest production of NO already at the concentration of 1 ng/mL (Figure 2.2 A).
The least endotoxic chemotype is lipid A-2Kdo which presented a rather regular
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Figure 2.1: Cell viability measurement by MTT assay in the presence of (A)
different LPS chemotypes and (B) the peptides LL37 or LFb. “*” P<0.05. “**”
P<0.01. “***” P<0.001.
increase of NO production proportional to the LPS concentration (Figure 2.2 A).
The chemotypes 0111B4 and J5 showed a rapid formation of NO production which
plateaued above the 10 ng/mL concentration. The amount of NO elicited by LPS
EH100 was significantly higher from 0111B4 and lipid A-2Kdo at concentrations
up to 10 ng/mL (P<0.05) whereas the amount of NO elicited by LPS EH100
was significantly lower than LPS 0111B4 and higher than lipid A-2Kdo above the
concentration of 100 ng/mL (P<0.05). The amount of NO elicited byLPS EH100
was not significantly different from the NO induced by LPS J5, excluding the 1
ng/mL and 100o ng/mL concentrations (P<0.001) in which the NO production
was respectively higher and lower. The NO production induced by LPS 0111B4
was significantly higher than the NO induced by lipid A-2Kdo at the concentra-
tions of 10 and 100 ng/mL (P<0.01) whereas it was significantly lower than the
NO induced by LPS J5 only at 1 ng/mL concentration (P<0.001.). LPS J5 nitric
oxide production is significantly higher than the NO induction by lipid A-2Kdo
at 1,10 and 100 ng/mL concentrations (P<0.001.).
The 100 ng/mL concentration for each LPS chemotype had been chosen to be
tested with either LL37 or LFb to identify any anti-endotoxic, anti-inflammatory
activity of the peptides. The statistical analysis of this data set revealed that the
LPSs 0111B4, EH100 and J5 are not significantly different between each other
in terms of endotoxicity but they are all significantly more endotoxic than lipid
A-2Kdo (P<0.01).
Neither of the peptides LL37 or LFb induced, at any concentration, a statisti-
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Figure 2.2: Nitric oxide production of J774.1 cells in the presence of (A)
different chemotypes of LPS and (B) the peptides LL37 and LFb.
cally significant reduction of NO production in the presence of any LPS chemo-
types tested. The poor statistics outcome could be due to the high variability
that affected the measurements. Hence the trend observed in the data was not be
supported by any statistical test. Nevertheless it was possible to notice some dif-
ferences between the activity of the two peptides. The peptide LFb did not induce
visible reduction of NO production at any concentration, in the presence of all the
LPS chemotypes tested; moreover the peptide itself did not show an inflammatory
stimulation of the macrophages, reporting a maximum nitrite production of 5 µM,
equal to the value of the untreated cells. On the other hand LL37 induced an
inflammatory stimulation of the J774.1 cells at the highest peptide concentration
of 50 mM and a consequent production of 16 µM of nitric oxide, three times the
basal NO production (Figure 2.3 A). LL37 ’s increasing concentrations seemed to
reduce the production of NO of the macrophages stimulated with 0111B4 and
EH100 LPSs, whereas it did not have a visible effect in the case of cells stimulated
with lipid A-2Kdo; the peptide seemed to increase the production of NO in cells
treated with LPS J5 up to the peptide concentration of 1 mM, and induced a
decrease of inflammatory stimulus above the peptide concentration of 10 mM.
2.4 Discussion
The activation of the immune system by endotoxins is not only related to the
molecular conformation of the lipid A part of LPS, the endotoxic principle, which
showed toxic activity in the negatively charged cubic or hexagonal inverted state
and non-toxic activity in the lamellar state [91, 199]. In fact naturally occurring









































































































































































































Figure 2.3: Nitric oxide production of J774.1 cells stimulate with 100 ng/mL
of different LPS chemotypes in the presence of different concentrations of (A)
LL37 and (B) LFb peptides.
LPS is composed of the lipid A part connected to the core and O-antigen regions
which have been shown to influence the molecular shape of LPS modulating its
toxicity [198]. As revealed by X-ray diffraction experiments, a longer core region,
such as the one of Ra and Rc chemotypes, favors the lamellar conformation while
a shorter core region, such as the one of the Re chemotype, determines the forma-
tion of a cubic/hexagonal conformation [56]. The limitation of these data resides
on the fact that the experiments were carried out with non-physiological water
content and in the absence of solutes whereas the structure of LPS is affected by
both solvation and the solutes contained in the medium.
A detailed comparison of the pro-inflammatory activity of naturally occurring
smooth and rough LPS chemotypes with different structures is limited. Previous
investigations of Gomes et al. showed that the presence of 100 ng/mL of either
smooth or Re LPS from S. minnesota induced significant NO release from human
monocytes, but these data lack any comparison with other chemotypes or any ef-
fect of different concentrations [196]. Schromm et al. investigated the LPS-induced
cytokine IL-6 release from human mononuclear cells and showed that smooth LPS
from Salmonella friedenau (S. friedenau) has a stronger pro-inflammatory activity
than the Re LPS and lipid A from E. coli [199].
The preliminary biological experiments conducted in this study aimed to com-
pare the diversity of the pro-inflammatory activity of different chemotypes of LPS
in relation to their structure, by the measurement of the NO produced by LPS-
stimulated J774.1 murine macrophages. At the LPS concentrations tested, the
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chemotypes smooth 0111B4, Ra EH100 and Rc J5 produced a dose-response stim-
ulation of the macrophages characterized by the formation of a plateau of NO
concentration whereas the lipid A-2Kdo showed an exponential trend of the curve
(Figure 2.2 A) . In consideration of an ideal dose-response sigmoidal curve, the
first three chemotypes may have reached the final part of the sigmoid whilst the
lipid A-2Kdo may be still at the initial exponential phase of the sigmoid. This
suggests that the smooth, Ra and Rc chemotypes may have a more potent im-
munostimulatory effect than the Re lipid A-2Kdo .
The anti-endotoxic activity of antimicrobial peptides and their derivatives had
been subject of several investigations such as the work of Gutsmann et. al. [114]
which synthesized various peptides which inhibit the cytokine production induced
by different chemotypes of LPS by the induction of a lamellar phase of the en-
dotoxin aggregates. A similar activity was suggested for LBP on the release of
TNF-α from human mononuclear cells stimulated with Re LPS from E. coli [69].
Nagaoka et al. [250] studied derivatives of LL37 and their anti-inflammatory ac-
tivity reporting a reduction of expression of TNF-α and mCD14 induced by the
peptides in cultured RAW 264.7 murine macrophages stimulated by LPS 0111B4.
The preliminary data presented in this study compared the antimicrobial peptides
LL37 and LFb and their anti-inflammatory role on LPS-stimulated macrophages.
Despite the poor statistics, the data show that LFb is not as active as LL37 on the
modulation of the inflammatory response of the cells stimulated by several chemo-
types of LPS. Neither of the peptides induce a significant production of NO below
10 mM concentration and LL37 showed a slight reduction in nitric oxide produc-
tion from cells stimulated with LPS 0111B4, EH100 and J5, whilst LFb had no
anti-inflammatory activity at this concentration.
The data were not sufficient to draw any definitive conclusion. The J774.1 cell line
system is a simple and yet useful tool to test the inflammatory activity of LPS
nevertheless it may substantially differ from other cell lines or techniques used
in the literature . Other biological assays, such as tests from whole blood, may
complement the data presented in this chapter and give a more realistic model of
the system in consideration of the fact that in vitro cell culture tests may lack
components of the immune system response such as LBP (partially de-activated
in FBS), which is present in the blood. The anti-endotoxic role of the two pep-
tides tested could not be supported or rejected and further analyses are needed.
These preliminary investigations however suggested that these biological tests are
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great challenges for the peptides in consideration of the amount of interactive com-
pounds present in the culture medium. More sensitive detection techniques, such
as the use of antibodies for cytokines and mediators of the inflammatory response,
may help to reduce the uncertainty of these tests.
Chapter 3
Interaction of the cationic
antimicrobial peptides LL37 and
LFb with aggregates formed by
different chemotypes of
Lipopolysaccharide from E. coli
in solution.
3.1 Introduction
The outer membrane component lipopolysaccharide (LPS) of Gram negative bac-
teria is one of the most potent activators of the human immune system and the
ability to induce an uncontrolled inflammatory reaction which can worsen into se-
vere septic shock syndrome and organ failure [62, 198]. The biological activity of
LPS is attributed to the membrane-anchoring moiety of LPS, the lipid A, which is
the ’endotoxin principle’ of LPS [211].The common architecture of lipid-A consists
of the highly conserved glucosamine disaccharide connected to two phospates and
usually six fatty acid acyl and hydroxyacyl chains with 12 or 14 carbons [44], but
the fine structure can change according to the different bacteria and the environ-
mental conditions [212, 213]. LPS is a macroamphiphilic glycolipid which forms
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Figure 3.1: Representation of the possible conformations assumed by lipid A
and relative toxicity.
colloidal aggregates in aqueous environments, the morphologies of which are de-
termined by the conformation of the lipid-A and the headgroup region (Figure
3.1). Studies carried out on the lipid-A moiety [199] showed that in a conical/-
concave conformation of lipid-A with a critical packing parameter (CPP) > 1 [83],
the hydrophobe volume (acyl chain’s volume) is bigger than the hydrophobe area
(the optimal headgroup area) and the immune system activation is greater than
a cylindrical or conical/convex conformation which has a CPP < 1 : the rela-
tionship between molecular conformation of lipid Aand its toxic effect, developed
the notion of the “conformational concept of endotoxicity” [84]. These earlier in-
vestigations, that gave rise to the structure-toxicity relationship, were limited to
the lipid-A structure without taking into consideration the influence of a more
complex headgroup on the packing behavior of a whole LPS molecule, as in the
case of rough and smooth chemotypes of LPS.
More recent studies reported that rough LPSs and lipid A are not active as a
monomers, but exert their toxic function only if they are in an aggregated form
[65, 70] which interacts with the membrane of the immune system’s cells such as
macrophages and monocytes, but also with endothelial cells, fibroblasts and mus-
cular cells [62]. Biophysical investigations on several rough chemotypes of LPS, as
well as lipid-A, were carried out [56, 87] to determine the structural polymorphism
of endotoxin aggregates by X-ray diffraction in the presence of MgCl2 at different
levels of hydration and at different temperatures. These and more recent inves-
tigations [84, 85] suggest that cubic and non-lamellar aggregate morphologies of
LPS exhibit greater toxicity than lamellar. The concept of morphology-dependent
toxicity of LPS aggregates introduced new possibilities for the study and develop-
ment of anti-endotoxic agents which interact with LPS aggregates. An emerging
therapeutic approach to reducing the LPS-mediated inflammation focuses on the
investigation of the anti-endotoxic role of CAPs. In addition to their anti-infective
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role [96], CAPs interact with LPS in a way which results in a reduced toxicity of
the aggregates [214–216].
In particular, the CAP LL37 is an amphiphatic α-helical peptide of human origin,
a member of the cathelicidin family [138], which is released by neutrophils and
epithelial cells upon digestion its pro-protein hCAP-18 [137]. LL37 shows multi-
functional properties including antimicrobial activity against Gram negative and
Gram positive bacteria [144, 146], binding and transport activity of DNA [142],
cell signaling [147, 217] and the capacity of binding LPS, which results in reduced
immune system response both in vitro and ex-vivo [115, 152, 218, 219].
The cationic peptide lactoferricin (LF) is derived from the N terminus of both
human and bovine lactoferrin proteins [117]. The bovine LF (LFb ) has an am-
phiphilic β-sheet structure [119] which allows an interaction with E. coli membranes
[125] resulting in a bactericidal activity [118] highly dependent on the structure of
LPS in terms of size of the oligosaccharidic moiety and number of negative charges
in the core region [129]. Despite the fact that α-helical peptides seem to have more
potent anti-endotoxic activity than β-sheet analogs [220], LFb peptide showed
strong anti-inflammatory activity against LPS-stimulated cells ex-vivo [116]. The
human analog of LFb neutralizes the LPS from E. coli 0111B4 in vitro and in
vivo [221] hence interaction studies were performed to understand its possible
anti-endotoxic role [207, 222]. Despite the stronger affinity for LPS of the bovine
lactoferricin LFb [134] these types of the interaction studies are absent, neglecting
its possible antiseptic function. The comparison between the peptides LL37 and
LFb would help to explain the mechanism of action of CAPs as anti-endotoxic
agents and the higher efficacy of α-helical conformation.
Studies on aggregates of LPS in solution have previously been conducted using
several biophysical techniques such as X-ray diffraction, electron microscopy, in-
frared and fluorescence spectroscopies, as well as biological toxicity tests. In order
to achieve a good scattering pattern from the sample during an X-ray experiment,
the concentration of lipid A or LPS has to be very high, up to approximately 100
mg/ml. High intensity difractometers allow the reduction of LPS concentration
down to 10-20 mg/ml. Alternative techniques such as SANS can be also used
to perform similar experiments at even lower concentrations of LPS than those
used in X-ray experiments, allowing for the use of more physiologically relevant
concentrations of endotoxin.
Previously only two groups, Hayter et al. [223] and Labischinski et al. [224], used
SANS to determine the structure of colloidal LPS aggregates in solution. These
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two studies presented data for fully hydrated Lipid-A and Re LPS. The amount
of amphiphile in solution was as low as 1 mg/ml, a value which is more physiolog-
ically relevant than the concentrations used in X-ray experiments. Labischinski
et al. found that fully hydrated lipid A at neutral pH above and below the Tm
forms lamellar structures of about 50 A˚ in thickness with interdigitation of the
acyl chains. Previous X-ray data for free lipid-A in the presence of low concentra-
tions of MgCl2 confirmed the presence of lamellar structures [59]. Furthermore,
at temperatures above 37◦C , the scattering curves showed Bragg reflections char-
acteristic of a coexisting cubic and lamellar phases. Hayter found that 10 mg/ml
of fully hydrated Re LPS in its NaCl salt form, at neutral pH (25◦C ), builds up
tubular micelles with a diameter of approximately 100 A˚ which seem to stiffen
and form pairs above pH 9.0. More recently, small-angle X-ray diffraction of Re
LPS at 24 mg/ml in the presence of MgCl2 at temperatures up to 55
◦C confirmed
the formation of lamellar structures for this chemotype of LPS [59]. A direct com-
parison of these different studies is not possible due to the different conditions and
salt concentration used, which strongly affect the packing of LPS and thus the
morphologies of the aggregates [25].
Electron microscopy techniques are useful in order to visualize colloidal agger-
gates and aid the interpretation of data obtained from small angle scattering ex-
periments. Cryo-TEM can be combined as a complementary technique to SANS
experiments. Previously, electron microscopy investigations have been carried out
in order to understand the structure of LPS in solution [225–227]. Effects of salts
[57] and peptides [228, 229] on LPS aggregates have been analyzed using trans-
mission electron microscopy (TEM), cryo-TEM and freeze fracture transmission
electron microscopy (ff-TEM). The diversity of the conditions applied makes it
difficult to compare the results of these studies therefore a generalized conclusion
from the literature cannot be drawn easily.
The experiments presented in this chapter investigate the suprastructure of three
diverse chemotypes of LPS in solution : a smooth chemotype of LPS from E.
coli 0111B4 (LPS 0111B4), a rough full-core chemotype from E. coli K12 D21
(LPS D21) and a deep rough LPS from E. coli K12 D21e7 (LPS E7), which struc-
tures are reported in Figure 1.5. SANS experiments and cryo-TEM methods are
combined to gain further insight into the structure of LPS aggregates. The same
techniques are used to study the interaction of two CAPs, LL37 and LFb , with
the aggregate of the LPS chemotypes. The aim is to define the morphological
changes induced by the peptides and to relate these changes to their putative
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anti-endotoxic activity.
3.2 Materials and Methods
3.2.1 Materials
LB broth, Kimax R© boro-silicate centrifuge tubes, liquefied phenol ≥ 96% pure ,
deuterium oxide D2O 99.990 atom % D and magnesium chloride anhydrous were
all purchased from Sigma-Aldrich Ltd. (Dorset, UK). The ultrapure water at 18.2
MΩ · cm was produced by a Purelab Ultra machine from ELGA process water
(Marlow, UK). The Spectra/Por 6 dialysis membrane with a MWCO of 1000 Da
was purchased from Spectrum Laboratories (Houston, USA). LPS 0111B4 was
purchased from Merck KGaA (Darmstadt, Germany). Petroleum ether (40-60
degree) was obtained from VWR International (Soulbury, UK). Chloroform and
diethyl ether were obtained from Fisher Scientific (Loughborough, UK). Details of
the peptides LL37 and LFb are reported in Appendix B.
3.2.2 Extraction of rough LPS from E.coli
The liquid phenol-chloroform-petroleum ether (PCP) extraction of Galanos et. al.
[230] is the extraction method best suited for rough chemotypes of LPS such as
LPS D21 and D21E7. However contaminants remain present at the end of the
PCP extraction especially nucleic acids which co-partition in the same phase as
LPS [231]. SDS-gel electrophoresis showed that proteins were still present after
PCP extraction (see Appendix A) and the spectroscopic quantification of nucleic
acids through the absorbance at 260 nm, revealed up to 29.1% (by weight) of nu-
cleic acid in the final extract of LPS D21 (data from two extraction). Therefore
in order to achieve a higher degree of purity, a few additional steps adapted from
the Darveau LPS extraction method [232] were added to the Galanos method.
The E. coli K12 mutants D21 and D21e7 were incubated at 37◦C in a 100 mL
pre-culture of LB media in the presence of 15 µg/mL ampicillin under continuous
mild shaking at 100 rpm. The optical density of the pre-culture was checked by
the use of a Jenway 6300 spectrophotometer (Bibby Scientific, Staffordshire, UK)
Chapter 3. SANS and cryo-TEM of LPS and peptides 57
until the mid-logarithmic phase was reached, corresponding to an O.D.600 of ∼ 1.
Pre/culture aliquots of 20 mL each were then transferred into four 1.25 L flasks
containing LB media with 15 µg/mL ampicillin and incubated at 37◦C for 8 to
10 hours under constant agitation at a speed of 170-200 rpm. After inoculation,
the bacterial pellet was collected by centrifugation at 9000 rpm for 15 minutes at
15◦C by the use of a Beckman J2-HS centrifuge (Beckman Coulter Inc, Pasadena,
USA) before being washed with 400 mL of deionized water and recentrifuged twice
to remove the excess LB media. The wet pellet was then transferred into one 50
mL polypropylene vials and washed with ethanol followed by acetone. To aid the
re-suspension of the cell pellet during this washing step a homogenizer was used.
Subsequently the pellet was centrifuged bu the use of a Boeco U-320 bench cen-
trifuge (Boeco, Hamburg, Germany) at 1000 rpm for 20 minutes at 4◦C , then it
was frozen thoroughly in liquid nitrogen and lyophilized with a Heto Powerdry
LL3000 freeze dryer (Thermo Scientific, Wilmington, USA). The resultant dry
product weighed approximately 1000-2500 mg.
Each gram of lyophilized pellet was homogenized in a 10 mL mixture of phenol,
chloroform and petroleum ether (2:5:8 v/v/v), followed by mixing on a magnetic
stirrer for two hours in a fume hood. The suspension was then centrifuged by
the use of a Beckman J2-HS centrifuge (Beckman Coulter Inc, Pasadena, USA)
in 35 mL Kimax R© boro-silicate centrifuge tubes at 5.000 rpm for 15 min and the
supernatant containing the LPS was collected in a 250 mL glass round bottom
flask. This extraction from the addition of the PCP mixture to the dry pellet
was repeated twice, homogenizing the residual pellet and finally combining the
supernatants from each replicate. Ether and chloroform were removed from the
supernatant on a rotary evaporator at 40◦C . During this process it is possible that
some water from the phenol solution is also evaporated, causing the crystallization
of the phenol. If this happens a small amount of water has to be added until the
crystallized phenol returns to its liquid state. The concentrated phenolic phase,
which should be of a pale, transparent yellow color, was transferred back into a
clean glass tube and ultrapure water was added dropwise until the LPS started to
precipitate. This suspension was allowed to sediment overnight at room temper-
ature. The precipitate was centrifuged at 3000 rpm for 40 minutes yielding in a
white pellet containing LPS which was carefully washed three times with diethyl
ether to remove any excess phenol. The pellet was then suspended in 50 mL of
ultrapure water and dialyzed overnight in 30-32 cm Spectra/Por 6 dialysis mem-
brane against 10 L of ultrapure water to further reduce the quantity of residual
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phenol.
The aqueous suspension of LPS was lyophilized and then resuspended in 25 mM
Tris HCl , 10 mM MgCl2 at pH 7.4. An enzymatic digestion was performed in
order to remove the residual nucleic acids and proteins by adding sufficient en-
zymes to give a final concentration of 50 µg/mL RNAse and 30 µg/mL DNAse.
The suspension was kept at 37◦C for 5-6 hours under constant agitation. Subse-
quently proteinase K was then added to reach a final concentration of 50 µg/mL
of enzyme and incubated for 12 hours at 37◦C under constant agitation. After
the enzymatic digestion, the mixture was deactivated in a water bath at 60◦C for
1.5 hours followed by further dialysis against ultrapure water before finally being
lyophilized. Another PCP extraction was then performed to remove the residual
enzymes and any digestion products which would partition into the supernatant.
The pellet containing the LPS was collected upon centrifugation, resuspended in
ultrapure water and dialyzed thoroughly. The suspension was then spun down
with a Beckman L8-M ultracentrifuge (Beckman Coulter Inc, Pasadena, USA) at
42000 rpm for 4.5 hours at 14◦C . The resulting pellet had a transparent-yellow
color and contained the purified LPS. This pellet was re-suspended in the appro-
priate volume of ultrapure water and lyophilized.
The purity of the extracted LPS was verified spectrophotometrically using a a
Nanodrop 1000 spectrophotometer (Thermo Scientific, Wilmington, USA). The
protein content was measured using a bicinchoninic acid (BCA) Pierce protein
assay kit (Thermo Scientific, Wilmington, USA) while the measurement of the
nucleic acid content was performed by recording the absorbance at 260 nm. The
purity of the LPS 0111B4 was measured following the same method. LPS 0111B4,
D21and E7 had an average protein content of respectively 2%, 2% and 1.6% while
the nucleic acid content was calculated to be respectively 1.95% 2.22% and 2.52%.
The average yield of the extraction for LPS D21 and E7 was approximately 0.36%
and 1.91% respectively according to the total mass of the dry bacterial pellet.
3.2.3 Cryo-transmission electron microscopy (Cryo-TEM)
The samples for cryo-TEM, prepared according to the technique described in the
next section (Section 3.2.4), were processed and analysed as follows. The cryo-
genic transmission electron microscopy (cryo-TEM) investigations were performed
by collaborators in the group of Prof. Katarina Edwards in the Department of
Chemistry of the University of Uppsala using a Zeiss Libra 120 (Carl Zeiss NTS,
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Oberkochen, Germany). The microscope was operating at an accelerating voltage
of 80kV and in zero loss bright-field mode. Digital images were recorded un-
der low dose conditions with a slow-scan CCD camera (TRS GmbH, Moorenweis,
Germany) and iTEM software (Olympus Soft Imaging Solutions GmbH, Mnster,
Germany). An under-focus of 1-2 µm was used to enhance the image contrast.
The cryo-TEM specimen preparations were performed in a custom-built climate
chamber at 25◦C and approximately 98-100% relative humidity. A small drop (∼1
µl) of sample was deposited on a copper grid covered with a carbon reinforced ho-
ley polymer film. Excess liquid was thereafter removed by means of blotting with
a filter paper, leaving a thin film of the solution on the grid. Immediately after
blotting the sample was vitrified in liquid ethane, held just above its freezing point
of 182◦C . Samples were kept below -165◦C and protected against atmospheric con-
ditions during both transfer to the TEM and examination, where representative
images for the samples were acquired. Full details of the technique are described
in Almgren et al. [233].
3.2.4 Small-Angle Neutron Scattering (SANS)
The SANS measurements presented in this chapter was carried out on the LoQ
instrument at the ISIS pulsed neutron source at the Rutherford-Appleton Lab-
oratory (Oxon, UK) [234]. This instrument produces an incident neutron beam
with wavelengths of 2.2 - 10 A˚ in time of flight mode. The instrument has a very
broad range in scattering vector resulting in wide Q range of approximately 0.01
- 0.34 A˚−1 ; this can be achieved in one single measurement without the need of
changing the settings of the instrument (i.e. the position of the detector). The
beam is collimated into the sample after being framed at a defined beam size. The
64 cm2 active area of the detector is placed at 4.1 meters from the sample into a
vacuum tube. A second detector placed at a closer position records the scattering
at higher Q [235].
The aggregates of LPS were prepared for SANS using the thin film hydration
method and re-suspension in D2O containing 1mM MgCl2 as counter ions for the
charges present in the endotoxin’s headgroups. The experiments concerning the
effect of the dilution on the scattering pattern of LPS were carried using LPS
concentrations of 4, 6, 8 and 10 mg/ml. For the interaction study with the pep-
tides LL37 or LFb , an LPS concentration of 6 mg/ml was used and each peptide
was added at the LPS/peptide ratios (w/w) of 50/1 and 10/1. The peptides were
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allowed to interact with the LPS for at least one hour prior to measurement in
the neutron beam. The samples were placed in cleaned quartz cells of 1 mm path
length and the scattering pattern was recorded at 37◦C with an acquisition time
of at least one hour. The transmission and background scattering from the saline
solution and solutes were subtracted from the samples prior to analysis.
3.2.4.1 Data analysis
Analysis of the SANS data was performed via the simple observation of the char-
acteristic features of the scattering pattern, but also with the manipulation of
the scattering curves by means of mathematical approximations of SANS data,
which apply particular plotting in order in order to determine sample parame-
ters by approximating the characteristic scattering patterns from defined colloidal
morphologies. This type of data manipulation is implemented together with a
more detailed analysis of the scattering curves which required the use of specific
software in order to apply complex mathematical modeling to the SANS data.
These models yielded more detailed information on the aggregate morphologies.
However, in some cases, the sample contained numerous complex morphologies
and therefore both the simple approximations and the more complex model fitting
must be considered as providing only approximate parameters.
Analysis of elongated objects The first type of manipulation implemented
for the study of scattering data was the Guinier approximation. This analysis is
more suitable for spherical form factors, nevertheless this it can be modified for
the analysis of elongated particles such as rigid rods. The Guinier approximation
for an assembly of identical particles is
∂Σ
∂Ω







where (∆ρ) is the SLD difference between the solute and the solvent, V is the
volume of one scattering centre and N is the number of scattering centres, Rg is
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where the parameters are the molecular weight of the object M , the volume frac-
tion (φ), Avogadro’s number NA, the length L and δ as the density of the molecule
in g/cm3. The plot ln[(δΣ/δΩ)(Q)] vs Q2 would result in a straight line at small
values of Q2 for a limit of Q×Rg <
√
3. The straight line at small Q2 values can









However this approximation has some limitations. The anisometry of the scatter-
ing centres and the inhomogeneous distribution of their SLDs require an alternative
analysis. Moreover the rigid rods approximation is possibly not the most accurate
representation of more flexible objects. Therefore the Kratky-Porod worm-like





















Figure 3.2: (A) Representation of a worm-like chain formed by n segments
of length l. (B) Possible cross sections for elongated objects with description
of the core/shell cross section. (C) Axial ratio in the case of an elliptical cross
section.
Figure 3.2 A shows a schematic representation of an elongated object of number
of segments (n), Khun length (l) and contour length (L) which are the same
parameters described by the Kratky-Porod model. Figures 3.2 B and C describe
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also the possible cross sections that an elongated object can have. The cross
sections can be either cylindrical or ellyptical depending upon the ratio between
the X and Y radii of the section; a cross section can be also formed by an inner
core and an outer shell distinguished by a core radius (rc) and a shell thickness
(ts). The Equation 3.6 is simplified for infinitely long chains in the intermediate-
high Q range with limits of Q > b−1 where b, the persistence length, is half of the
l factor (see Figure 3.2 A), hence it becomes
∂Σ
∂Ω






where ML is the mass per unit length equal to M/n and c is the concentration
of solute in g/ml. In order to incorporate the cross sectional radius of gyration























(3.10) intercept = ln
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This approximation is valid if it is linear at high Q2 values and for a limit of
Q × Rg,xs < 1.1; the value of Rg,xs allows the calculation of the radius of the
elongated object R =
√
Rg,xs. In addition the intercept can be used to determine
the mass per unit length ML [238] in Da/A˚ as
ML =
1000 intercept δ2 NA
pi C (ρworm − ρsolvent)2 (3.12)
where C is the concentration in g/L.
Following the data approximation it is logical to try to apply a more defined
mathematical model to fit the scattering curve in order to maximise the amount
of extractable information from the SANS data. The Kratky-Porod theory is at
the base of the Kholodenko worm-like chain models [239] used in the FISH software
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and applied to elongated flexible objects. Two different Kholodenko models are
available whether the chain is considered as having a uniform SLD or differing
SLDs between the core and the shell region (see Figure 3.2 B). The model with
the uniform SLD presents the scale factor:
scale = 10−24 φ (ρworm − ρsolvent)2 (3.13)
while the core/shell model presents a scale factor of
scale = 10−24 φcore (ρ1 − ρ2)2 (3.14)
and a contrast of
Contrast =
(ρ2 − ρ3)
(ρ1 − ρ3) (3.15)
where ρ1, ρ2, ρ3 are respectively the core, shell and solvent scattering length den-
sities in cm-1.
Analysis of lamellar aggregates A lamellar aggregate is considered to be
formed by at least one bilayer of amphiphiles in which the core hydrophobic re-
gion contains the acyl chains and the shell hydrophilic region is composed of the
headgroups, in contact with the aqueous bulk. Such a structure could be repeated
indefinitely to form stacks defined by the space in between the bilayers (d-spacing)
with a core thickness (tc) and a ts (Figure 3.3). In our specific case the core of the
lamellae consists solely of the hydrocarbon chains of LPS while the shell of the
bilayer is composed of the the Core region and eventually the O-antigen region of
the oligosaccharide headgroup.
Figure 3.3: Representation of bilayer structure with shell/core/shell features.
Shell and core have different SLDs.
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Again a Guinier approximation can be used as a first attempt in order to obtain
















The plot ln[Q2 × (δΣ/δΩ)(Q)] vs Q2 allows for the calculation of Rg as Rg =√−2× slope. In this case the criteria for the validity of the approximation are
0.41 < Q×Rg < 0.92.
In the mathematical model provided by the fitting software used for the fitting
of neutron scattering data as monodisperse oriented sheet with a shell/core/shell
feature (Figure 3.3), the neutron scattering intensity IQ is calculated as:
I(Q) = I(Q) + Scale · LN(Q) · f 2(Q) (3.18)
where Scale is the scale factor defined by the model, LN(Q) is a Lorentzian factor
which considers a random orientation of the sheets and f(Q) is the molecular form










in which l1 and ts are respectively the core and the shell thickness, therefore the
total thickness (T ) is T = tc + 2ts; ρ1 and ρ2 are the scattering length densities
of respectively the hydrophobic and the hydrophilic regions of the LPS molecule
(Appendix D), whilst ρ3 is the solvent scattering length density. The main pa-
rameters for this model are tc and ts, Rσ which is a parameter that describes the
uniformity of an object, the contrast is expressed as
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Contrast =
(ρ2 − ρ3)
(ρ1 − ρ3) (3.20)
and the scale factor
Scale factor = 10−32 · Π · (ρ1 − ρ3)2 · S · (Rσ)2 (3.21)






in the case of a truly infinite sheet; it is therefore possible to calculate back the φ
in order to check the validity of its calculated value.
3.3 Results
3.3.1 Cryo-TEM
The analysis of Cryo-TEM micrographs of the three LPS chemotypes 0111B4, D21
and E7 at the concentration of 6 mg/ml in the absence or presence of peptides
LL37 and LFb at a weight ratio of LPS/peptide 10/1 in 1mM MgCl2 saline solu-
tion revealed diverse populations of aggregates (Figures 3.4 and 3.5 to 3.10), the
morphologies of which differed according to the LPS chemotype and the peptide
added.
3.3.1.1 Cryo-TEM of LPS 0111B4 and peptides
LPS 0111B4 at a concentration of 6 mg/ml in saline solution containing 1mM
MgCl2 forms elongated worm-like micelles (Figure 3.4 A) with an approximate di-
ameter of 150 A˚; it must be considered however that the precise diameter value can
not be calculated directly from the micrograph because of the low resolution of the
image and the possibility that the micellles are flattened or twisted. However it is
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A B
C
Figure 3.4: (A) Cryo-TEM micrographs of smooth LPS 0111B4 at 6 mg/mL
in aqueous solution containing 1 mM MgCl2 at 37
◦C forming elongated micelles
(black box). (B) and (C): the arrows show details of the structures such as
branches and interparticles spaces.
possible that the O-antigen is not truly visible and therefore the measured diam-
eter is an underestimation of the actual one. Nevertheless the diameter seems to
be realistic in consideration of the dimensions of the whole molecule. The micelles
are branched (Figure 3.4 B) and have the tendency to form connected structures
which could be described as torroidal or torroids, depicted in Figure 3.6, which re-
semble loops of regular or irregular shape and different sizes. Smaller particles are
also present which could be either the product of the disruption of larger micelles,
or could represent new micelles in formation. Being a two dimensional image of
a three dimensional system, the orientation which the particles can assume has
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to be taken into consideration. Some smaller particles may actually be visual
artefacts made of the axial view of elongated micelles. When the micelles are not
connected there are large inter-particle spaces (around 400 A˚, see Figure 3.4 C)
the dimensions of which can be measured between two parallel micelles.
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A LPS 0111B4 with LL37
B LPS 0111B4 with LFb
Figure 3.5: Cryo-TEM micrographs of LPS 0111B4 at 6 mg/mL in aqueous
solution containing 1 mM MgCl2 at 37
◦C with addition of the peptides at a
LPS/peptide ratio of 10/1. The addition of LL37 (A) or LFb (B) reduces the
length, diameter and the number of branches of the micelles.
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The addition of LL37 peptide to LPS 0111B4 (Figure 3.5 A) prevented the forma-
tion of toroids and connections between the elongated micelles and the number
of branched structures decreased in comparison to the LPS alone. The peptide
appeared to halve the diameter of the chains to approximately 80 A˚. The peptide
LL37 also shortened the length of LPS 0111B4 micelles, augmented the number
of small objects and reduced the inter-particle space. The peptide LFb induced
a smaller reduction of the diameter of the micelles, to 115 A˚ LFb had a lesser
impact on the length of the particles than LL37 (Figure 3.5 B) and it seemed to
cause a closer packing of the aggregates, with a visible reduction of the inter-
particle spaces. Frequently the micelles appeared connected and branched even in
the presence of LFb peptide but there are no sign of toroidal structures or loops.
LFb peptide as well as LL37 increased the number of smaller structures or frag-
ments, probably due to the detergent-like activity of the peptides in disrupting
the micelles.
A B C
Figure 3.6: Diverse type of toroids: (A) irregular and (B) regular. (C) Dimen-
sion of the toroid with the toroidal internal diameter D Int. and the diameter
of the micelle D.
3.3.1.2 CryoTEM of LPS D21 and peptides
The LPS D21 at a concentration of 6 mg/mL in saline solution containing 1 mM
MgCl2 forms mainly sheet-like structures distributed as single lamellae, possibly
coexisting with toroids as outlined in the black boxes in Figure 3.7. The resolution
of the micrographs does not allow a more precise definition of such a structure,
which in this case could be mistaken for ripples or undulations of the lamellae.
In the micrograph the presence of small white holes, or dots, in the sheets is due
to the effect of radiation damage on the sample; they can be easily distinguished
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from toroids and pores because of their white clear background.
Figure 3.7: Cryo-TEM of LPS D21 at 6 mg/mL forming sheet-like structures
(upper black boxes) coexisting with toroids (lower black box) in aqueous solution
containing 1 mM MgCl2 at 37
◦C .
The peptide LL37 induced the formation of a mixture of organized and irregular
toroids (Figure 3.6 A and B) opening up into elongated micelles. The micelles
forming the toroids had a diameter (D) of ∼77 A˚, however it was not possible
to measure the inner diameter of the toroids because of the wide range of sizes
and shapes. Toroidal structures were the most commonly visible structures with
patches of uneven shapes and others with a more regular and ordered structure;
some micelles were visible free from the network and formed elongated structures.
The situation in the presence of LFb peptide (Figure 3.6 B) showed a much more
regular structure than in the presence of LL37 . The toroids formed appeared much
more uniform in terms of shape and dimensions, with an homogeneous toroidal
pattern; the micelles forming the toroids had a diameter of approximately 82 A˚ and
the toroidal internal diameter was approximately 78 A˚; this structure resembles
lamellae which have been perforated by closely packed pores.
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A LPS D21 with LL37
B LPS D21 with LFb
Figure 3.8: Cryo-TEM micrographs of LPS D21 at 6 mg/mL in aqueous solu-
tion containing 1 mM MgCl2 at 37
◦C with addition of peptides at a LPS/peptide
ratio of 10/1. (A) addition of LL37: formation of elongated particles closing up
into irregular toroids (black boxes). (B) addition of LFb: regular toroids.
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3.3.1.3 Cryo-TEM of LPS E7 and peptides
The LPS E7 at a concentration of 6 mg/mL in aqueous solution containing 1 mM
MgCl2 forms irregular sheets with an undulating surface (Figure 3.9); possible
toroidal structures are highlighted in the black boxes on the micrograph, however
these could be artefacts due to the irregular surface of the bilayer. The addition
of the peptide LL37 caused the formation of mixed sheet-like structures together
with irregular toroids and elongated micelles, the latter having an approximate
diameter of 90 A˚ (Figure 3.10 A). LFb peptide added to LPS E7 induced the
formation of mixed irregular sheets and very thin elongated structures for which
the inter-particle space was not clearly distinguishable and it was not possible to
measure the diameter of these chains from the micrographs (Figure 3.10 B). The
micrographs showed a few patches of possible toroidal structures, which are high-
lighted within the black boxes.
Figure 3.9: Cryo-TEM of LPS E7 at 6 mg/mL in aqueous solution containing
1 mM MgCl2 at 37
◦C forming undulated lamellae (black box).
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A LPS E7 with LL37
B LPS E7 with LFb
Figure 3.10: Cryo-TEM micrographs of LPS E7 at 6 mg/mL in aqueous solu-
tion containing 1 mM MgCl2 at 37
◦C with addition of peptides at LPS/peptide
ratio of 10/1. (A) addition of LL37: formation of elongated particles closing into
toroids and lamellae (black boxes). (B) addition of LFb: formation of mixed
thin elongated particles and lamellae (black boxes).
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3.3.2 Small-angle neutron scattering
The SANS investigation of the samples described above (Section 3.2.4) required
specific model fitting for each system investigated. During the modeling process
of the raw data, some initial parameters such as the SLD and the φ are required.
Usually the value of SLD can be calculated back from the fitting of the data but
in this case, being a highly polydisperse molecule, the calculation of an SLD value
for each LPS chemotype was more complex. Therefore the SLD values were es-
timated by calculations based on the theoretical molecular structure of each LPS
chemotype reported in Section 1.2.1 and implemented at the beginning of the
model fitting process. The calculated SLD values are reported in the Table D.1 of
Appendix D. Each SLD value has been checked for consistency by employing the
calculation for the scale factor of each model. The modeling process was carried
out using a combination of the FISH and the SansView software programs. SANS
dilution studies of all three LPS chemotypes were carried out at LPS concentra-
tions of 4 mg/mL, 6 mg/mL, 8 mg/mL, 10 mg/mL in order to ascertain whether
any change in the scattering patterns could be attributed to LPS concentration. In
the studies involving the challenge by LL37 or LFb peptides, an LPS concentration
of 6 mg/mL was used at LPS/peptide weight ratios of 50/1 and 10/1.
3.3.2.1 LPS 0111B4 scattering data
The data from LPS 0111B4 experiments were plotted in a log10Iq vs log10Q graph
in order to obtain the Q dependency of the scattering intensity from the slope of
the linear parts of the curve. The representative example data for LPS 0111B4
at 6 mg/ml alone and in the presence of either LL37 or LFb peptides at a ratio
of 10/1 are shown in Figure 3.11. In all the three cases, the scattering patterns
do not present features indicative of rigid rods, as characterized by a slope of 1,
and the the experimental data deviates from the theoretical model (dashed lines).
Possibly the structure which could approximately fit the curve of LPS 0111B4 6
mg/ml in the Porod region is the collapsed coil (solid grey line with slope equal to
3 in Figure 3.11) even though other features are also present (Figure 3.11 A); the
addition of the two peptides (Figure 3.11 B and C) seems to increase this evidence
and the theoretical model (solid grey line) more closely follows the scattering curve.
Therefore the Guinier and the Kratky-Porod analysis for elongated particles were
applied in order to have a better idea of the dimensions of these particles.
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Figure 3.11: Scattering curves showing the Q dependency of the intensity of
LPS 0111B4 at 6 mg/mL in 1 mM MgCl2 saline solution at 37
◦C alone (A) or
in the presence of the peptides LL37 (B) and LFb (c) at a LPS/peptide weight
ratio of 10/1. n is the slope of the straight lines.
The Guinier plot ln[(δΣ/δΩ)(Q)]vsQ2 of the dilution data of LPS 0111B4 in 1mM
MgCl2 saline solution is reported in Figure 3.12 A, and it shows the dependency of
the scattering intensity on the concentration of the solute. From the linear fitting
of the plot at low Q in Figure 3.12 B, it is possible to define some parameters
as expressed by the Equations 3.4 and 3.5. Table 3.1 shows the calculated values
obtained from the linear fits of the Guinier plot over the low Q range 0.015-0.032,
equivalent to a Q2 range of 0.00024-0.00103.
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Figure 3.12: (A) Guinier plot of scattering data of LPS 0111B4 dilutions in
1 mM MgCl2 saline solution at 37
◦C . (B) Linear curve fitting of the expanded
low Q2 range of 0.000-0.003 of the Guinier plot.
Table 3.1: Values from the linear fitting of Guinier plot of LPS 0111B4 dilu-
tions in 1 mM MgCl2 saline solution at 37
◦C at the low Q range of 0.015-0.032.
0111B4 R2 fiti Q ∗Rg valueii Rg (A˚)
10 mg/ml 0.959 2.75 86.5
8 mg/ml 0.964 2.87 89.3
6 mg/ml 0.955 2.89 90.0
4 mg/ml 0.944 2.91 90.5
i coefficient of determination ii limit Q ∗Rg <
√
3
The Guinier approximation requires values of Q∗Rg <
√
3, which are not complied
by any of the samples analyzed. Thus it is not possible to make further use of these
data other than to make superficial speculations on the intrinsic changes of the
sample in relation to an increasing concentration of LPS. It is clear, however, that
the radius of gyration Rg of the rod is not significantly affected by the dilutions
at the three lowest LPS 0111B4 concentrations, with very little value fluctuation
between 89 and 91 A˚, whilst the 10 mg/mL concentration presents a lower Rg
equal to 86.5 A˚.
The Kratky-Porod approximation might be more useful for analysing data from
particles which are more flexible than simple rods. Hence the data for the LPS
0111B4 dilution study was plotted as ln[Q × (δΣ/δΩ)(Q)] vs Q2 in Figure 3.13.
The linear fitting of the data in the intermediate-high Q range 0.032-0.067 (equiv-
alent to a Q2 range of 0.00103-0.00447) allowed the calculations of the parameters
reported in Table 3.2, as described by the Equations 3.10 and 3.11. Additionally
Chapter 3. SANS and cryo-TEM of LPS and peptides 77
the plot allows the calculation of the mass per unit length ML in Da/A˚ according
to the Equation 3.12; in this calculation the parameters considered are the parti-
cles SLD ρworm of 1.57*10
10 cm-2, the solvent SLD ρsolvent of 6.35*10
10 cm-2 and a
density of LPS equal to 1.4 g/cm3 as reported by Ulevitch [241].
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Figure 3.13: (A) Kratky plot of scattering data of LPS 0111B4 dilutions in
1 mM MgCl2 saline solution at 37
◦C . (B) Linear curve fitting of the expanded
intermediate-high Q2 range of 0.001-0.005 of the Kratky plot.
Table 3.2: Values from the linear fitting of Kratky plot of LPS 0111B4 dilu-
tions at intermediate-high Q range of 0.032-0.067.
0111B4 R2 fit Q ∗Rg valuei Rg R =
√
2 ∗Rg (A˚) ML (Da/A˚)
10 mg/ml 0.982 1.74 26.0 37 55’124
8 mg/ml 0.977 1.74 26.1 37 74’282
6 mg/ml 0.973 1.69 25.2 36 108’855
4 mg/ml 0.921 1.64 24.5 35 180’744
i limit Q ∗Rg < 1.1
As found with the Guinier approximation, the Kratky analysis applied to these
dilutions experiments does not meet the requirement Q∗Rg < 1.1. Nevertheless we
can estimate that the radius of the worm-like micelle is not changing significantly
and maintains values between 35 and 37 A˚. Being inversely proportional to the
concentration of the solute, ML incresaes with decreasing concentration and can
be used to estimate the amount of molecules present over the length of the micelle.
Unfortunately being a structurally polydisperse molecule, makes it is difficult to
calculate this number for LPS but according to Aurell et al. [242] the average
molecular weight is estimated to be 10000 Da. Therefore we can see how the
number of molecules per micelle increases as the concentration decreases. The
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Guinier plot of LPS011b4 6mg/ml with and without peptides at LPS/peptide
ratios of 50/1 (data not shown) and 10/1 (Figure 3.14) was fitted to a straight
line at low Q range as described before. The values of Q ∗ Rg and Rg obtained
from the linear fits are reported in Table 3.3. The Q ∗ Rg value does not meet
the requirement for the reliability of the approximation but it is still possible to
approximate a radius of gyration of the elongated particles: LL37 and LFb seem to
slightly decrease Rg of the particles especially at the higher peptide concentration.
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Figure 3.14: Guinier plot of scattering data of LPS 0111B4 (6 mg/mL) in
1 mM MgCl2 saline solution at 37
◦C alone and with the addition of peptides
LL37 or LFb at a LPS/peptide ratio of 10/1. The linear fit was applied at the
low Q2 range of 0.000-0.003.
Table 3.3: Values from the linear fitting of the Guinier plot of LPS 0111B4
6 mg/mL in 1 mM MgCl2 saline solution at 37
◦C alone and following challenge
by the peptides LL37 or LFb at a low Q range of 0.015-0.032.
Sample R2 fit Q ∗Rg valuei Rg
0111B4 6mg/ml 0.955 2.89 90.0
+ LL37 50/1 0.958 2.84 88.4
+ LL37 10/1 0.985 2.39 74.4
+ LFb 50/1 0.969 2.83 87.9
+ LFb 10/1 0.977 2.50 77.9
i limit Q ∗Rg <
√
3
Because of the poor fit of the Guinier approximation to the SANS data from LPS
0111B4 6 mg/mL in the presence of the peptides, the Kratky-Porod model was
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applied instead. In Figure 3.15 only the fitting for the 10/1 LPS/peptide ratio
is depicted as example. The linear fit at the intermediate-high Q range gave the
values for Q ∗ Rg, Rg and R, listed in Table 3.4. The data show that similar to
the Guinier approximation, the fit does not meet the Q ∗ Rg value requirement.
The radius radius (R) values are much smaller than the values calculated with the
Guinier approximation and a significant reduction in Rg was not observed except
for the sample containing the highest concentration of LL37 peptide (ratio 10/1).
No modification of ML was observed in the presence of the two peptides.
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Figure 3.15: Kratky plot of LPS 0111B4 (6 mg/mL) in 1 mM MgCl2 saline
solution at 37◦C alone and with the addition of peptides LL37 or LFb at a
LPS/peptide ratio of 10/1. The linear fit was applied at the intermediate-high
Q2 range of 0.003-0.005.
Table 3.4: Values from the linear fitting of Kratky plot of LPS 0111B4 (6
mg/mL) in 1 mM MgCl2 saline solution at 37
◦C alone and following challenge
by the peptides LL37 or LFb at the intermediate-high Q range of 0.032-0.067.
Sample R2 fit Q ∗Rg valuei Rg R =
√
2 ∗Rg (A˚) ML (Da/A˚)
0111B4 6mg/ml 0.973 1.69 25.2 36 108’855
+ LL37 50/1 0.974 1.66 24.9 35 104’677
+ LL37 10/1 0.995 1.50 22.5 32 101’600
+ LFb 50/1 0.979 1.70 25.4 36 102’703
+ LFb 10/1 0.985 1.70 25.4 36 96’710
i limit Q ∗Rg < 1.1
Both the Guinier and the Kratky approximation failed to provide trustworthy in-
formation about the systems, therefore, in order to obtain more details and to
have a more reliable fitting, structural models from the fitting software programs
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FISH and SansView were used to extract as much information as possible. These
models are more complex than the simple Guinier and Kratky approximations and
allowed a closer fit to the scattering curves across the entire Q range. The fitting
attempts of the sample containing LPS 0111B4 at a concetration of 6 mg/mL in
1 mM MgCl2 saline solution at 37
◦C are here reported as being representatives of
the analysis of the other samples not mentioned in this section. Based on the Cryo
TEM micrographs a range of models for elongated objects were attempted. The
first attempts were made using a simple rod model number 18 in FISH software
(attempts not reported) and it proved to be unsuccessful for the fitting of the
curves. This particular model considers the scattering objects as rigid rods, prob-
ably too rigid for such apparently flexible particles. Attempts to fit the data with
models for flexible cylinders with and without elliptical cross sections (Figure 3.2)
were made, where the number of elements n and their length l are given in order
to approximate the flexibility of the objects, in addition to the radial dimensions
of the particles. Unfortunately these further attempts at fitting the data did not
result in a good outcome. First the FISH software has been used running a Kholo-
denko worm-like chain model [239] with a circular cross section. The cylinder can
have either an homogeneous SLD or a core/shell feature, with two different SLDs
for the inner part and the outer part of the worm-like micelle, both alternatives
were attempted with similar results. The fitting of LPS 0111B4 at a concentration
of 6 mg/ml as core/shell flexible cylinder is depicted in Figure 3.16.
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Figure 3.16: LPS 0111B4 (6 mg/mL) fitting as (A) core/shell flexible cylinder
in FISH software and (B) as elliptical flexible worm in SANSview software.
As mentioned above, the value of the contrast has been entered from the calculated
SLDs of the molecule (contrast Equation 3.15). The Kholodenko model provided
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Table 3.5: Parameters for
the fitting in FISH software of






rc core 3.70E+01 A˚
ts shell 2.15E+01 A˚
contrast 8.24E-01
i unreal negative value
Table 3.6: Parameters for the
fitting in SANSview software of








i unreal value comapred to l
by the FISH software would give as an output the n and the l of each segment
composing the flexible cylinder, the rc and the ts; therefore the total radius of the
cross section R = rc + ts can be calculated. As an example for the fitting of LPS
0111B4 at a concentration of 6mg/mL in saline solution containing 1 mM MgCl2
(Figure 3.16) , the number of segments is unrealistically negative (Table 3.5) but if
the parameters are restrained inputting a reasonable number, another parameter
would subsequently be calculated as negative.
The second model used in other attempts, including the example reported here
(Figure 3.16) for LPS 0111B4 at 6 mg/mL, was a flexible cylinder with elliptical
cross section model provided by the fitting software program SANSview, the pa-
rameters of which are reported in Table 3.6 and described in Figure 3.2. The axes
ratio is the ratio between the major radius r2 and the minor radius r1 and has to
be > 1; other parameters of the model are the l and L, the latter being defined
as the total length of the object. The scale in this case is equal to the φ of the
LPS in solution. From the values of Table 3.6 it is possible to note an irregularity
in the length values because L < l, which is theoretically impossible (the length
of a single segment cannot be bigger than the total length of the object). If the
length was restrained in order to have reasonable values, the axes ratio becomes
< 1 which is not possible according to the limits of the model. Equivalent results
were found for all the models attempted during the analysis of the dilutions of
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LPS 011B4 and its interaction with the peptides LL37 and LFb .
3.3.2.2 LPS D21 and peptides LL37 and LFb.
The first data analysis carried out for LPS D21 dilutions in saline solution con-
taining 1mM MgCl2 scattering curves is the Guinier approximation for lamellar
structures. In Figure 3.17 the approximation for the dilution experiment are de-
picted with the linear fitting at intermediate-high Q of 0.01973-0.05236 (equal to
a Q2 range of 0.000389-0.002741). The thickness T of the bilayer (Table 3.7) does
not change considerably with the increasing concentration and the value is stable
between the range 72-74 A˚. The approximation almost satisfies the requirements
(limit 0.41 < Q ∗ Rg < 0.92) therefore we can consider these calculations to be
valid. A more precise characterization of the scattering curves can be achieved ap-
plying a lamellar model using a scattering data fitting software. LPS D21 dilutions
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Figure 3.17: Guinier approximation for lamellar structures of the scattering
data of LPS D21 dilutions in 1 mM MgCl2 saline solution at 37
◦C and relative
linear fitting at intermediate-high Q2 range of 0.0004-0.003.
were fitted as a monodisperse oriented sheet with a shell/core/shell feature (Fig-
ure 3.3). In this case the shell was considered as being formed by the hydrophilic
regions of LPS (the core of LPS), and the core being composed of the hydrophobic
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Table 3.7: Values from the linear fitting of the Guinier approximation for
lamellar structures of LPS D21 dilutions in 1 mM MgCl2 saline solution at
37◦C at the intermediate-high Q range of 0.02-0.052
D21 R2 fit Q ∗Rg valuei Rg T =
√
12 ∗Rg (A˚)
10 mg/ml 0.878 1.08 20.81 72.08
8 mg/ml 0.910 1.09 20.80 72.04
6 mg/ml 0.941 1.09 20.83 72.16
4 mg/ml 0.964 1.12 21.41 74.18
i limit 0.41 < Q ∗Rg < 0.92
acyl chains of the lipid A region. The fitting of the data reported in Figure 3.18
shows the scattering curves of D21 at different concentrations. At 4 mg/ml and
6 mg/ml the mono-disperse oriented sheet fitting is acceptable, while at higher
concentrations (8 mg/ml and 10 mg/ml) the sheet features are lost and the model
gives a less precise fit. It is interesting to note the formation of three shoulders at
high concentrations which are not visible in the scattering curve at 4 mg/ml; these
might be Bragg reflections from a multi-lamellar structure. If these reflections are
grouped in equidistant ratios of the lamellar repeat d-spacing we can approximate
the value of the distance repeat as d = 2Π
Q
; the resulting d-spacing values between
bilayers, calculated at high Q range (Q value of the first reflection on the right)
for D21 at 6 mg/mL, 8 mg/mL and 10 mg/mL are respectively 70.6 A˚, 57.7 A˚ and
59.6 A˚; the ripples at lower Q values are separate from the first reflection by a ratio
of respectively 0.41± 0.05, 0.40± 0.09 and 0.41± 0.09 which suggests a repeated
distance of 1/2.5. While the first reflection at high Q suggests a spacing between
two bilayers, the other reflections might represent the spacing between lamellae
present in a stack of bilayers rather than a space between two lamellae. However,
the formation of ripples might also suggest the formation of different populations
of objects which could be either sheets with different thickness or alternatively
particles with diverse morphologies. This might explain the steadiness of the mid-
dle reflection (Q 0.032) which would describe one population that does not change
with the dilutions, together with other populations described by the other ripples
at diverse Q values. Due to the complexity of the system, an adequate model to
fit is not available, although several attempts to mix different form factors have
been made unsuccessfully. The output parameters of the monodisperse oriented
sheet shell/core/shell model provided by the FISH software are reported in the
Table 3.8. The contrast value was fixed in the model and was calculated to be
0.904 for LPS D21, according to the Equation 3.15. The values of the bilayer’s
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Figure 3.18: SANS data for LPS D21 dilutions in saline solution containing
1 mM MgCl2 at 37
◦C fitted as monodisperse oriented sheet shell/core/shell
provided by the FISH software. The Q values reported have been considered of
interest.
Table 3.8: Parameters obtained from the fitting of LPS D21 dilutions with
the monodisperse oriented sheet shell/core/shell model provided by the FISH
software.
D21 4mg/ml 6mg/ml 8mg/ml 10mg/ml
Scale 0.042 0.039 0.016 0.014
tc (A˚)
i 22.91 ±0.00 23.05 ±0.01 23.38 ±0.01 23.28 ±11.5
ts (A˚)
ii 16.96 ±0.00 16.68 ±0.01 18.05 ±0.01 17.17 ±5.55
T iii(A˚) 56.83 56.41 58.04 57.62
Rσ (A˚) 503.06 408.47 228.53 211.12
i core thickness ii shell thickness iii Total thickness T = 2 ∗ ts + tc
shell and core thickness did not change with the increasing concentration of LPS,
therefore the T is similar at all the dilutions (between 55 and 58 A˚). The scale
factor decreased because it is proportional to the power of Rσ.
The Kratky-Porod approximation for elongated objects of the scattering curves of
the LPS D21 (6 mg/mL) in saline solution containing 1mM MgCl2 at 37
◦C with
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peptides LL37 or LFb at the LPS/peptide ratios of 50/1 and 10/1 is shown in
Figure 3.19. The linear fitting of the intermediate-high Q values was carried out
for all the scattering curves over the Q range 0.032-0.067 (equivalent to a Q2
range of 0.00103-0.00447). The parameters obtained from the calculations for this
approximation are reported in Table 3.9.
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Figure 3.19: (A) Kratky plot of LPS D21 6 mg/mL in saline solution con-
taining 1mM MgCl2 at 37
◦C alone and following challenge with the peptides
LL37 or LFb at LPS/peptide ratios of 50/1 and 10/1. (B) Linear fitting of the
Kratky plot expanded over the Q2 range of 0.0005-0.005.
Table 3.9: Parameters obtained from the linear fitting of the Kratky plot of
LPS D21 6 mg/mL in saline solution containing 1mM MgCl2 at 37
◦C with the
peptides LL37 or LFb at the LPS/peptide ratios of 50/1 and 10/1.
D21 6mg/ml R2 fit Q ∗Rg valuei Rg R =
√
2 ∗Rg (A˚) ML (Da/A˚)
+ LL37 50/1 0.979 1.85 27.7 39 78’053
+ LL37 10/1 0.983 1.59 23.8 34 67’821
+ LFb 50/1 0.987 1.95 29.3 41 39’597
+ LFb 10/1 0.978 1.83 27.5 39 43’514
i limit Q ∗Rg < 1.1
Despite the fact that the approximation does not fully comply with the prescribed
Q range limits for the Kratky approximation, it is possible to observe different
effects of LL37 and LFb peptides on the aggregates of LPS D21 from these curves.
The Rg value did not change considerably with the addition of the two peptides
at different ratios. The ML values are different when comparing the samples with
LL37 and the samples with LFb peptide. From the observation of the CryoTEM
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micrographs of LPS D21 with LFb (Figure 3.8 B) it seems that D21 forms perfo-
rated lamellae or regular toroidal structures rather than tightly packed elongated
structures. This might suggest that the Kratky approximation is not correct for
this system, a fact that is corroborated by the highest Q ∗ Rg values of the data
set (Table 3.9). The thickness of lamellae of the sample containing LPS D21 chal-
lenged by LFb peptide was calculated using the Guinier approximation for lamellar
structures plotting the scattering curve as ln[Q2× (δΣ/δΩ)(Q)] vsQ2 (Figure 3.20
A). The linear fitting of the Guinier plot (Figure 3.20 B) over the intermediate
Q range 0.016-0.043, equivalent to a Q2 range of 0.00026-0.00186, allowed for the
calculation of the parameters shown in Table 3.10. The Guinier approximation
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Figure 3.20: (A) Guinier approximation for lamellar structures of LPS D21
(6 mg/mL) in saline solution containing 1mM MgCl2 at 37
◦C alone and with
the peptide LFb at LPS/peptide ratios of 50/1 and 10/1. (B) Linear fitting of
the Guinier plot over the expanded intermediate-high Q2 range of 0.0002-0.005.
Table 3.10: Output values of the Guinier approximation for lamellar structures
of LPS D21 with LFb peptide at 50/1 and 10/1 LPS/peptide ratios.
D21 R2 fit Q ∗Rg valuei Rg T =
√
12 ∗Rg (A˚)
6 mg/ml 0.941 1.09 20.83 72.16
+ LFb 50/1 0.996 0.92 22.38 77.53
+ LFb 10/1 0.987 0.90 22.03 76.33
i limit 0.41 < Q ∗Rg < 0.92
fits correctly the data of LPS D21 with LFb peptide and the Q ∗ Rg limit is re-
spected; there was an increase of the layer thickness upon addition of LFb to the
sample. The thickness of the bilayer was comparable to the radius of the elongated
particle found with the previous Kratky approximation. Following the findings of
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the approximations, the LPS D21/LL37 and LPS D21/LFb samples were fitted to
respectively a Kholodenko flexible cylinder model and a monodisperse sheet shel-
l/core/shell model with the use of FISH software. LPS D21/LL37 fitting is shown
in Figure 3.21 and the resultant parameters are reported in Table 3.11. The value
of the contrast is 8.17e-01 (see Equation 3.15) . The number of segments n
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Figure 3.21: Kholodenko flexible cylinder model fitting of LPS D21 (6
mg/mL) in saline solution containing 1mM MgCl2 at 37
◦C with the peptide
LL37 at LPS/peptide ratios of 50/1 and 10/1.
Table 3.11: Kholodenko flexible cylinder model parameters of the fitting of
LPS D21 at 6 mg/mL in saline solution containing 1mM MgCl2 at 37
◦C with
the peptide LL37 at LPS/peptide ratios of 50/1 and 10/1.
D21 6mg/ml + LL37 50/1 + LL37 10/1
Scale 4.58 e-07 2.18 e-07
φi 1.39 e-04 6.60 e-05
n 12.8 ±6.8 7.9 ±2.1
l (A˚) 109.0 ±36.1 103.0 ±17.1
total L (A˚) 1397.05 816.23
rc core (A˚) 20.7 ±1.1 13.4 ±0.5
ts shell (A˚) 17.4 ±2.5 16.9 ±0.8
total R (A˚) 38.1 30.3
i calculated volume fraction from the Scale according to Equation 3.14
appeared to reduce upon addition of more LL37 peptide, whilst the Khun length
l seemed scarcely affected. Overall the total length of one single particle reduced
at higher concentration of LL37 . The core radius rc decreased from the peptide
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ratio 50/1 to 10/1, whilst the shell thickness ts was not influenced by the increased
concentration of peptide. The contrast value was constant and introduced into the
fitting as explained above. The volume fraction for each sample was also calculated
from the Scale value, and they did not match the theoretical value for LPS D21
alone which is 0.004267; this is consistent with the presence of the peptide within
the micelle which is likely to alter the density and the SLD of the aggregates.
The scattering curves of LPS D21/LFb peptide were fitted with the lamellar
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Figure 3.22: Monodisperse sheet shell/core/shell model fitting of LPS D21 at
6 mg/mL in saline solution containing 1 mM MgCl2 at 37
◦C alone and with the
peptide LFb at LPS/peptide ratios of 50/1 and 10/1.
Table 3.12: Monodisperse sheet shell/core/shell model parameters obtained
from the fitting of LPS D21 at 6 mg/mL in saline solution containing 1 mM
MgCl2 at 37
◦C alone and with the peptide LFbat LPS/peptide ratios of 50/1
and 10/1.
D21 6mg/ml + LFb 50/1 + LFb 10/1
Scale 0.039 4.771 0.838
φi 0.00157 0.00273 0.00277
tc (A˚) 23.05 ±0.01 21.66 ±0.00 25.69 ±0.00
ts (A˚) 16.68 ±0.01 15.72± 0.00 12.52 ±0.00
T (A˚) 56.41 53.10 50.73
Rσ 408 330 210
i calculated volume fraction from the Scale according to Equation 3.21
model described previously. As with the LPS D21/LL37 sample, the contrast
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value input into the model was fixed; the model provides a close fit to the scatter-
ing curves (Figure 3.22) and the resulting values for the parameters are presented
in Table 3.12. At the LPS/peptide ratio of 50/1, tc and ts values did not change
considerably compared to the LPS D21 alone, with a reduction of both core and
shell thickness of approximately 1-1.5 A˚ each; increasing the concentration of the
peptide to a LPS/peptide ratio of 10/1, the core thickness increased while the
shell layer became thinner. In this case the overall T of the bilayer reduced by
∼10% compared to the bilayer without the presence of LFb . The volume fraction
φ values increased with the addition of the peptide at both the LPS/peptide ratios.
3.3.2.3 LPS E7 and peptides LL37 and LFb.
The scattering curves of LPS E7 dilutions were approximated with a Guinier plot
(Figure 3.23) for lamellar structures at the intermediate-high Q range of 0.01624-
0.04308 (equal to a Q2 range of 0.000264-0.001856). The parameters presented
in Table 3.13 show that the approximation is reliable since the value of Q ∗ Rg
is within the limit range of 0.41 < Q ∗ Rg < 0.92. The thickness of the bilayer
formed by LPS E7 is constant, for each dilution, at ∼60 A˚, suggesting that there
is no effect of dilution on the packing of the lamellae.
The fitting of LPS E7 dilutions (Figure 3.24) as monodisperse sheet shell/core/shell
was accurate and the output parameters (Table 3.14) confirm that the concentra-
tion did not change the lamellar thickness. In detail both the shell and the core
thickness, ts and tc respectively, are similar for each dilution; the value of Rσ does
not change significantly except for the LPS E7 sample 8 mg/mL. The scattering
curve of LPS E7 retained the same shape for each concentration; the scattering
intensity increases, as expected, with the increase in LPS concentration.
The LPS E7 (6 mg/mL) in saline solution containing 1 mM MgCl2 at 37
◦C was
challenged with the peptides LL37 or LFb at the LPS/peptide ratios of 50/1 and
10/1, and the scattering data were analysed with different models and approxima-
tions due to the complexity of the system. The addition of peptide LL37 to samples
containing LPS E7 (6 mg/mL) was first analysed plotting the Q dependency of the
intensity of the scattering curves as reported in Figure 3.25. The curves show how
the scattering pattern of LPS E7/LL37 suggests the presence of a Gaussian chain
feature at low Q (slope n = 2) and a polymer coil behavior at intermediate-high
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Figure 3.23: Guinier approximation for lamellar structures for the scattering
data of LPS E7 dilutions in saline solution 1 mM MgCl2 at 37
◦C and relative
linear fitting at intermediate-high Q2 range of 0.0003-0.0019.
Table 3.13: Parameters of the linear fitting of the Guinier approximation
for lamellar structures of LPS E7 dilutions in saline solution 1 mM MgCl2 at
37◦C at the intermediate-high Q range of 0.02-0.04
E7 R2 fit Q ∗Rg valuei Rg T =
√
12 ∗Rg (A˚)
10 mg/ml 0.983 0.76 17.63 61.09
8 mg/ml 0.989 0.74 17.16 59.44
6 mg/ml 0.978 0.75 17.45 60.46
4 mg/ml 0.971 0.74 17.26 59.81
i limit 0.41 < Q ∗Rg < 0.92
Q values (slope n = 3); therefore the Guinier approximation for rigid rods was ex-
cluded and the data were processed using the Kratky approximation for elongated
particles. The data concerning the addition of the peptide LFb were approximated
with a ln[Q× (δΣ/δΩ)(Q)] vs Q2 plot fitted linearly over the intermediate-high Q
range of 0.03215-0.06683 , equal to a Q2 range of 0.001033-0.004466 (fitting not
shown).
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Figure 3.24: Monodisperse oriented sheet shell/core/shell model fitting of
LPS E7 dilutions in saline solution containing 1 mM MgCl2 at 37
◦C .
Table 3.14: Parameters obtained from the monodisperse oriented sheet shell/-
core/shell model fitting of LPS E7 dilutions in saline solution containing 1 mM
MgCl2 at 37
◦C .
E7 4mg/ml 6mg/ml 8mg/ml 10mg/ml
Scale 0.042 0.423 1.107 0.885
tc (A˚)
i 17.25 ±7.67e-17 17.25 ±4.83e-17 17.04 ±1.43e-17 17.24 ±4.79e-14
ts (A˚)
ii 13.02 ±4.88e-17 13.02 ±3.08e-17 12.63 ±9.08e-18 12.93 ±3.05e-14
T iii(A˚) 43.29 43.29 42.30 43.10
Rσ (A˚) 769.85 769.85 875.82 716.09
i core thickness ii shell thickness iii Total thickness T = 2 ∗ ts + tc
The values of the parameters for the Kratky approximation are listed in Table
3.15. The approximation does not comply with the requirement of the fitting in
all the cases, however it shows the approximate values of the radius R and the
parameter ML for the elongated particles. The addition of more LL37 peptide
slightly decreases the radius of the micelle and increases the mass per unit length
of the objects. It should be pointed out that, compared to the 50/1 ratio, the
highest concentration of LL37 at 10/1 ratio seems to provide a closer fit (lower
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Figure 3.25: Q dependency of the intensity of LPS E7 (6 mg/mL) in saline so-
lution containing 1 mM MgCl2 at 37
◦C with the peptide LL37 at a LPS/peptide
ratio of (A) 50/1 and (B) 10/1. n is the slope of the straight lines.
Table 3.15: Parameters obtained from the linear fitting of Kratky plot of LPS
E7 (6 mg/mL) with the peptides LL37 and LFb at 50/1 and 10/1 LPS/peptide
ratios at the intermediate-high Q range of 0.03215-0.06683.
E7 6mg/ml R2 fit Q ∗Rg valuei Rg R =
√
2 ∗Rg (A˚) ML (Da/A˚)
+LL37 50/1 0.988 1.80 26.9 38.1 61’730
+LL37 10/1 0.992 1.72 25.7 36.4 65’721
+LFb 50/1 0.987 1.80 26.9 38.1 67’357
+LFb 10/1 0.983 1.77 26.5 37.5 67’536
i limit Q ∗Rg < 1.1
R2 value) and presents a Q ∗ Rg value closer to the limit, although still not sat-
isfactory. Regarding the addition of the LFb peptide, both the values of Rg and
the mass per unit length (ML) do not show relevant differences between the two
ratios, suggesting a weak LFb effect upon increase of its concentration.
Subsequently the Kholodenko model was applied to the data in order to obtain
more detailed parameters relevant to elongated objects. The scattering curves
for the samples challenged with LL37 and LFb are presented in Figure 3.27. The
E7 scattering data in the presence of the peptides were additionally plotted with
a Guinier approximation for lamellar structures, considering the possibility of a
mix of diverse structures. The plot ln[Q2 × (δΣ/δΩ)(Q)] vs Q2 was fitted lin-
early in the intermediate-high Q range of 0.01624-0.04308 (equal to a Q2 range of
0.000264-0.001856). In Table 3.16 the data obtained from the plot clearly show
that the addition of increasing amount of LL37 peptide reduces the thickness of
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the bilayer proportionally. While the addition of LFb peptide initially seemd to
decrease T at the ratio 50/1, followed by an increase of thickness at the higher
LFb concentration. All the approximations respect the the Q∗Rg limits, therefore
the values can be considered reliable; moreover the thickness magnitude seems to
be reasonable according to previous analysis of the data set. It is worth higlight-
ing that the highest concentration of LL37 drags the trend line away from an ideal
linearity value, with a poor value for the coefficient of determination.
Since it is likely that the samples contained a mixture of structures, a number of
Table 3.16: Parameters obtained from the linear fitting of the Guinier ap-
proximation for lamellar structures of LPS E7 at 6 mg/mL in saline solution
containing 1 mM MgCl2 at 37
◦C , alone and with the addition of the peptides
LL37 or LFb at LPS/peptide ratios of 50/1 and 10/1 LPS/peptide ratios, at
the intermediated-high Q range.
Sample R2 fit Q ∗Rg valuei Rg T =
√
12 ∗Rg (A˚)
E7 6mg/ml 0.978 0.75 17.45 60.46
+LLL37 50/1 0.953 0.67 15.59 54.01
+LL37 10/1 0.659 0.46 10.76 37.28
+LFb 50/1 0.975 0.69 16.08 55.71
+LFb 10/1 0.973 0.73 17.02 58.97
i limit 0.41 < Q ∗Rg < 0.92
different models are applied to the data for LPS E7 at 6 mg/mL concentration in
saline solution containing 1 mM MgCl2 , at 37
◦C , with the addition of the pep-
tides LL37 or LFb at LPS/peptide ratios of 50/1 and 10/1, using both a lamellar
structure model and a flexible cylinder structure model.
The application of the monodisperse shell/core/shell model is shown in Figure
3.26 A and B, respectively, for LL37 and LFb peptides. The model fitted closely
the scattering curves and produced the parameters reported in Table 3.17. The
peptide LL37 reduced the overall thickness of the lamellae relatively to an increase
in the peptide concentration. This effect is mostly concentrated on the shell part
of the bilayer, as a matter of fact the thickness of the core is almost unchanged at
the highest concentration of peptide (ratio LPS E7/LL37 of 10/1). The value of
Rσ was halved exclusively at the highest concentration of peptide, compared to
the value of LPS E7 alone. The volume fraction remains rather constant for all
the three samples within the LL37 group. The addition of LFb peptide has a more
irregular effect on the bilayer (see parameters in Table 3.17). Compared to the
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sample without peptide, the data for LPS/LFb ratio of 50/1 presents a mere total
thickness reduction coupled with a noteworthy increase of the core thickness tc at
the expenses of a decrease of the shell thickness ts. At the highest concentration
of LFb (ratio 10/1) there is a drop of total thickness of ∼3 A˚ mainly due to a
reduction of the core thickness tc, this effect contrasts with the effect noted at
lower LFb concentration at the LPS/peptide ratio of 50/1. The value of Rσ has
undergone a slight reduction upon addition of the peptide LFb , and it is constant
for both peptide ratios. LFb seems to induce a low reduction of the volume frac-
tion, compared to the less pronounced effect on φ of the peptide LL37 .
The LPS E7 alone forms lamellar structures, therefore a direct comparison with
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Figure 3.26: Monodisperse sheet shell/core/shell model fitting of LPS E7 at
6 mg/mL in saline solution containing 1 mM MgCl2 at 37
◦C with (A) LL37
peptide and (B) LFb peptide at LPS/peptide ratios of 50/1 and 10/1.
Table 3.17: Parameters obtained from the monodisperse sheet shell/core/shell
model fitting of LPS E7 at 6 mg/ml in saline solution containing 1 mM MgCl2
at 37◦C alone and with the peptides LL37 or LFb at LPS/peptide ratios of 50/1
and 10/1.
E7 6mg/ml +LL37 50/1 +LL37 10/1 +LFb 50/1 +LFb 10/1
Scale 0.623 0.527 0.136 0.365 0.406
φi 0.00468 0.00415 0.00432 0.00408 0.00338
tc (A˚) 17.25 ±0.00 16.43 ±0.17 17.05 ±2.48 21.33 ±1.31 15.60 ±0.00
ts (A˚) 13.02 ±0.00 12.52 ±0.10 10.64 ±1.24 10.40 ±0.66 12.63 ±0.00
T (A˚) 43.29 41.46 38.34 42.14 40.85
Rσ (A˚) 770 734 372 702 695
i calculated volume fraction from the Scale according to Equation 3.21
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the samples containing the two peptides fitted using the Kholodenko model (Fig-
ure 3.27) is not possible. From the parameters obtained from the fitting reported
in Table 3.18 it is possible to observe that the scale factors and the volume frac-
tions for all the samples are unchanged. Concerning both LL37 and LFb added it
is striking to note the value of n and l, where both peptides induced the formation
of a large number (ranging form 4000 to 48000) of very short segments of micelles
of approximately 8 to 11 A˚. In the case of LL37 peptide, the highest peptide con-
centration (ratio 10/1) revealed a ten-fold reduction of n compared to the 50/1
ratio, while the l value is reduced from 8 to 10 A˚. However the large errors must
be considered. The core radius and the shell thickness have not undergone major
changes apart from a reduction of rc from 9 to 8 A˚ and the total radius of the
objects is set between 23-24 A˚. The peptide LFb induced a six-fold reduction of n
and a l decrease from 11 to 8 A˚ probably because it affects mostly the headgroup
region of the LPS.
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Figure 3.27: Kholodenko flexible cylinder model fitting of LPS E7 at 6 mg/mL
in saline solution containing 1 mM MgCl2 at 37
◦C (A) LL37 peptide or (B) LFb
peptide at LPS/peptide ratios of 50/1 and 10/1.
3.3.2.4 Calculation of the volume fraction
From the fitting of the scattering curves of the dilution experiments it was possible
to calculate back the φ through the Scale parameter of each model. The equations
to be considered are Equation 3.21 and Equation 3.22. Table 3.19 compares the
calculated volume fraction for each concentration of LPS D21 and D21E7 and the
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Table 3.18: Parameters from the Kholodenko flexible cylinder model fitting
of LPS E7 at 6 mg/mL in saline solution containing 1 mM MgCl2 at 37
◦C (A)
LL37 peptide or (B) LFb peptide at LPS/peptide ratios of 50/1 and 10/1.
Parameter +LL37 50/1 +LL37 10/1 +LFb 50/1 +LFb 10/1
Scale 2.02E-07 2.18E-07 2.19E-07 2.09E-07
φi 6.11E-05 6.59E-05 6.62E-05 6.33E-05
n 48698 ±25330 4877 ±1687 61979 ±8877 13788 ±3653
l (A˚) 8.38 ±0.50 10.04 ±1.68 8.46 ±0.40 11.27 ±0.41
total L (A˚) 407915 48948 524625 155352
rc (A˚) 9.30 ±0.37 8.05 ±0.79 10.82 ±0.34 8.36 ±0.20
ts (A˚) 15.52 ±0.31 15.00 ±0.72 14.12 ±0.27 15.67 ±0.19
total R (A˚) 24.82 23.06 24.94 24.03
i calculated volume fraction from the Scale according to Equation 3.14
relative φ values obtained from the fittings. Only data concerning the dilution
experiments of the pure LPSs (without peptides) were considered. The reliability
of the calculations depends upon the closeness of the model fits therefore data
from the model fitting of LPS E7 as monodisperse sheet shell/core/shell could
be considered more representative than the data from the fitting of LPS D21.
Nevertheless the calculations are valid and show that the φ calculated values and
the obtained values from the fitting are comparable. The volume fraction for LPS
0111B4 could not be obtained because of the inability to closely match the data
to a valid model.
Table 3.19: Calculated and theoretical volume fractions for LPS E7 and D21
Sample Calculated φ φD21 φE7
4mg/ml 0.00285 0.00318 0.00389
6mg/ml 0.00427 0.00468 0.00529
8mg/ml 0.00568 0.00635 0.00688
10mg/ml 0.00709 0.00768 0.00707
3.4 Discussion
In this study the TEM, combined with the SANS technique, allowed the scattering
data modelling to be informed by observation of the micrographs, thus producing
models with greater relevance to the samples’ morphologies. The diverse molecular
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structure of each LPS chemotype induces the formation of various colloidal aggre-
gates (Figure 3.28) which are affected by the presence of the peptides LL37 and
LFb . The modifications to the LPS aggregates induced by the peptides (Figure
3.28) depended upon the peptides’ physico-chemical characteristics such as con-
formation, charge and hydrophobicity, as well as to the molecular structure and
physico-chemical features of the LPS chemotype studied.
Figure 3.28: Representation of the aggregate structures formed by various
LPS chemotypes and the effect of the peptides LL37 and LFb on the morphology
of the aggregates.
3.4.1 LPS 0111B4 and peptides
Previous ff-TEM and cryo-TEM analysis of the LPS 055B5 smooth chemotype in
PBS buffer solution containing only mono-valent cations reported the formation
of spherical aggregates in solution [226, 243]. The effect of mono- and di-valent
cations on the aggregates of LPS is different [25] therefore, considering the paucity
of data regarding the structure of smooth LPS in the presence of divalent cations,
the aggregation of smooth LPS 0111B4 was investigated in the presence of 1 mM
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MgCl2 . Cryo-TEM of LPS 0111B4 showed the formation of worm-like micelles
with wide inter-particle distances. The SANS data analyzed by the Kratky ap-
proximation for elongated particles confirmed the presence of worm-like micelles.
Despite the changes observed from the TEM, the neutron scattering data suggest
a minimal effect of both peptides on the aggregates of LPS 0111B4 (Figure 3.28).
The electrostatic attraction between CAP and the negative charges present on lipid
or LPS headgroups (specifically the phosphates present in the core oligosaccharide
and lipid A of the endotoxin) is the dominant driving force of the interaction [183],
but in the case of the smooth LPS 0111B4, these negative charges are shielded by
the LPS O-antigen chains. Recent investigations on the interaction between the
α-helical antimicrobial peptide magainin and liposomes made of mixed hDPPC ,
dipalmitoylphosphatidylglycerol (DPPG) and the negatively charged ganglioside
molecule (GM1), showed that the peptide is trapped into the sugar region of GM1,
which might resemble the core region of LPS with its negative charges [244]. The
presence of a long polymeric chain such as the O-antigen of LPS shields the nega-
tive charges in the core oligosaccharide and the lipid-A from the cationic peptides.
Previous evidence suggests that the steric hindrance of large polymeric headgroups
such as the one of poly(ethylene glycol) (PEG), reduces the fibrinogen protein in-
teraction with mixed liposomes made of several lipids (zwitterionic and negatively
charged) and pegylated phosphatidylethanolamine [245]. It may therefore be as-
sumed that most of the interaction of the peptides LL37 and LFb is concentrated
on the O-antigen part of the LPS molecule resulting in a lower penetration of the
peptides in the innermost core of the micelles. This would be consistent with the
protective role of the O-antigen oligosaccharidic headgroup of LPS on the outer
membrane of the bacteria where the charged groups, which the peptides would be
expected to interact with, are buried in the core of the LPS headgroup and the
peptides are sterically hindered from access by the long oligosaccharidic chains.
The SANS technique is more sensitive to changes in the core region of the micelles
therefore the lack of modifications to the scattering pattern upon addition of the
peptides suggests that both LL37 and LFb are not penetrating the O-antigen bar-
rier of LPS thus are not allowed to bind to the negatively charged phosphates on
the core region and the lipid-A headgroup of the LPS. In addition, the unmodified
values of mass per unit length obtained from the analysis of LPS 0111B4 SANS
data even in the presence of the peptides, suggests that there is no modification
of the packing of the micelles, hence no interaction with the innermost part of
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the particles. The packing effect induced by both peptides on LPS 0111B4 aggre-
gates reported by cryo-TEM could be the result of the modifications caused to the
outermost hydrophilic region of the particle. The peptides interacting with the
O-antigen region, induce the collapse of the oligosaccharidic chains and therefore
the steric repulsion between different micelles, resulting in smaller spaces between
the micelles and their consequent tighter packing.
3.4.2 LPS D21 and peptides
The Cryo-TEMs of LPS D21 at a concentration of 6 mg/ml in saline solution
containing 1 mM MgCl2 at 37
◦C show the formation of very complex lamellar
structures in agreement with the negative stain TEM performed by Coughlin,
Haug and McGroarty on the same LPS D21 Ra chemotype [57]. More recently
Richter et al. [227] found that Ra LPS from S. minnesota R60 in 20 mM HEPES
buffer, analyzed by ff-TEM and cryo-TEM, forms elongated fibrilles made up by
two tightly packed bilayers. The apparent discrepancy between the data reported
in the current study and those reported by Richter et al. can be explained by the
tendency of Mg2+ to induce a higher order state of Ra LPS and an increase in the
“lamellarity” of the aggregates [56].
The analysis of SANS data for the dilution of LPS D21 confirmed the presence
of lamellar structures (Figure 3.28), the thickness of which is not affected by LPS
concentration. The formation of fringes in the scattering curve at higher LPS
concentration, suggests that the lamellae are becoming more ordered and rigid in
response to increasing concentrations of LPS.
The addition of LL37 peptide to the LPS D21 at the concentration of 6 mg/mL
in the presence of 1mM MgCl2 , caused the formation of elongated particles, clos-
ing up into packed irregular toroids as shown by cryo-TEM micrographs (Figure
3.28). A consistent result in terms of radii values of the elongated particles was
obtained from the Kratky approximation of the SANS data set. The number of
LPS molecules per unit length of the micelles decreases upon addition of LL37 ,
suggesting that the peptide acts on the innermost core oligosaccharide region of
the LPS D21, and possibly on the lipid-A region as well, affecting its packing
within the aggregate and probably displacing LPS molecules. The Kholodenko
worm-like micelle model fit of the SANS data in the presence of LL37 suggests the
formation of elongated objects composed by numerous segments of 100-110 A˚ in
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length, each of which has radius values in agreement with those obtained from the
TEM micrographs. The elongated structures formed by LPS D21 in the presence
of LL37 may be rather flexible and the forming chains may close up into irregularly
shaped toroids, as seen from the cryo-TEM micrographs.
LPS D21 treated with LFb peptide forms tightly packed, extremely regular toroids
which resemble a bilayer perforated by pores (Figure 3.28). Such a complex sys-
tem could not be analyzed, as with the previous samples, as a flexible micelle
model therefore a better description of this structure might be given through the
approximation of the system as a bilayer. The Guinier approximation of the SANS
reports a little increase in the bilayer thickness upon the addition of LFb peptide,
evidence corroborated by the data fitting with the monodisperse sheet shell/-
core/shell model. The model shows that most of the changes in thickness induced
by LFb occur at the shell level which decreases upon addition of the peptide. Less
consistent conclusions can be drawn when observing the core thickness of the bi-
layer, which decreases at the lower peptide concentration and increases again at
the highest LFb concentration, in comparison to the untreated LPS E7.
Previous investigations showed that LFb peptide partitions into the lipid bilayer
in the presence of negatively charged lipids [128, 246] but at a physiological mem-
brane lateral pressure (i.e. 30 mN/m [165]), as could be expected in the aggregates
of Ra LPS, the peptide does not partition into the bilayer but lays parallel at the
bulk solvent/lipid interface [127], as suggested by the experiments reported in this
thesis as well (Chapter 2). As proposed by Ulvatne et al. [130] LFb has no pen-
etrating properties on the cytoplasmic membrane of the bacteria but acts on the
surface of the membrane depolarizing it and causing the bilayer to curl on itself.
The regular structures observed in the cryo-TEM micrographs formed by LPS
D21/LFb could be the result of the curling effect of the peptide on the LPS D21
lamellae.
It is clear that the removal of the O-antigen and the exposure of the negatively
charged phosphate groups in the heptose level of the core region and in the lipid-A
headgroup level of the LPS D21, allows for a stronger interaction of both peptides
with the core part of the LPS aggregates. LL37 influences more than LFb the core
of the objects, which corresponds to the hydrophobic part of the LPS structure
(the lipid-A acyl chains). LL37 , as other peptides with an α-helical conforma-
tion, presents amphiphilic properties which allow for an effective interaction and
a deep penetration into the lipid membranes [105, 247]. The ability of LL37 to
partition effectively in monolayers and bilayers composed of LPS Ra is reported
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in Chapter 2. The drastic change of morphology of LPS D21 lamellae into elon-
gated micelles/toroids could be due to the effect of LL37 on the critical packing
parameter (CPP) of the LPS aggregates as a result of a deeper interaction. The
change in the aggregation number observed from the SANS data induced by LL37 ,
suggests that the peptide modifies the curvature of the bilayer, an effect that has
already been shown by the α-helical peptide magainin [248] on model membranes.
It may be assumed that the cylindrical molecular shape of the untreated LPS
D21 in the bilayer (CPP ∼ 1 ) has been extensively modified to a conical shape
(1/3 < CPP < 1/2) which favors the formation of elongated micelles. On the
other hand the weaker interaction of the peptide LFb with the bilayer formed by
LPS D21, could not modify broadly the critical packing parameter of the LPS.
This resulted in LPS maintaining its cylindrical molecular shape with exception
of areas, probably at high peptide concentrations, in which the bilayer is curved,
or curled, into pore-like structures due to a local modification of the CPP of LPS.
3.4.3 LPS E7 and peptides
The cryo-TEM micrographs for LPS E7 in solution at the concentration of 6 mg/ml
in the presence of 1 mM MgCl2 show the formation of complex lamellar structures
with some areas characterized by toroids (Figure 3.28). Former cryo-TEM analysis
Rc LPS from S. minnesota in HEPES buffer reported the formation of elongated
particles [228] while more recent ff-TEM investigations of the same system suggest
the presence of spherical liposomes and planar bilayers [227]. The latter findings
and the data presented in this chapter are supported by X-ray diffraction of Rc
LPS from S. minnesota in the presence of Mg2+ [56]. The Kratky approximation
and the data model fitting as monodisperse sheet shell/core/shell of the SANS data
for the LPS E7 dilution experiment show no concentration effect on the lamellar
structures formed by the LPS. The high values of the Rσ describes a system with-
out a rigid geometry, probably due to lamellae placed very far away, or due to a
heterogeneous population of lamellae or due to high undulation of the bilayers,
which results in the smoothing of any long-range structure between the lamellae
and therefore the absence of fringes in the scattering curves.
The cryo-TEM micrographs for LPS E7 with LL37 peptide suggest the formation
of a mixed population of lamellae, toroids and worm-like micelles (Figure 3.28).
The SANS data set for LPS E7/LL37 samples were analyzed as lamellar structure
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through the Guinier approximation and data modelling monodisperse sheet shel-
l/core/shell revealing that LL37 affects the shell thickness rather than the core of
the aggregates. Despite the heterogeneous population of structures observed at
the higher LL37 concentration, the value of Rσ suggests a controversial increase of
the order of the system, confirmed by the appearance of fringes in the scattering
curve, which had no explanation.The same SANS data set analyzed as worm-like
micelles reports the formation of elongated objects with no detectable changes in
the number of molecules per unit length. The elongated particles seem to be be
formed by a high number of very short segments suggesting the presence of very
flexible structures which easily can close up into toroids. The thickness of the
lamellae shell of the untreated LPS E7 is comparable to the shell thickness of the
worm-like micelles but most of the modifications occurred at the core level, re-
porting a radius of the micelle which is almost half of the lamellae core thickness.
The addition of LFb peptide to the aggregates of LPS E7 caused similar morpho-
logical changes as seen for the addition of LL37 by the observation of the cryo-TEM
micrographs (Figure 3.28). As for the previous case, the SANS data were analyzed
both as lamellae and elongated particles. LFb induced a general decrease in the
lamellae thickness but interestingly the lowest LFb concentration (LPS/peptide
ratio of 50/1) has a bigger impact than the 10/1 ratio when the values of tc and
ts are compared. This unexpected result might be due to the limitation of the
model when it comes to analysis of such a complex system. The analysis of LPS
E7 challenged by the LFb peptide as elongated objects revealed that increasing
concentrations of peptide do not affect the radius and the mass per unit length of
the particles.
Both LL37 and LFb peptides interact with the aggregates of LPS E7 to such an
extent that the system became extremely complex and the intricacy data inter-
pretation reflects such complexity. The inhomogeneity of the aggregates formed
did not allow for a defined and precise analysis of the SANS data. What is clear
is that the removal of the steric shielding of part of the core of LPS and the
phosphates at the heptose level allows for a deeper interaction of the peptides
with the negatively charged phospahte groups at the lipid-A level of the LPS E7.
This deeper interaction of both peptides resulted in the modification of the inner-
most part of LPS E7 aggregates culminating in mixed complex structures. The
higher number of LPS E7 molecules in the samples, compared to the experiments
carried out with LPS 0111B4 and D21, may result in the sequestration of the
peptide in areas in which the peptides could exert their activity, and other areas
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in which there is a limited presence or total absence of peptide, explaining the
lack of uniformity of the samples. In those area of peptides’ activity the extent of
the modification induced by LL37 is qualitatively comparable to the case of LPS
D21. The peptide LL37 already proved to interact efficiently with the LPS D21
aggregates and the removal of part of the core oligosaccharide, as in the LPS E7,
allowed for a stronger modification of the packing parameter of LPS resulting in
defined elongated structures and toroids. On the other hand LFb induced different
morphologies (elongated structures) on LPS E7 aggregates when compared to the
LPS D21 case (pore-like structures in a bilayer of LPS). This could be explained
by the absence of the phosphate groups in the heptose level of the core of LPS
E7, which allowed the peptide LFb to partition more effectively into the aggre-
gate, acting directly with the negatively charged groups of the lipid-A region and
perhaps interacting with the hydrophobic chain region as well . This deeper inter-
action resulted in a stronger curvature effect on the LPS E7 bilayer, resulting in
the formation of elongated micelles favored by a change in the LPS E7 molecular
shape to a CPP value of 1/3 < CPP < 1/2.
3.5 Conclusion
The data presented in this chapter show that LL37 and LFb peptide are not able
to modify the aggregates of smooth LPS 011B4 due to the steric shielding of the
O-antigen part of the LPS molecule. The removal of such a barrier, as seen on
the data set for LPS D21, allowed a stronger interaction of the peptides with
the LPS aggregates. LPS D21 retains some shielding properties due to the core
oligosaccharidic region of LPS therefore LL37 is more effective than LFb peptide
in the modification of the core of the aggregates most likely due to its propitious
physico-chemical properties. The further removal of some of the core LPS shielding
as in the case of LPS E7, uniformed the effect of LL37 and LFb which produced a
comparable modification. Considering the theory of the conformational concept of
endotoxicity [84], both peptides failed to modify the aggregates of smooth, Ra and
Rc LPS from E. coli K12 into a lamellar, less toxic form, as reported previously for
other peptides [207, 215, 228, 249]. LL37 could exert its anti-endotoxic role with
different mechanisms of action than the modification of the morphology of LPS
aggregates as speculated in previous investigations: it can reduce the recognition
of LPS aggregates by the LBP and other mediators of the immune system [250] and
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it can decrease the cell activation induced by LPS acting as an immunonodulatory
molecule [152, 251]. Previous studies on peptides with a β-sheet conformation
[135, 252] showed the potential of such molecules as interacting agents with LPS.
Peptides derived from human LF [207] are able to reduce LPS toxicity inducing the
lamellarization of the aggregates. The data presented in this chapter suggest that
LFb does not reduce LPS toxicity through the lamellarization of the aggregates and
its anti-endotoxic role [221] could be the result of the interaction and sequestration
of LPS molecules as speculated in previous investigations [129, 222].
Chapter 4
Interaction of LL37 and LFb
peptides with monolayers and
bilayers composed of DPPC and
Lipopolysaccharide.
4.1 Introduction.
The OM of Gram negative bacteria is an asymmetric bilayer, the external leaflet
of which is mainly composed of lipopolysaccharide (LPS). The outer membrane
gives structure and stability to the whole bacterial cell and is the first line of
defence against environmental perturbations (e.g. unfavorable temperature, ionic
strength, pH), competitive microorganisms and, in the case of symbiotic bacteria,
defence against host defense immune system reaction. The protective role of the
OM affects also the microbicidal activity of antibiotic drugs used in the treatment
of bacterial infections in humans (Section 1.2). The consequences of a reduced
susceptibility of Gram negative bacteria to common treatments promoted the in-
vestigations of new, more efficient antiseptic molecules [94, 253]. For this reason
particular attention has been given to the class of cationic antimicrobial peptides
(CAPs) as possible therapeutics or adjuvant treatments for highly resistant mi-
crobial infections [95].
In this chapter the interaction of the antimicrobial peptides LL37 and LFb and
monolayers and asymmetric bilayers composed of mixtures of hDPPC and the Ra
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LPS EH100 or the Rc LPS J5 was investigated. Despite not being a natural mem-
brane component, the introduction in the mixture of the zwitterionic hDPPC lipid,
which presents two saturated acyl chains with a Tm of 41
◦C [254], allowed the
stabilization of LPS liposomes and it was chosen in the light of the relative low
interaction of CAPs with membranes composed of lipids which are in the gel phase
state and have a neutral headgroup charge at physiological pH and temperature
[121, 183, 255]. Exploiting the theoretical noninterference of hDPPC , the studies
are focused on the role of different LPSs on the structure of the outer membrane
and the interaction with CAPs, by the use of biophysical techniques. The diver-
sity of the active conformations adopted by the peptides LL37 and LFb would shed
light on the different putative mechanisms of action of CAPs which have shown
binding properties towards bacterial endotoxins [129, 152, 207, 222] and Gram neg-
ative bacterial membranes [130, 144]. The ordered structure of D62DPPC within a
lipid membrane allows the highlighting of the role of LPS molecules in the packing
of the bilayer, thus identifying the structural role of the endotoxin in the cytoplas-
mic membrane of the bacteria.
Both monolayers and bilayers are used to study different aspects of the peptide-
LPS interaction. The Langmuir Blodgett (LB) technique is used to study the
physico-chemical properties of the mixed monolayers of amphiphiles at the air-
water interface and their interaction with the antimicrobial peptides of choice, im-
plemented with NR experiments of the same monolayers at the air-water interface
and asymmetric bilayers supported by a silicon crystal. The subphase injection of
amphiphiles below lipid monolayers at the air/liquid interface is a good method
to study the CAP/LPS interaction because it resembles the biological membranes
[165, 172, 256] and is well suited for NR experiments (Section 4.3.4). In considera-
tion of the fact that the Gram negative bacterial outer membrane is an asymmetric
bilayer in which the outer leaflet is composed almost exclusively of LPS (Section
1.2) this study reports NR investigations on asymmetrical bilayers, supported by
silicon crystals, consisting of an inner leaflet of hDPPC and an outer leaflet of
either the Rc LPS J5 or the Ra LPS EH100 (Section 4.3.5). Recently the very
same system has been investigated by Clifton et. al. [161] which suggested fur-
ther interaction studies with antimicrobial peptides and DPPC/LPS asymmetric
bilayers to study the permealizing activity of CAPs on the OM of the bacteria.
The experiments presented in this study are focused on such an aim and bilayers
composed of either Ra LPS EH100 or Rc LPS J5 and DPPC were challenged by
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the antimicrobial peptides LL37 and LFb to shed light on the mechanism of inter-
action of CAPs with membrane models containing LPS.
In addition, tryptophan fluorescence spectroscopy experiments carried out on vesi-
cles containing mixtures of hDPPC and either Rc LPS J5 or Ra LPS EH100 is used
to compare the depth of the bilayer penetration by the peptides in relation to their
physico-chemical properties, in order to understand how the binding activity of
CAPs with different conformations is affected by the structure of LPS. The same
lipid/LPS mixtures were analyzed by solid state 2H NMR in order to examine the
contribution of the two LPS chemotypes on the packing of the bilayer, and the
effect of the interaction of the peptides on the chain order of the vesicles.
4.2 Materials and methods
4.2.1 Materials
Rc LPS from E. coli J5 (purity: protein 1.4%, nucleic acid 0.340%, phosphate
7.3%, Kdo 5.9%), was obtained from Merck KGaA (Darmstadt, Germany) and
was used without further purification. LPS from E. coli EH100 was obtained from
Sigma-Aldrich Ltd. (Dorset, UK) and used after purification following the method
described in Section 3.2.2. Deuterium oxide D2O 99.990 atom % D, L-tryptophan
and MgCl2 anhydrous were also obtained from Sigma Aldrich Ltd. The lipids
hDPPC andD62DPPC were obtained from Avanti Polar Lipids (Alabaster, USA)
and used without further purification. Chloroform and methanol were obtained
from Fisher Scientific (Loughborough, UK). Ethanol 99% was obtained from VWR
International (Lutterworth, UK). All the organic solvent used were of analytical
grade or better. The ultrapure water at 18.2 MΩ·cm was produced by a Purelab
Ultra machine from ELGA Process Water (Marlow, UK). Whatman chromato-
graphic paper No.1 from Merck KGaA (Darmstadt, Germany) was used to produce
the Wilhelmy plates used for monolayer surface pressure measurements. Details
of the peptides LL37 and LFb are reported in Appendix B.
4.2.2 Tryptophan fluorescence measurements.
Liposomes were prepared containing the same formulations of hDPPC and LPS
used in the LB experiments (Section 4.2.4) according to the formulations reported
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in Table 4.1. The vesicles composed of pure hDPPC will henceforth be referred to
as DPPC, those with a composition of 20% Rc LPS J5 and 80% hDPPC (molar
ratio) will be named J5-20 whereas those composed of 20% Ra LPS EH100 and
80% hDPPC (molar ratio) will be referred to as Eh-20.
Table 4.1: Composition of the lipid/LPS mixtures used in the Langmuir-
Blodgett experiments and tryptophan fluorescence experiments.
Monolayer ID Descriptioni
PC pure hDPPC
Eh-20 20% EH100 - 80% hDPPC
J5-20 20% J5 - 80% hDPPC
lipid A-2Kdo-20 20% lipid A-2Kdo- 80% hDPPC
i for all the mixtures the components’ ratio is expressed in molar percentage.
The thin lipid film hydration method was used to produce the liposomes [257]
whereby the lipid components were mixed in chloroform, according to the required
formulation, in a 5 mL round bottomed flask. The organic suspension was bath-
sonicated at room temperature with an Elmasonic P ultrasonic bath (Elma Hans
Schmidbauer GmbH & Co. KG, Singen, Germany) to ensure the homogenization
of the lipids. The chloroform was removed through the use of a Buchi rotovapor
system R-210 (Buchi Labortechnik AG, Flawill, Switzerland) connected to a KNF
Lab Neuberger Laboport Diaphragm Vacuum Pump UN840.3 FTP (KNF Neu-
berger UK, Witney, UK) and equipped with a Buchi waterbath at 40◦C . The dry
thin film produced by solvent evaporation was rehydrated in an aqueous buffer
containing 10 mM Tris pH 7.4, 1 mM MgCl2 to ensure a final lipid concentration
of 500 µM and was vortex mixed followed by 10 minutes of bath-sonication at
room temperature until the entire film was detached from the sides of the flask.
The resultant lipid suspension was sonicated for 30 minutes with a Soniprobe
model 7535A (Lucas Dawe Ultrasonics, London, UK) in an ice bath to prevent
over-heating of the sample.
The static tryptophan fluorescence measurements were recorded at 37◦C in a 10
mm × 4 mm dual path length cell (Hellma analytics, Mllheim, Germany) with
a Cary Eclipse spectrofluorimeter (Varian Ltd, Oxford, UK) equipped with a
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temperature-controlled water bath, allowing for 5 minutes of temperature equi-
libration before data acquisition. The tryptophans were excited with a monochro-
mated incident beam at 290 nm wavelegnth and the emission spectrum was recorded
between 300 nm and 450 nm, averaging 5 measurements for each sample. Each
liposome formulation at a concentration of 500 µM was challenged with 5 µM
(lipid/peptide ratio 100/1) and 10 µM (ratio 50/1) of either LL37 or LFb , which
was allowed to interact for 5 minutes prior to data acquisition. Correction mea-
surements were employed in order to compensate for the effect of light scattering
by the vesicles [179] which affects the intensity of the fluorescence emission from
the Trp residues. The correction involves the measurement of the emission from
a solution of the amino acid L-tryptophan in buffer (Itrp) and in the presence of
the vesicles (ItrpV) at a concentration equal to the molarity of Trp present in the
relevant samples with the peptides. The background spectra of samples contain-
ing only vesicles (IV) were subtracted from the emission spectra of samples with
vesicles, giving the fluorescence intensities of the samples containing either the
peptides (IpepV) or L-Tryptophan (L-Trp) (ItrpV) only. The corrected value for the





where Itrp is the intensity of the L-Trp without vesicles, ItrpV is the emission of
L-Trp with then vesicles and IpepV is the emission of the peptides with vesicles.
The influence of any inner-filter effect was avoided by adjusting the concentration
of fluorophore in order to maintain an optical density below O.D. 0.05 [179]. The
tryptophan fluorescence intensity was plotted against the wavelength of the emis-
sion (range 300-400 nm) to produce the fluorescence spectrum. From the same
spectrum it was possible to estimate the depth of the insertion through the blue
shift (hypsochromic shift) of the emission by following the wavelength and the
intensity of the maximum emission peak [179]. The emission peak wavelength was
calculated through the maximum intensity of the emission curve by the software
Spekwin32 [258].
Chapter 4. Interaction of CAPs with LPS/DPPC mixtures 110
4.2.3 Solid state 2H NMR measurements.
The lipid/LPS mixtures used to produce the multilamellar liposomes for the 2H
NMR experiments contained 30 or 40% D62DPPC in lieu of the equivalent amount
of hDPPC . The various liposome mixtures used in these experiments are reported
in Table 4.2 with their appropriate acronyms, and these were designed to match
the formulations used for the tryptophan fluorescence experiments and the LB
monolayer at the air-water interface experiments to maintain consistency across
all the techniques. A total of 4 mg of each lipid and LPSs mixture was prepared
Table 4.2: Composition of the LPS-lipid mixtures used in the solid state NMR
experiments.
Liposome mix ID Composition (% molar ratio)
DPPC 60% hDPPC - 40% D62DPPC
Eh-20 20% EH100 - 30% D62DPPC - 50% hDPPC
J5-20 20% J5 - 30% D62DPPC - 50% hDPPC
according to the formulations reported above (Table 4.2), by combining stock solu-
tions of each pure lipid dissolved in chloroform at known concentration in a 25 mL
round bottomed flask. Where necessary, at the mixing stage, the peptides were
added to the lipid mixture solutions at a final lipid/peptide molar ratios of 50:1 or
100:1, from solutions prepared in ethanol . The organic solvents were evaporated
to form a thin film using the same methodology described in Section 4.2.2. The
flask containing the thin film was placed overnight (minimum 12 hours) under
vacuum in a dessicator chamber to ensure that all the chloroform and ethanol
were removed from the thin film. The dry lipid/LPS and lipid/LPS/peptide films
were resuspended in 4 mL of 10 mM TRIS, 1 mM MgCl2 , pH 7.4 buffer to give a
final total lipid concentration of 1 mg/mL. At this stage, to ensure the complete
resuspension of the thin film, the flasks were placed at room temperature in an
Elmasonic P ultrasonic bath (Elma Hans Schmidbauer GmbH & Co. KG, Singen,
Germany) for 10 minutes. In order to produce multilamellar vesicles the lipid sus-
pension was subjected to 5 cycles of freeze/thawing by the use of liquid nitrogen
followed by immersion in a water bath at 40◦C . The suspension was transferred
into centrifuge tubes and centrifuged at 15000 g for 30 min with a Heraeus Biofuge
Pico (Thermo Scientific, UK) to obtain a dense white pellet containing the vesi-
cles.
The pellets were transferred in a Bruker 4 mm MAS rotor. 2H quadruple echo
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experiments on a Bruker advance 400 NMR spectrometer were performed at 61.46
MHz using a 4 mm MAS probe. The spectral width of 100 KHz was used with
recycle delay of 0.25 s, echo delay of 100 µs, acquisition time of 2.6 ms and
90◦C pulse lengths 3 µs. Experiments were performed at 45◦C which is above
the hDPPC phase transition temperature of the lipids and LPSs, to ensure that
the acyl chains were in the fluid phase. Spectra were symmetrized and dePaked by
the Amix software (Bruker) using mixed Gaussian-Lorentian fitting to determine
the quadrupolar splittings [187] and then fitted with the software PeakFit (fitting
r2>0.997) to obtain the SCD plotted against the carbon number in the chain [194].
4.2.4 Langmuir-Blodgett monolayers at the air-liquid in-
terface
P − Area isotherms measurements were carried out at the temperature of 22 ±
3◦C on a Nima Langmuir trough 602A (Nima Technologies Ltd., Coventry, UK)
fitted with a Nima PS4 surface pressure microbalance (0-240 mN/m range, 0.1
mN/m resolution) controlled by a PC equipped with the Nima IU4 computer in-
terface unit software. The microbalance was calibrated with a 10 mg standard
weight and the area enclosed by the barriers was calibrated. Prior to use, the
PTFE surface of the trough was extensively cleaned with ethanol and chloroform
in order to remove any impurities. A clean Whilelmy plate made of Whatman
Grade 1 chromatography paper, 1cm width (GE Healthcare life sciences UK, Lit-
tle Chalfont, UK) was attached to the microbalance and dipped into the subphase
made of a 1 mM MgCl2 solution in ultrapure water. The subphase surface was
cleaned of dust and contaminants prior the experiment, by repeated compression
of the barriers and suction of the surface using a glass pipette attached to a vacuum
pump. The subphase was considered clean when, upon compression, the surface
pressure would not exceed 0.2 mN/m.
The pure lipid or lipid/LPS mixtures were reconstituted by sonication in pure chlo-
roform at a total concentration of 1 mg/mL producing a homogeneous suspension.
For each isotherm, approximately 70 µL of lipid suspension was added dropwise to
the subphase surface using a Hamilton syringe (Hamilton Co. Europe, Bonaduz,
Switzerland), with the barriers open at their maximum. Ten minutes were allowed
for the solvent to evaporate, then the barriers were closed at a constant rate of 35
cm2/min while the changes in surface pressure were constantly recorded and the
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monolayer was compressed until its collapse point was reached.
The limiting molecular area for each monolayer was calculated from the P −Area
isotherm from the intercept on the X-axis of the tangent to the curve at the pres-
sure of 30 mN/m, as reported in Section 1.4.5. Since the monolayers were formed
by mixtures of lipids and LPSs, the additive area per molecule rule was employed
according to the equation
Atot = A1 ·N1 + A2 ·N2 + An ·Nn . . . (4.2)
where Atot is the area per molecule of the mix whilst An and Nn are respectively the
area per molecule and the molar ratio of each single component within the mixture.
Table 4.1 reports the acronyms used in this experiment for each monolayer and
their composition in mixed monolayers, where the ratio between the components
is expressed in molar percentage.
4.2.4.1 Brewster angle microscopy.
A direct qualitative analysis of the macroscopic properties of a film at the air-water
interface can be addressed with the Brewster angle microscopy (BAM) microscopy
technique. The BAM technique exploits the property of interfaces (gas, liquids
and solid) to reflect and refract an incident beam of polarized radiation according
to the refractive index and the angle formed between the surface normal and
the incoming radiation for each interface. The system composed of a lipid film
spread on a water subphase, is a system consisting of three different layers, i.e.
air, lipid film and water, each of them having different refractive indexes. A
polarized He-Ne Laser hitting a LB monolayer at the Brewster angle would be
reflected and captured by a CCD detector pointed toward the surface, specular
to the incident beam. The incident polarized laser beam that hits a clean water
surface will be reflected differently if a monolayer is present at the interface because
the monolayer changes the reflectivity of the interface. The maximum change in
reflectivity happens when the laser beam is at the Brewster angle θB calculated
to be approximately 53◦ from the normal of the surface for the air-water interface
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where n1 and n2 are the refractive indexes of the different media (air and wa-
ter) that the light propagates through. If the lipid monolayer is in a coexistence
state between two phases (e.g. the gas and liquid phases) these two phases would
have different reflectivities. The image that the CCD camera produces might have
brighter regions formed by lipid in a denser phase such as liquid-condensed or solid
phases, and darker regions consisting of less dense phases such as those in the gas
or liquid-expanded phases. A homogeneous image without domains or patches
corresponds to a homogenous phase monolayer in a uniform ordered state. The
BAM measurements were performed at the Soft Matter facility at the Institut
Laue-Langevine (ILL) by the use of a custom made BAM apparatus fitted on a
Nima/KSV Spot LB trough (Nima/KSV Ltd., Espoo, Finland). The monolayers
were spread according to the methodology described in the previous section (Sec-
tion 4.2.4).
The BAM technique has been extensively used in order to study monolayers of
lipids [260–262] as well as monolayer composed of Rc LPS from E. coli [21] qual-
itatively and to investigate the insertion of proteins into films [263, 264]. This
technique would help the characterization of the LB isotherms in terms of attrac-
tive/repulsive forces between the molecules in the film. The visualization of the
domains of a lipid monolayer would shed light on the effect of exogenous compo-
nents, i.e. LPS, on the packing behavior of a well characterized film of hDPPC .
.
4.2.4.2 Interaction studies of LL37 and LFb peptides and the mixed
DPPC/LPS monolayers.
A variation of the LB trough technique was used to investigate the interaction
of the peptides LL37 and LFb and the mixed monolayers hDPPC /LPS described
above (Table 4.1). The experiment was performed at 22◦C using the Nima PS4
surface pressure microbalance with a 50 mm diameter Petri dish made out of
fluorinated ethylene propylene (FEP) (Welch fluorocarbon Inc., Dover, UK) and
placed over a magnetic stirring plate. The Petri dish was filled with filtered ultra-
pure water containing 1 mM MgCl2 giving a final subphase volume of 15 mL. A
small magnetic stirrer was placed into the subphase into which a Whilelmy plate
attached to the pressure sensor was dipped. A small disposable plastic syringe of 1
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mL volume (BD biosciences UK, Oxford, UK) containing a solution of 250 µg/mL
of peptide was clamped into a stand close to the dish and the gauge inserted into
the subphase below the surface. The surface was cleaned from contaminants by
suction with a vacuum pump and the mixtures of LPS and lipid in chloroform
was spread dropwise on the subphase until a surface pressure of approximately 32
mN/m was reached. The surface pressure was recorded at constant slow stirring
of the subphase, with the magnet speed set at its minimum in order to avoid
a variation of pressure greater than 0.2 mN/m. The monolayer was allowed to
equilibrate until it reached a plateau before carefully injecting 100 µL of peptide
solution into the subphase. The change in pressure was plotted against time and
the binding isotherms produced were fitted with a simple exponential equation
y = A(1 − e−k(x)) to obtain kinetics parameters for A the maximum change in
pressure and k the rate of pressure increase.
4.2.5 Neutron reflectivity of mixed LPS/DPPC monolay-
ers at the air/liquid interface and their interaction
with antimicrobial peptides.
The NR measurements were carried out on mixed monolayers composed of the
LPS chemotypes Rc J5 or Ra EH100 and hydrogenated hDPPC or tail-deuterated
D62DPPC described in Table 4.3 spread onto a water subphase containing 1 mM
MgCl2 at 22
◦C , before and after the subphase injection of the peptides LL37 or
LFb , were performed on the FIGARO beam line at the ILL high-flux reactor in
Grenoble (France). A reduced area custom-made Teflon R© Langmuir trough (50
mL subphase volume) was placed on an active anti-vibration movable table for
which the height could be controlled by the user or automatically set up by the
instrument. The alignment of the instrument beam and the detector was achieved
by the use of a laser hitting the subphase; the same laser was used during the
NR experiment to automatically align the beam to the interface. The incoming
neutron beam had a wavelength between 2 A˚ and 30 A˚ and grazed the subphase
from above. The specularly reflected beam was collected by a movable two dimen-
sional detector.
The mixed monolayers under study contained either hDPPC or D62DPPC depending
upon the desired isotopic contrast, and the relative acronyms for each monolayer
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Table 4.3: Composition of the lipid/LPS mixtures used in the NR air/liquid
interface monolayer experiments.
Monolayer ID Descriptioni
Eh-20 20% EH100 - 80% hDPPC
J5-20 20% J5 - 80% hDPPC
d-Eh-20 20% EH100 - 80% D62DPPC
d-J5-20 20% J5 - 80% D62DPPC
i for all the mixtures the components’ ratio is expressed in molar percentage.
used during the experiments are reported in Table 4.3. The tail deuterated DPPC
was mixed with the LPS chemotypes to be used with either D2O or ACMW (8%
D2O in water v/v) subphase in order to highlight the properties of the hydro-
genated headgroups and the hydrophobic region of the monolayers, respectively.
The hydrogenated DPPC was used on D2O subphase to focus on the properties of
the whole monolayer. Both D2O and ACMW subphases always contained 1 mM
MgCl2 .
The monolayer mixtures were suspended in chloroform after extensive sonication
in a Elmasonic P ultrasonic bath (Elma Hans Schmidbauer GmbH & Co. KG,
Singen, Germany) and were spread on a clean subphase free of contaminants (see
Section 4.2.4) using a Hamilton syringe (Hamilton Co. Europe, Bonaduz, Switzer-
land). The chloroform was allowed to evaporate for 10 minutes and the barrier
were closed at a constant rate of 15 cm2/min in order to compress the monolayer
until the lateral pressure of 30 mN/m was reached. The barriers were then kept
fixed at a constant area and the monolayer was allowed to equilibrate and reach
a stable pressure, determined by the formation of a plateau on the P − Area
isotherm (Figure 4.1). A concentrated peptide solution of either LL37 or LFb was
carefully injected into the subphase by the use of a small syringe to transfer a
total amount of 300 µg of peptide into the subphase. The interaction between
the peptides and the monolayer was allowed to progress until a surface pressure
plateau was reached, as shown in Figure 4.1.
The acquisition of the NR spectra was performed during the plateau phases of
the monolayers defined by the P − Area isotherms and the reflectivity data was
collected at two different angles to achieve the full Qz range. The NR profiles for
each monolayer mixture with diverse isotopic contrast in the absence or presence
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of either LL37 or LFb peptides were reduced and the data from the different con-
trast were simultaneously fitted with the RasCAL analysis software, the fitting
being considered acceptable when the Chi-square value was lower than 60.






















Figure 4.1: Isotherm of the monolayer d-Eh-20 on D2O with the injection of
the peptide LL37. The area and the pressure of the monolayer are reported over
time.
The chain region was considered to be composed of the hydrophobic acyl chains
only, whilst the inner headgroup was taken to be composed of the glucosamine
(GlcN) and the Kdo residues of LPS together with the headgroup of hDPPC . The
carbohydrates constituting the core of the LPS over the Kdo residues were consid-
ered to form the outer headgroup of the monolayer. Some additional parameters
were implemented into the fitting program and kept constant, these included the
amount of solvent present in the chain region, which was considered to be negligi-
ble, and the SLD of the fully hydrogenated and mixed hydrogenated/deuterated
chains. The calculation of the total SLD of the chains considered the ratio between
the lipid (D62DPPC or hDPPC ) and the hydrogenated LPSs (respectively 80 to
20, molar ratio) and their relative SLDs. It was found that the total SLDs of the
fully hydrogenated and mixed H/D chain regions were respectively −1.34 × 10−7
and 6.10× 10−6 A˚−2 .
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4.2.6 Neutron reflectivity of asymmetric bilayer of DPPC
and LPS and interaction with antimicrobial peptides.
The Langmuir-Schaefer technique was used for the deposition of the bilayer on a
clean polished silicon single-crystal block by the use of a LB Nima/KSV trough
(Nima/KSV Ltd., Espoo, Finland). The block was submerged into the ultrapure
water subphase containing 1mM MgCl2 kept at 4
◦C and the water surface was
cleaned thoroughly by suction to remove the superficial impurities. A monolayer
of hDPPC was spread at the interface and compressed slowly to a constant sur-
face pressure of 30 mN/m. The submerged silicon block was lifted through the
air-water interface at a speed of 3 mm/min and the barrier of the trough were al-
lowed to close in order to maintain the surface pressure at 30 mN/m (close to the
natural membrane lateral pressure [165]). The silicon block, now covered with a
homogeneous hDPPC layer with the headgroup adsorbed to the silicon block and
the hydrophobic tails facing the environment, was attached to a holder above the
water surface with the acyl chains pointed downward toward the interface. The
surface was cleaned and a monolayer of LPS was spread until the surface pressure
of 30 mN/m, which was kept constant. A built-in laser equipped device attached
to the LB trough was used to level the surface of the crystal to make it parallel
with the interface. The silicon block was lowered at a speed of 3 mm/min through
the interface in order to allow the lipid monolayer on the block to match the LPS
monolayer on the subphase via the hydrophobic chains, producing a bilayer. The
block was then allowed to continue moving downwards until the bottom of the
trough was reached where a customised sample cell made of PTFE was placed.
The sample cell and silicon block were placed in a custom made metal holder to
ensure the bilayer was fully contained and sealed inside the small water chamber
of the sample cell, for which total volume was 3 mL.
The specular NR measurements were carried out using the CRISP instrument at
the Rutherford Appleton Laboratory (Oxfordshire, UK) which utilizes a neutron
beam wavelength λ from 0.5 to 6.4 A˚ to hit the sample at the incident angles
θ of 0.35◦C , 0.8◦C and 1.8◦C on a special adjustable anti-vibration table. The
intensity of the reflected beam was measured as a function of the momentum
transfer Qz = (4pisinθ)/λ (Section 1.4.1). The sample holder was fitted with a
L7100 HPLC pump (Hitachi/Merck, Germany) which allowed for the automated
control of the exchange of the different isotopic contrast solvents and their flow,
directly from the same software (OpenGENIE) used to run the command script
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that controlled the CRISP instrument. For each isotopic contrast the reflectivity
was measured after the bulk phase was equilibrated at the temperature of 37◦C by
the use of a Julabo water bath (Julabo GmbH, Seelbach, Germany) connected
to the sample holder and controlled by the instrument’s software. In the case of
the experiments in the presence of LL37 and LFb , the peptides were dissolved
directly into the bulk phase solvent to produce a solution with a concentration
of 250 µg/mL and were injected into the sample cell’s chamber and allowed to
equilibrate for 30 minutes before data acquisition. During the experiments all the
isotopically matched bulk phases contained 1 mM MgCl2 .
In order to highlight the different components of the hydrogenated bilayer of
DPPC/LPS, the three different isotopic contrasts used were 100% D2O , silicon
matched water (SMW) ( 38% D2O ) and 100% H2O , producing three different
reflectivity profiles. The three contrasts allowed the determination of structural
parameters of the layer model described in Figure 1.16 by the use of the reflectivity
fitting software RasCAL, which simultaneously fitted the three different reflectiv-
ity profiles by the calculation of the common parameters obtained from datasets
of multiple contrasts. The calculated SLDs for the subphases D2O , SMW and
H2O were respectively 6.38 × 10−6 A˚−2 , 2.08 × 10−6 A˚−2 and −0.55 × 10−6 A˚−2 .
The limited number of contrasts used in this study did not allow a sensitive dis-
crimination between the silicon oxide layer and the adjacent water layer hence the
fitting model considered those two layers as a single layer named oxide layer, the
parameters of which were determined by the best fit produced by the software.
The best fits allowed the calculation of the parameters of the inner headgroup,
tails and outer headgroup layers, as well as the bilayer roughness which considers
the imperfections of the surface of the bilayer. The tail SLD value for the bilayers
in the absence of peptides was kept constant at −3.9×10−7 A˚−2 as previously cal-
culated [265] whereas the percent of tail hydration was calculated from the fitting.
The values of the SLD of the inner and outer headgroup layers were calculated
separately for each contrast applied by the fitting software. For each layer, the
thickness was calculated in order to determine any structural changes induced by
the presence of the peptides.
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4.3 Results
4.3.1 Tryptophan fluorescence spectra.
Tryptophan fluorescence measurements were conducted using vesicles composed
of pure hDPPC , Eh-20 and J5-20 (see formulations reported in Table 4.1). The
tryptophan emission spectra of the peptides were acquired and these, together
with the spectra for the lipid/peptide ratio 50/1, are plotted in Figure 4.2 as an
example, whilst the emission peak wavelengths and the emission peak intensity
for both the ratios 100/1 or 50/1 are reported in Table 4.4.
Table 4.4: Parameters obtained from static fluorescence emission measure-
ments of the tryptophan emission from the peptides LL37 and LFb in the pres-
ence of hDPPC, Eh-20 or J5-20 liposomes at 37◦C in 10 mM Tris pH 7.4, 1 mM
MgCl2 . Lipid/peptide ratios 100/1 and 50/1.
Peak Wavelength (nm) Peak intensity (a.u.)
Lipid/peptide ratio 100/1
Vesicle LL37 LFb LL37 LFb
no vesicles 350.0 353.5 192.3 174.5
DPPC 346.5 349.0 193.8 157.3
J5-20 325.0 341.0 623.1 288.9
Eh-20 326.0 339.5 508.2 316.0
Lipid/peptide ratio 50/1
Vesicle LL37 LFb LL37 LFb
no vesicles 348.5 353.0 366.5 318.5
DPPC 347.0 351.5 344.0 292.7
J5-20 326.0 342.5 718.5 501.1
Eh-20 324.5 340.0 1105.0 552.1
At the lower peptide concentration, ratio 100/1 (Table 4.4), LL37 peptide does not
effectively penetrate the hDPPC vesicles, since the position of the emission peak
and intensity are very similar to the ones obtained from the peptide alone. The
fluorescence emission in the presence of vesicles composed of the mixtures Eh-20
and J5-20 showed a significant hypsochromic shift of the peaks and an increase
of the intensity, suggesting that LL37 interacts and partitions into the membrane
in the presence of LPS. The peak shift of the emission of LL37 ’s tryptophans
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between the two LPS-containing liposome compositions is comparable whereas
the peak intensity is higher in the case of the J5-20. This may suggest that
despite a similar penetration depth, more peptides are bound to the J5-20 vesicles
than Eh-20 vesicles. As for the case of LL37 peptide, LFb at a lipid/peptide ratio
of 100/1 does not interact effectively with hDPPC vesicles and it seems that the
peak intensities are reduced compared to the peptide alone. This could be due to
a possible aggregation of the peptide which forms apolar domains assembled from
the hydrophobic facets of each monomer and that bury the tryptophans slightly
shifting the fluorescence peak; such behavior was hypothesized by Haukland and
Vorland [266]. The emission of LFb in the presence of either J5-20 or Eh-20 vesicles
produced a comparable hypsochromic wavelength shift. The higher peak intensity
detected in the presence of Eh-20 may suggest a greater amount of peptide close to
the hydrophobic chains when LPS EH100 is present in the bilayer, compared to the
intensity peak obtained from the sample containing the vesicles J5-20. Compared
to LL37 , LFb appears to interact less with the vesicles containing either LPS at
the lipid/peptide ratio of 100/1.
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Figure 4.2: Interaction of LL37 (A) and LFb (B) peptides with liposomes of
pure hDPPC, Eh-20 and J5-20 mixtures at 37◦C in 10 mM Tris pH 7.4, 1 mM
MgCl2 at a lipid/peptide ratio of 50/1.
Even at the higher LL37 peptide concentration (ratio 50/1), in the presence of
hDPPC vesicles, there is no hypsochromic shift of the emission peak suggesting
that the peptide does not penetrate effectively into the bilayer of these vesicles. In
the presence of both J5-20 and Eh-20 vesicles the wavelength shift of LL37 emission
peak is comparable to the one at the lower peptide concentration of the 100/1
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ratio, but the peak intensity increased especially in the presence of Eh-20 vesi-
cles. The intensities of the peaks are increased in both cases perhaps due to
a greater presence of LL37 into the bilayer. At this concentration LL37 has a
greater affinity for Eh-20 vesicles, in contrast with the findings at a lower peptide
concentration. LFb behaves in a similar way to LL37 concerning the interaction
with hDPPC liposomes, showing a similar emission peak wavelength and a slight
lower peak intensity. The presence of either EH100 or J5 LPSs in the mixtures
increased significantly the emission peak intensity maximum, concurrently with a
hypsochromic shift of the emission peak. The LFb emission peak intensities in-
creased with the increasing concentration of the peptide although there was no
modification of the peak position for the two peptide/liposome ratios studied.
4.3.2 Solid state 2H NMR.
The measurement of the SCD profile for a lipid bilayer provides a quantitative esti-
mation of the order state along the chain length of the lipids by the measurement
of the molecular motion within the chains (details are provided in Section 1.5.2).
The profile consist of a plateau in the SCD order values in the carbons proximal to
the interface of the bilayer, followed by a magnitude decrease toward the chain’s
terminal carbon [267]. The 2H NMR quadrupole splitting allows a description of
the dynamic and conformation of acyl deuterated lipid within a bilayer and regis-
ters any perturbation of the order parameter induced by the addition of CAPs or
other membrane perturbing molecules [185, 194, 268]. Solid state 2H NMR experi-
ments were carried out on vesicles of pure DPPC and mixtures Eh-20 and J5-20 as
reported in the formulations of Table 4.2. The addition of the two LPS chemotypes
induced a limited broadening of the 2H NMR spectrum of hDPPC (Figure 4.3 A)
suggesting the conferring of an ordering effect on the lipid bilayer above the Tm of
hDPPC . The ordering effect induced by J5 LPS is of greater magnitude than the
effect induced by EH100 LPS, as shown by the smoothed order parameter SCD in
Figure 4.3 B. The J5-20 bilayer induces an ordering effect which is be distributed
along the carbon chains of D62DPPC , from the distal carbons to the ones closer to
the heagroup. EH100 LPS influence on the ordering of D62DPPC chains is more
subtle and it is mostly limited to the carbons closer to the headgroup region.
The effect of the peptides LL37 and LFb on the order state of the bilayers at a
lipid/peptide molar ratio of 50/1 was investigated in the same conditions men-
tioned above.
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Figure 4.3: 2H NMR analysis at 45◦C of the pure DPPC , Eh-20 and J5-20
vesicles.(A) DePaked powder spectra of D62DPPC signal. (B) Smoothed order
parameter (SCD ) plot versus the carbon position of the D62DPPC NMR spectra.
LL37 scarcely modifies the 2H NMR spectrum of the Eh-20 vesicles, whereas it
induces more significant changes in the J5-20 vesicles with an appreciable broad-
ening of the powder spectrum of D62DPPC (Figure 4.4 A). The SCD plot shows
that Eh-20 order parameter is not modified by the presence of LL37 , whilst J5-20
signal in the presence of the peptide produced a decrease in order of the distal
carbon of the chains (Figure 4.4 B) suggesting a disordering effect on the bilayer.
The LFb peptide had no noticeable effects on the 2H NMR spectrum of the Eh-20
bilayer and the modifications induced to the 2H NMR spectrum of J5-20 are less
marked than the LL37 case. The SCD profiles of the Eh-20 vesicles in the absence
or presence of the peptide LFb at a lipid/peptide molar ratio of 50/1 are identical
(Figure 4.5 B). A detailed observation of the smoothed order parameter of J5-20
bilayer in the presence of LFb shows that the peptide induces a slight ordered state
of the bilayer at the carbons closer to the headgroup region.
For a comparison the DPPC vesicles were challenged by the peptides LL37 and
LFb at the same conditions. LFb at the lipid/peptide ratio of 50/1 reduced no-
ticeably the SCD values of DPPC vesicles; the disordering effect was marked on
the carbons closest to the headgroup region (Appendix C). LL37 did not allow
the formation of vesicles when mixed with the hDPPC /D62DPPC lipids; even at
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Figure 4.4: 2H NMR analysis at 45◦C of Eh-20 and J5-20 vesicles in the pres-
ence or absence of the peptide LL37 at a lipid/peptide molar ratio of 50/1. (A)
DePaked powder spectra of D62DPPC signal. (B) Smoothed order parameter
(SCD ) plot versus the carbon position of the D62DPPC NMR spectra.
lower peptide concentration it was not possible to obtain a liposome pellet.
4.3.3 Langmuir-Blodgett monolayers of mixed Ra and Rc
LPS and DPPC.
Surface pressure-area per molecule isotherms (P −Area) were used to characterize
the mixed monolayers of lipids and LPS and to calculate the area per molecule of
each LPS chemotype. The P −Area isotherms of pure hDPPC and mixed mono-
layers containing molar ratios of 80% hDPPC and 20% of either LPS EH100 or LPS
J5 on water subphase of 1 mM MgCl2 solution at 22
◦C , are shown in Figure 4.6
whilst the values of the area per molecule of each component are reported in Table
4.5. The total area per molecule of the mixed monolayers containing the LPSs is
greater than the one of pure hDPPC , due to the presence of the bulky headgroup
of the LPS. In consideration of the additive rule for the area per molecule within
a mixed monolayer described by Equation 4.2 in Section 4.2.4 it is possible to
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Figure 4.5: 2H NMR analysis at 45◦C of Eh-20 and J5-20 vesicles in the pres-
ence or absence of the peptide LFb at a lipid/peptide molar ratio of 50/1. (A)
DePaked powder spectra of D62DPPC signal. (B) Smoothed order parameter
(SCD ) plot versus the carbon position of the D62DPPC NMR spectra.
calculate back the area per molecule of each single component; the resultant area
per molecule of EH100 LPS and J5 LPS are thus respectively 175.1 and 119.7 A˚2
which are in accordance with the relative sizes of the headgroups. The isotherms
for pure hDPPC obtained in this experiment are comparable with those observed
in previous experiments [269] and present the characteristic liquid expanded (LE)
to liquid condensed (LC) phase transition occurring below 10 mN/m in the pres-
ence of Mg2+ ions [270, 271]. The addition of 20% molar ratio of either LPS
EH100 (Eh-20 monolayer) or LPS J5 (J5-20 monolayer) to hDPPC monolayers
removed the LE-LC phase transition of hDPPC and the shape of the curve from
the gaseous to the solid phase is gradual (Figure 4.6); this effect has already been
observed in monolayers containing hDPPC and either smooth or Re LPSs at differ-
ent hDPPC /LPS ratios [175, 176]. A detailed observation of the three isotherms
(Figure 4.6) in the liquid condensed phase, between ∼10 and ∼20 mN/m, shows
that the LC phase of the hDPPC isotherm is steeper than the LC phase of the
curves of the monolayers containing LPS, suggesting that in this phase the pure
hDPPC monolayer is less compressible while the addition of the LPS chemotypes
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makes the film more fluid and elastic. In the region of the LC-solid phase, at sur-
face pressures above 20 mN/m, thehDPPC monolayer and the Eh-20 monolayer
present a steeper isotherm curve compared to the monolayer containing Rc J5
LPS, suggesting that during this phase only J5 LPS has a greater fluidizing effect
on the hDPPC monolayer.
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Figure 4.6: Surface pressure-area per molecule isotherms at 22◦C on subphase
of 1 mM MgCl2 solution of pure hDPPC, J5-20 and Eh-20 monolayers.
Table 4.5: Area per molecule of hDPPC and LPSs calculated according to
Equation 4.2.
Molecule Area per molecule Standard
(A˚2/molecule) deviation
hDPPC 57.5 2.4
LPS J5 119.7 7.3
LPS EH100 175.1 13.0
The calculation of the surface compressional modulus from the isotherms allows
a better understanding of the compressibility of the monolayers and the effect of
the addition of LPS to hDPPC films. The compressibility modulus (ES) is derived
from the reciprocal of the monolayer’s compressibility modulus (CS) according to










Chapter 4. Interaction of CAPs with LPS/DPPC mixtures 126
where A is the area per molecule and dpi/dA is the slope of the isotherm at a
defined surface pressure. A liquid condensed state is characterized by ES values
within 100-250 mN/m whereas a solid state is characterized by ES values above
250 mN/m. [273]. The plot ES vs surface pressure allows an appreciation of the
effect of the addition of 20% of either EH100 or J5 LPS in hDPPC monolayers
(Figure 4.7) [274]. Pure hDPPC monolayers enter the liquid condensed state right
above the surface pressure of 10 mN/m and the rapid ES increase suggests a low
compressibility of this monolayer which reaches the solid state at 30 mN/m pres-
sure equivalent to the the lateral pressure of the biological membranes [165]. The
compressibility curves of the mixed monolayers containing 80% of hDPPC and
20% of either EH100 or J5 LPS show a different behavior. Both LPSs decrease
the ES values of hDPPC isotherms allowing the formation of a liquid expanded
phase up to the surface pressure of 25 mN/m, the pressure at which the mono-
layers entered a liquid condensed state. Neither of the mixed monolayers Eh-20
and J5-20 show the formation of a proper solid phase, according to the values of
the compressional modulus. This evidence suggests a fluidizing effect of the LPSs
on hDPPC monolayers at 22◦C , despite the data obtained from the isotherms
which indicate the reach of a condensed state. The disordering effect of LPS on
hDPPC monolayers has been observed before in LB experiments with hDPPC and
smooth LPS [175] and solid state NMR experiments containing hDPPC and rough
LPS from E. coli , below the Tm of DPPC [275].
Table 4.6: Surface compressive modulus ES for each monolayer at 22
◦C at 30
mN/m lateral pressure on a water subphase containing 1 mM MgCl2 .
Monolayer Surface compressive modulus ES
(mN/m)
PC 250 ± 45
J5-20 175 ± 38
Eh-20 168 ± 12
A detailed investigation of the curves in Figure 4.7, despite the considerable error
bars, shows that over the surface pressure of 30 mN/m (Table 4.6) the compress-
ibility of monolayers containing J5 is lower than the compressibility of monolayers
containing EH100, something not apparent from the direct observation of the
isotherms.
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Figure 4.7: Surface compressive modulus ES for hDPPC, 20% J5-80%hDPPC
and 20% EH100-80%hDPPC monolayers at different pressure on water subphase
containing 1 mM MgCl2 at 22
◦C .
Stability of mixed monolayers. In order to define the stability of the mixed
monolayers composed of 80% DPPC and 20% of either EH100 or J5 LPS at 22◦C on
water subphase of 1 mM MgCl2 solution, the films were subjected to multiple cycles
of compression and relaxation and the surface pressure was continuously recorded.
The cycled isotherms of the mixed monolayers do not overlay completely (Figure
4.8 A and B) and show the presence of some hysteresis, caused by the loss of
material into the subphase which results in a lower area per molecule at high
pressures.
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Figure 4.8: Eh-20 (A) and J5-20 (B) monolayers cycled up to the target
pressure of 40 mN/m at 22◦C on water subphase of 1 mM MgCl2 solution.
The monolayer stability in the same subphase conditions at 22◦C was studied at a
constant surface area measuring the change in surface pressure over time as well.
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Figure 4.9: Eh-20 (A) and J5-20 (B) monolayers stability at constant barrier
area over time at 22◦C on water subphase of 1 mM MgCl2 solution.
The isotherms reported in Figure 4.9 show that the monolayer Eh-20 reached a
final pressure of approximately 24 mN/m were it stabilizes in two hours, whilst
the J5-20 monolayer took longer to equilibrate to a final pressure of approximately
28 mN/m in more than three hours.
4.3.3.1 Brewster angle microscopy
BAM images at 22◦C on water subphase containing 1 mM MgCl2 were taken for the
monolayers hDPPC , Eh-20 and J5-20 in order to investigate the structural modifi-
cations induced by the presence of 20% of either EH100 or J5 LPS inhDPPC films.
In Figure 4.10 the BAM images of the monolayers at different lateral pressure are
reported. The hDPPC monolayer developed the characteristic cluster pattern with
the formation of white lobed-like domains of lipids typical of the LE-LC transition
state [261]. The compression of the hDPPC monolayer over the LE-LC transition
shows the aggregation of the condensed domains until, upon further compression
above 14.5 mN/m, they disappear when the film is compressed up to its solid
phase. During the solid phase no islands are visible because the repulsive forces
between the different clusters are overcome by the lateral pressure and the film
presents a homogenous surface.
The J5-20 monolayer (Figure 4.10) at a surface pressure below 15 mN/m presents
domains which are probably formed by hDPPC in the liquid condensed state,
whereas the remainder of the monolayer is still in a liquid expanded state (Fig-
ure 4.7). The presence of LPS J5 modified the shape of the domains of hDPPC
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Figure 4.10: BAM images of surface pressure-area per molecule isotherms at
22◦C on water subphase of 1 mM MgCl2 solution of pure hDPPC, Eh-20 and
J5-20 monolayers.
suggesting a close interaction between the amphiphiles. A similar effect was ob-
served for Re LPS and hDPPC monolayers in the presence of Ca2+ , using a fluores-
cence microscopy technique on monolayers at the air-water interface [176]. Above
15 mN/m the film enters the liquid expanded phase and the image becomes more
homogeneous, but still some clusters are visible up to 35 mN/m. Probably the
existence of domains at every surface pressure suggests that the J5-20 monolayer
is in constant coexistence between two phases corresponding to the absence of a
defined phase transition of the P − Area (Figure 4.6).
The Eh-20 monolayer is characterized by the absence of domains at low surface
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pressure up to 10 mN/m, suggesting a homogeneous gas phase. This homogeneity
may suggest that EH100 has a fludizing effect on hDPPC , removing completely the
characteristic LC domains of DPPC. The nucleation visible at 15 mN/m suggest
the formation of a coexistent LE-LC phase, which is maintained up to 35 mN/m.
The actual shift of the phase transition of hDPPC towards higher pressure sup-
ports the hypothesis of a disordering effect of EH100 on the hDPPC monolayer.
The dashed white line on the picture of Eh-20 monolayer at 35 mN/m highlights
a possible rupture of the monolayer, indicating the proximity to its collapse.
4.3.3.2 Interaction studies of LL37 and LFb peptides and the mixed
DPPC/LPS monolayers
The mixed hDPPC /LPS monolayers spread on the water subphase containing
1 mM MgCl2 solution at 22
◦C held at a constant area per molecule were chal-
lenged by a subphase injection of the two peptides LL37 and LFb . The resultant
changes in surface pressure of the monolayers were recorded and the data plotted
in binding isotherm plot of pressure against time (Figure 4.11). The initial lat-
eral pressures of the pure DPPC, Eh-20 and J5-20 monolayers were respectively
29±3 mN/m, 25±4 mN/m and 28±2 mN/m. The curve was fitted as a simple
exponential function which parameters k, the rate of the change in the surface
pressure, and PMax, the maximum change in pressure, describe respectively how
quick and efficient is the interaction and the extent of this interaction in terms of
surface pressure modifications (Table 4.7).
The presence of 20% of either EH100 or J5 LPS in the monolayer of hDPPC allows
for a rapid binding of LL37 , characterized by a linear increase in the surface
pressure already in the initial 5 minutes of interaction (Figure 4.11 A); the rate
of surface pressure increase k is 0.004 and 0.003 s-1 respectively for Eh-20 and
J5-20 monolayers, hence the increase of surface pressure induced by LL37 on Eh-
20 monolayer is faster than in the case of the J5-20 monolayer. LL37 induces a
greater total surface pressure change in Eh-20 monolayer than in J5-20 monolayer,
as reported by the PMax values which were respectively 17.3 and 11.2 mN/m.
LL37 binds less with the monolayer composed of pure hDPPC (Figure 4.11 A) as
revealed by a slow and gradual surface pressure change with a rate (k) value tenfold
lower than the value in the presence of LPSs in the mixture; the extent of the sur-
face pressure modification is also lower and the PMax reaches only 4.4 mN/m and
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Figure 4.11: Binding isotherms of the peptides LL37 (A) and LFb (B) with
pure hDPPC, Eh-20 and J5-20 monolayers at 22◦C on water subphase contain-
ing 1 mM MgCl2 solution.
approaches a plateau after one hour. The LFb peptide injection yields identical k
values for both monolayers containing EH100 and J5 LPS (Table 4.7). Whereas
the PMax values for the monolayers containing EH100 (14.8mN/m) is slightly
higher than for the monolayer containing J5 LPS (12.0 mN/m). LFb showed no
interaction with hDPPC , and the monolayer pressure stayed constant.
In general the k and PMax values are lower for the LFb interactions than for
the LL37 , suggesting a signficantly weaker binding capacity of LFb with mixed
monolayers of hDPPC /LPSs.
Table 4.7: Kinetic parameters obtained from the fitting of the binding
isotherms of LL37 and LFb peptides and the monolayers at 22◦C on water sub-
phase containing 1 mM MgCl2 solution. k is the rate of pressure increase, P
max is the maximum pressure reached.
Parameters DPPC J5-20 Eh-20
LL37 P Max (mN/m) 4.4 ± 1.6 11.2 ± 1.3 17.3 ± 1.4
k (s-1) 6.0e-04 ± 4.0e-5 3.0e-03 ± 2e-4 4.0e-03 ± 3e-4
LFb P max (mN/m) — 12.0 ± 1.6 14.8 ± 1.0
k (s-1) — 1.0e-03 ± 9e-4 1.0e-03 ± 4e-4
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4.3.4 Neutron reflectivity of mixed LPS/DPPC monolay-
ers at the air/liquid interface and interaction with
antimicrobial peptides.
Previous interaction experiments were carried out in Section 4.3.3.2 for the same
mixed monolayers containing 80% of DPPC and 20% of either Ra EH100 LPS
(Eh-20 monolayer) or Rc J5 LPS (J5-20 monolayer). In that case, using a 50
mm diameter circular trough with a significantly smaller volume of subphase, the
binding of the peptides LL37 and LFb was much faster than the binding observed
with the LB trough used in these NR experiments. The reason of this discrep-
ancy resides in the greater volume of the trough of the NR experiments and the
lack of a stirring apparatus which would have more rapidly distributed the pep-
tide throughout the subphase, thus increasing the rate of peptide binding to the
monolayers. In the NR experiments the velocity of the binding relied only on the
passive diffusion of the peptide in the subphase which was more than three times
the volume of the subphase used in the previous experiments. This resulted in a
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Figure 4.12: Scheme of the layers in which the monolayers are divided during
the NR data fitting and the parameters obtained from the fitting.
Nevertheless the study of the interaction between CAPs and monolyers containing
LPS proved to be remarkably useful and a reliable method to assess the interac-
tion and the permeation capacity of the peptides into Gram negative membrane
mimetic systems [172, 256, 276].
Both the peptides LL37 and LFb interacted more rapidly with the Eh-20 mono-
layer than with the J5-20 monolayer (Figure 4.13 A and B). The LL37 peptide
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induced a similar magnitude of change of surface pressure in the monolayers EH-
20 and J5-20. It is evident that, compared to LL37 , the peptide LFb shows less
interaction with both Eh-20 and J5-20 monolayers. The interaction of LFb with
the monolayers seems to be more gradual than the LL37 peptide which suggests
a lower binding affinity (Figure 4.13 B). These findings are in agreement with the
interaction studies described above in Section 4.3.3.2.
The simultaneous fitting of the NR data from at least two contrasts for each
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Figure 4.13: Examples of kinetics of binding isotherms (pressure over time)
of the monolayers Eh-20, J5-20 and lipid A 2Kdo-20 after subphase injection of
LL37 and LFb peptides at 22◦C on D2O subphase containing 1 mM MgCl2 .
monolayer facilitated the construction of the reflectivity and the SLD profiles of
the monolayers Eh-20 and J5-20. The model applied to the reflectivity data con-
sidered a monolayer divided into adjacent layers as reported in the scheme of
Figure 4.12. The parameters obtained from the data fitting of the NR data of the
bilayers Eh-20 and J5-20 in the absence or presence of the peptides, either LL37 or
LFb , are reported in Table 4.8. The full range of reflectivity plots are reported in
Appendix E.
The reflectivity and the SLD profiles for the monolayers Eh-20 and J5-20 are
shown in Figures 4.14 and 4.15 respectively. The chain thickness values obtained
for the mixed monolayers Eh-20 and J5-20 were respectively 19.34 A˚ and 16.76
A˚; these values are higher than the thicknesses obtained from experiments carried
out on monolayers at the air/liquid interface of pure D62DPPC (16 A˚) [277] and
pure Rc J5 LPS (12 A˚) [21]. The SLD values for the mixed DPPC/LPS chain
region of the monolayers were in accordance with previously published data for
pure lipids [278] and Rc J5 LPS [21]. The similarity between the values of SLD
obtained for the deuterated chain region in both contrasts D2O and ACMW sug-
gest a limited penetration of solvent in the chain region of the Eh-20 monolayer, as
Chapter 4. Interaction of CAPs with LPS/DPPC mixtures 134
reported in Table 4.8 and as shown in Figure 4.14. The penetration of solvent was
more pronounced in the J5-20 monolayer, as shown by the SLD profiles of Figure
4.15.The values for the inner headgroup thickness, consisting of the headgroup of
DPPC and the core region of LPS that includes the GlcN and the Kdo moieties,
obtained for the monolayers Eh-20 and J5-20 were respectively 7.00 and 9.98 A˚.
These values are smaller than expected in consideration of the DPPC headgroup
thickness (9 A˚) and the Rc J5 LPS inner headgroup thickness (14 A˚) previously
published [21, 277]. The differences in the SLD values between the two contrasts
for both the monolayers may suggest a strong penetration of solvent in this layer.
The outer headgroup thicknesses for the Eh-20 and J5-20 monolayers were respec-
tively 26.53 and 20.00 A˚. The headgroup thickness of the monolayer containing
EH100 LPS was lower than the headgroup thickness value of 31 A˚ obtained from
the NR investigation of asymmetric bilayers composed of DPPC and EH100 LPS
[265] whereas the J5 LPS headgroup thickness was in agreement with the data
published by the same group. The differences in SLD between the two contrasts
obtained for both the monolayers under study suggests a consistent solvation of
the outer headgroup region.
The subphase injection of the peptide LL37 under Eh-20 and J5-20 monolayers
was investigated (Table 4.8). LL37 increased the chain thickness of the Eh-20
monolayer of ∼3 A˚ (Table 4.8) and reduced the D chain SLD in ACMW (Figure
4.16) and increased the H chain SLD in D2O (Figure E.1) which may suggest the
penetration of the peptide within the tail region. The peptide reduced the chain
thickness of the J5-20 monolayer by 2 A˚, increased H chain SLD in D2O (Figure
E.3) and the D chain SLD in D2O (Figure E.4). This observation suggests a possi-
ble penetration of deuterated material such as D2O , rather than the penetration
of the hydrogenated LL37 .The inner headgroup thickness of the Eh-20 mono-
layer was reduced by LL37 to 5.43 A˚ and the modification of the SLDs suggests
an increased solvation. The inner headgroup thickness of J5-20 monolayer was
increased by ∼5 A˚ and the SLDs modified by the addition of LL37 into the sub-
phase. The peptide increased the outer headgroup thickness of both the Eh-20
and J5-20 monolayers by ∼5 A˚ with limited modifications on the SLD profiles
(Figures 4.16 and 4.17). The minor effect on the SLD may be due to the high
solvation of the region which masks the contribution of the peptide to the density
of the layer.
The NR data for the interaction of LFb with the Eh-20 and J5-20 monolayers
were available only for the deuterated mixed monolayer in either D2O or ACMW
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subphase. The peptide LFb reduces by ∼2 A˚ the chain thickness of the Eh-20
monolayer with no significant modifications of the SLDs of this region; this is
confirmed by the observation of the SLD profile in ACMW (Figure 4.16) which
shows a similar maximum of the chain region peak and a reduction of width upo
addition of the peptide. LFb induced a minor increase of ∼1.5 A˚ on the chain
thickness of J5-20 monolayer which is hardly recognizable from the SLD profiles
(Figure 4.17 and E.3). The peptide increased the inner headgroup thickness of
Eh-20 and J5-20 monolayers by ∼7 A˚ and ∼5 A˚ respectively, with modifications
of the density of the headgroup region (Figures 4.16 and 4.17). LFb reduced the
outer headgroup region of the monolayers Eh-20 and J5-20 by ∼-9 and ∼-5 A˚ .
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Figure 4.14: NR fitted data of either Eh-20 or d-Eh-20 monolayers on two
contrasts (D2O , ACMW) subphase containing 1 mM MgCl2 solution at 22
◦C .
Upper plot: reflectivity profile. Lower plot: SLD profile.
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Figure 4.15: NR fitted data of either J5-20 or d-J5-20 monolayers on two
contrasts (D2O , ACMW) subphase containing 1 mM MgCl2 solution at 22
◦C .
Upper plot: reflectivity profile. Lower plot: SLD profile.
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Figure 4.16: NR fitted data of d-Eh-20 monolayer on ACMW subphase con-
tianing 1 mM MgCl2 solution at 22
◦C before and after the subphase injection of
the peptides LL37 and LFb. Upper plot: reflectivity profile. Lower plot: SLD
profile.
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Figure 4.17: NR fitted data of d-J5-20 monolayer on ACMW subphase con-
tianing 1 mM MgCl2 solution at 22
◦C before and after the subphase injection of



























Table 4.8: Parameters obtained from the fitting of NR data of the mixed Eh-20 and J5-20 monolayers a the air/liquid interface at
22◦C in the absence and presence of the peptides, either LL37 or LFb
Eh-20 + LL37 +LFb J5-20 +LL37 +LFb
Parameter Unit value error value error value error value error value error value error
Chain h SLD d2o x10-6 (A˚−2 ) -0.39 0.00 0.59 0.05 – – -0.39 0.00 -0.28 0.06 – –
Chain d SLD d20 x10-6 (A˚−2 ) 5.85 0.05 5.76 0.03 5.98 0.04 6.65 0.05 7.20 0.06 6.15 0.06
Chain d SLD acmw x10-6 (A˚−2 ) 5.68 0.02 4.38 0.01 5.83 0.02 5.66 0.03 5.74 0.02 5.14 0.01
Chain Thickness (A˚) 19.34 0.06 22.12 0.05 17.08 0.05 16.76 0.12 14.76 0.01 17.18 0.06
Inner headgroup h SLD d2o x10-6 (A˚−2 ) 1.91 0.10 1.00 0.00 3.77 0.00 3.75 0.01 4.10 0.03 4.50 0.05
Inner headgroup h SLD acmw x10-6 (A˚−2 ) 1.00 0.00 0.00 0.01 0.86 0.03 1.00 0.04 1.52 0.03 0.61 0.03
Inner headgroup thickness (A˚) 7.00 0.01 5.43 0.07 14.90 0.08 9.98 0.10 14.97 0.01 15.00 0.01
Outer headgroup h SLD d2o x10-6 (A˚−2 ) 5.92 0.05 5.80 0.02 5.96 0.05 6.35 0.00 6.08 0.04 6.35 0.01
Outer headgroup h SLD acmw x10-6 (A˚−2 ) 0.34 0.01 0.88 0.01 1.02 0.03 0.00 0.00 0.04 0.02 0.25 0.03
Outer headgroup thickness (A˚) 26.53 0.05 30.52 0.20 15.00 0.30 20.00 0.02 24.96 0.04 15.00 0.00
Monolayer roughness (A˚) 5.57 0.05 5.22 0.05 5.64 0.04 5.05 0.12 5.50 0.06 4.40 0.08
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4.3.5 Neutron reflectivity of asymmetric bilayer of DPPC
and LPS and interaction with antimicrobial peptides.
The asymmetric bilayer composed of an inner leaflet of hDPPC and an outer layer
composed of either LPS Ra EH100 or LPS Rc J5, was investigated at 37◦C in
water subphase containing 1 mM MgCl2 solution in the absence or presence of the
antimicrobial peptides LL37 and LFb .
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Figure 4.18: Reflectivity (upper plot) and SLD (lower plot) profiles of the
EH100 bilayer in three contrasts solution containing 1 mM MgCl2 at 37
◦C .
The fitting of three reflectivity profiles allowed the determination of the bilayer
structure parameters reported in Table 4.9. The comparison between the two
asymmetric bilayers of LPSs EH100 and J5 revealed an inner headgroup thickness
of 10.0±0.01 A˚ which is lower than previously published data [265]. In particular
the thickness of the inner headgroup of the J5 bilayer was significantly different
from the thickness of 9.3 A˚ of the hDPPC headgroup reported in the literature
[277]. The hydration of the oxide layer did not significantly change between the
two bilayers, even in the presence of the peptides, and the values were considerably
lower than previously published data [265]. The SLDs of the inner headgroup of
the EH100 and J5 bilayers were comparable with previously published data [265]
apart from the SLD in D2O of J5 bilayer which was considerably higher. The
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Figure 4.19: Reflectivity (upper plot) and SLD (lower plot) profiles of the J5
bilayer in three contrasts solution containing 1 mM MgCl2 at 37
◦C .
chain thicknesses of the EH100 and J5 bilayers were respectively 32.72±0.12 and
35.77±0.25 A˚, in agreement with previous data [265]. The tail hydration values
of the EH100 and J5 LPS bilayers were respectively 11.95±0.59 % and 2.83±0.72
%, which suggest a coverage of approximately 88% and 97%, a higher value in
respect to the coverage obtained by Clifton et al. [265]. The outer headgroup
layer thickness for the EH100 and J5 bilayers were respectively 29.49±0.51 and
21.46±0.07 A˚, which are in agreement with previously published data [265]. The
SLD in D2O of the outer headgroup for the EH100 bilayer was higher than the
relevant values for the J5 bilayer, whereas the SLDs in H2O and SMW were lower
for the EH100 bilayer in respect to the values of the J5 bilayer.
Most of the structural changes occurred in the bilayer EH100 upon addition of
the peptide LL37 involved the chain region and the outer headgroup layers which
increased respectively by ∼3 and ∼6 A˚ ( Table 4.9), whereas LL37 did not affect
significantly these regions in the J5 bilayer. The model fitting applied to both the
bilayers did not show any significant modification of the values of the SLD of the
tail region (Table 4.9) despite the modification of the SLD profiles in D2O shown
in Figure 4.20 and Figure 4.21) respectively for the EH100 and the J5 bilayer.
The hydration of the outer headgroup of the EH100 and the J5 bilayers increased
respectively by ∼12% and ∼5% upon addition of LL37 . The values of outer head-
group SLD in each contrasts for both the bilayers were not affected by the presence
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of the peptides which is surprising in consideration of the increase in hydration
of the layer. The plots of the reflectivity and SLD profiles for other contrasts are
reported in Appendix F.
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Figure 4.20: Reflectivity (upper plot) and SLD (lower plot) profiles of the
EH100 bilayer in D2O solution containing 1 mM MgCl2 at 37
◦C in the absence
or presence of the peptides, either LL37 or LFb.
The addition of the peptide LFb to the EH100 bilayer did not affect significantly
the chain region thickness of the bilayer but increased the tails hydration by
6%; such minor increase in solvation did not affect significantly the tails’ SLD.
LFb increased the outer headgroup thickness by ∼4.5 A˚ but did not induce any
appreciable modification of the SLDs of this layer. In general the peptide LFb did
not influence the SLDs of the bilayer, as shown by the SLD profiles in D2O of
Figure 4.20.
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Figure 4.21: Reflectivity (upper plot) and SLD (lower plot) profiles of the
J5 bilayer in D2O solution containing 1 mM MgCl2 at 37
◦C in the absence or


























Table 4.9: Parameters obtained from the fitting of the NR curves for the asymmetric bilayers containing either LPS EH100 or LPS
J5 in the absence and in the presence of the peptides, either LL37 or LFb.
Ra Eh100 +LL37 +LFb Rc J5 +LL37
Parameter Unit value error value error value error value error value error
Oxide layer thickness (A˚) 18.90 0.23 13.60 0.08 16.37 0.12 18.93 0.27 12.02 0.18
Oxide layer roughness (A˚) 3.00 0.01 7.00 0.02 5.56 0.02 3.00 0.01 4.65 0.01
Oxide Layer SLD x10-6 (A˚−2 ) 2.83 0.03 3.37 0.01 3.26 0.02 3.25 0.02 3.65 0.01
Oxide hydration (%) 3.74 1.34 0.03 0.06 3.33 0.99 2.90 1.34 3.60 1.46
Inner headgroup thickness (A˚) 10.00 0.01 10.00 0.00 8.85 0.07 6.47 0.08 10.00 0.01
Inner headgroup SLD D2O x10-6 (A˚−2 ) 3.86 0.03 3.07 0.09 3.56 0.06 6.33 0.02 4.59 0.02
Inner headgroup SLD SMW x10-6 (A˚−2 ) 2.12 0.02 2.46 0.02 2.25 0.01 2.07 0.01 2.38 0.02
Inner headgroup SLD H2O x10-6 (A˚−2 ) 1.45 0.01 3.00 0.03 1.01 0.01 1.50 0.01 0.98 0.01
Tails thickness (A˚) 32.72 0.12 35.77 0.25 33.21 0.09 35.22 0.22 35.39 0.21
Tails SLD x10-6 (A˚−2 ) -0.39 -0.40 0.00 -0.40 0.00 -0.39 -0.40 0.00
Tail hydration (%) 11.95 0.59 24.04 0.52 17.97 0.43 2.83 0.72 7.74 0.70
Outer headgroup thickness (A˚) 29.49 0.51 35.49 0.60 34.13 0.33 21.46 0.07 19.01 0.13
Outer headgroup in D2O x10-6 (A˚−2 ) 6.05 0.02 6.05 0.00 6.06 0.04 5.89 0.07 5.59 0.08
Outer headgroup in SMW x10-6 (A˚−2 ) 2.60 0.01 2.33 0.01 2.32 0.01 3.00 0.02 2.89 0.02
Outer headgroup in H2O x10-6 (A˚−2 ) 0.62 0.03 0.73 0.02 0.66 0.03 1.17 0.01 1.19 0.02
Bilayer roughness (A˚) 5.00 0.00 5.00 0.01 5.02 0.03 6.57 0.05 5.01 0.01
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4.4 Discussion
4.4.1 Tryptophan fluorescence spectra.
When discussing the results of the study of the fluorescence emission of the Trp
residues, the position of this amino acid within the structure of the peptides has to
be considered. Figure 1.10 shows the relative locations of the residues and details
of the hydrophobicity of the peptides. It is clear that the α-helical structure of
LL37 provides a more defined separation between the hydrophilic and hydropho-
bic facets, which contains the Trp residue. Whereas this clear distribution of
hydrophobicity is not as marked in the structure of LFb , yet the Trp residues
are contained in an extended hydrophobic region [119]. The emission of the Trp
residues depends upon the polarity of the environment, therefore the position of
this residue in the LL37 and LFb structure is important. The defined hydropho-
bic facet of the LL37 helix more likely interacts with the hydrophobic region of
the lipid bilayer [279] and probably it would result in a deeper penetration into
the bilayer compared to the residues in the structure of LFb . Therefore a higher
emission intensity could be expected from the samples containing LL37 despite the
lower number of Trp residues.
The presence of negative charges on the surface of the bilayer facilitates the in-
teraction of both LL37 [151, 183] and LFb [128, 246] with lipid bilayers. Previous
studies suggest that LL37 penetrates deeply into the bilayer in a concentration
dependent way, as reported for other α-helical peptides [151, 280]. On the other
hand LFb seems to affect the bilayer more at the interface, rather than at the
level of the hydrophobic chains [127, 130]. Certainly the electrostatic interaction
between the cationic peptides and the negative charges carried by the LPS is the
predominant driving force of their interaction, as revealed by the low binding ac-
tivity of both LL37 and LFb peptides on the zwitterionic vesicles composed of pure
DPPC. Nevertheless the activity of the peptides on vesicles containing Eh100 was
greater than on vesicles containing J5 LPS despite their equal theoretical negative
charge.
The fluorescence emission experiments were carried out at 37◦C which is below
the phase transition of hDPPC (41◦C ) but is slightly above the Tm of the Ra
and Rc LPS chemotypes (between 32◦C and 36◦C [88]). Experiments on mixed
hDPPC /LPS monolayers at the air/liquid interface at 22◦C (Section 4.3.3) re-
vealed a fluidizing effect of Ra EH100 LPS and Rc J5 LPS on hDPPC , when the
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temperature is below the Tm, whereas solid state
2H NMR experiments at 45◦C on
vesicles containing the same components revealed an ordering effect of LPSs on
the bilayers. Hence at the temperature of 37◦C it is not straightforward to predict
whether the LPSs will be in their gel or fluid phase. A stronger interaction with
vesicles containing LPS may be an indication of a more fluid bilayer due to the
disordering effect of EH100 and J5 LPSs, whereas a reduced penetration would
occur for pure hDPPC vesicles, the bilayer of which is in the gel phase state. The
LB experiments on mixed monolayers at the air/liquid interface (Section 4.3.3)
revealed a fluidizing effect of both LPS on the DPPC monolayer. The fluidizing
effect of EH100 LPS at the lateral pressure of 30 mN/m (the approximate lateral
pressure within the natural membranes) was greater than the effect of J5 LPS (Ta-
ble 4.6), although the error on the values was high. Hence the greater “fluidity”
of the vesicles containing EH100 LPS than the ones containing J5 LPS, allowed a
deeper penetration of both the peptides into the bilayer.
LL37 does not penetrate into hDPPC vesicles but increasing its concentration fa-
vors the accumulation of the peptide at the interface, which may comply with its
initial theoretical “carpet model” mechanism of action (Section 1.3.2). The pres-
ence of the LPSs, either Ra EH100 or Rc J5, increases significantly the interaction
of both peptides with the vesicles. LL37 at the concentrations tested showed the
same penetration depth indicating the attainment of an insertion limit into the hy-
drophobic chains; moreover the depth of insertion is greater than the one exerted
by the LFb peptide, supporting the greater propensity for LL37 to interact with
the hydrophobic chains. At the lower concentration, LL37 accumulates more at
the interface of vesicles containing LPS J5 than LPS EH100; this could be due to
the absence of part of the core region in the LPS J5 which would otherwise hinder
the interaction, as it happens in the vesicles containing EH100. At the higher
concentration, the peptide showed an opposite behavior with a greater binding to
LPS EH100 than LPS J5 containing vesicles, perhaps due to the achievement of
a threshold concentration which allowed for a greater, additive interaction [145].
LFb , as the LL37 peptide, had no interaction with hDPPC vesicles. LFb , in
general, interacts and penetrates to a lesser extent than LL37 all the vesicles con-
taining the LPSs studied, corroborating the hypothesis of its greater activity at
the interface rather than at the hydrophobic chains level. The amount of peptide
binding to the membranes containing LPS, regardless of the chemotype, is concen-
tration dependent; moreover LFb showed a higher affinity for vesicles containing
EH100 LPS at every concentration tested. In general the LL37 peptide penetrates
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more effectively into the bilayer containing LPS than the LFb peptide, which acts
mostly on the core region of the LPS headgroup.
4.4.2 Solid state 2H NMR
Previous studies regarding 2H NMR experiments performed on mixtures of
D62DPPC and LPS from E. coli K12 mixtures (1:1 w/w) in buffer containing
10 mM MgCl2 showed that LPS increases the order of DPPC hydrocarbon chains
above the Tm of DPPC when the bilayer is in a fluid phase; whereas below the Tm
of DPPC, when the chains are more ordered, LPS induces a disordering effect on
the chain packing [275]. The 2H NMR experiments in this chapter agree with these
observations, suggesting an ordering effect of Ra and Rc LPSs on DPPC bilayers
above the lipid melting temperature (41◦C ). The addition to the D62DPPC vesicles
of 20% molar ratio of the Rc J5 LPS induced a higher ordering of the acyl chains,
compared to the addition of Ra EH100 LPS. This is in accordance with the FT-IR
data reported by Brandenburg et al. [89] and the molecular simulations of Wu et
al. [281] which suggested that a smaller oligosaccharide region of LPS induces a
higher order state. Ciesielski et al. performed NMR studies on mixtures of DMPC
and smooth LPS from E. coli , suggesting a weak ordering effect and a reduced
bilayer mobility upon addition of the LPS [282].
LL37 pre-mixed with hDPPC /D62DPPC did not allow the formation of vesicles
probably because of a solubilizing effect on the membranes, at the concentrations
tested in this chapter (lipid/peptide ratio 100/1 and 50/1) . The addition of both
J5 and EH100 LPS to DPPC may have helped the aggregation of the lipids be-
cause of the ordering effect of LPS. LL37 does not noticeably modify the order
parameter of vesicles containing 20% of EH100, but has a disordering effect upon
the distal carbons of the vesicles containing LPS J5. Previous 2H NMR exper-
iments on LL37 showed that the peptide effectively inserts into the hydrophobic
region of POPC/POPG bilayer driven by the attraction for the negative charges of
POPG, thus inducing a disordering effect [279]. The same investigations suggested
that disordered chains react to the insertion of LL37 with less modification of their
SCD , whereas ordered chains are modified more extensively by the insertion of the
peptide [279]. This rational explains the lower disordering effect of LL37 on Eh-20
vesicles, which would be in a more disordered state than J5-20 vesicles, hence more
sensitive to the penetration of the peptide. The activity of LL37 is mostly concen-
trated into the hydrophobic region of the bilayer, due to its greater penetration
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activity (Section 4.3.1).
LFb did not modify the order parameter of vesicles containing 20% Ra EH100 LPS
but marginally increased the order parameter of the carbons close to the headgroup
region of the vesicles containing Rc J5LPS which may be due to its stronger in-
terfacial activity, unlike LL37 which interacts more with the chain region (Section
4.3.1).
4.4.3 Mixed DPPC and LPS monolayers at the air/liquid
interface
The LB film technique at the air-liquid interface was used to characterize the mixed
hDPPC /LPS monolayers on an aqueous subphase containing 1 mM MgCl2 solu-
tion at 22◦C and the interaction with the antimicrobial peptides LL37 and LFb .
The areas per molecule of the LPS EH100 and J5 were calculated to be respec-
tively 175.1±13 and 119.7±7.3 A˚2. Previous neutron reflectivity experiments at
the air-liquid interface for monolayers of pure J5 LPS found an area per molecule
of 109 A˚2 [21], which is comparable to the findings of the experiments reported
here. Both Ra EH100 and Rc J5 LPSs increased the fluidity of hDPPC lipids in
the mixed monolayers Eh-20 and J5-20, reported by a reduction of the ES value at
surface pressures up to 35 mN/m below the Tm of hDPPC . This disordering effect
of LPS on hDPPC monolayers is supported by previous investigations on Re rough
and smooth LPS [175, 176]. These findings are supported by 2H NMR experiments
which showed that below the DPPC Tm rough LPS from E. coli has a disordering
effect on D62DPPC vesicles [275]. The BAM images confirmed the fluidizing effect
of both LPSs on hDPPC monolayers. This disordering effect seems to be more
pronounced with EH100 than with J5, which is in accordance with previous FT-
IR experiments suggesting a greater disorder of the chains with the increasing size
of the oligosaccharide region [89]. The more fluid monolayers containing either Ra
EH100 or Rc J5 LPS may allow a stronger binding of the peptides than the more
ordered monolayer containing pure hDPPC . The binding of CAPs with the Eh-20
monolayer is greater than the binding with the J5-20 monolayer, in agreement
with the higher fluidizing effect of EH100 LPS which allows a stronger peptide
interaction.
LL37 peptide interacts more than LFb with all the monolayers tested, supporting
the rational by which α-helical peptides are stronger membrane-active agents. The
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peptide LL37 interacts more with monolayers containing EH100 than with mono-
layers containing J5 in terms of the rate of binding and the magnitude of the change
of the monolayer surface pressure, moreover LL37 has a reduced binding affinity
towards pure hDPPC monolayers. LFb does not bind to hDPPC monolayers and
seems to possess a similar rate of binding with both EH100 or J5 LPS-containing
monolayers.The peptide shows a greater magnitude of change of pressure for the
Eh-20 monolayer.
4.4.4 Neutron reflectivity on LPS/DPPC monolayers at
the air/liquid interface.
The chain thickness values obtained in this experiment for the Eh-20 and J5-20
monolayers are higher than the ones observed by others for monolayers of pure Rc
J5 LPS [21] or pure D62DPPC [277]. This could be due to an irregular organization
of the LPS and DPPC molecules within the monolayer resulting in an uncoordi-
nated acyl chains position, increasing the estimation of the chain thickness. On
the other hand the values for the inner headgroup thickness of the monolayers
Eh-20 and J5-20 were considerably understimated compared to the headgroup
thickness of monolayers composed of pure DPPC or pure Rc J5 LPS [21, 277].
The reason for this discrepancy may reside in the different model used to analyze
the reflectivity data and the different monolayer composition used in the experi-
ment presented in this chapter. The outer headgroup thickness of the monolayer
composed of EH100 LPS is greater than that of the monolayer composed of J5
LPS, as could be expected in consideration of the relevant core region dimensions.
The SLD profiles of the inner and outer headgroup regions of both monolayers
suggest a high degree of solvation as it is likely to be for such hydrophilic moieties.
The peptide LL37 has conflicting effects on the Eh-20 and J5-20 monolayers and
it is difficult to interpret and form definite conclusions on a rational mechanism
of action. The peptide seems to increase the chain thickness and outer headgroup
of the Eh-20 monolayer, decreasing the value of the inner headgroup thickness.
LL37 decreases the chain thickness and increases significantly the thickness of
both the headgroup regions of the J5-20 monolayer. A possible interpretation
may suggest that LL37 penetrates more the Eh-20 monolayer due to its stronger
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interaction with EH100 LPS (Sections 4.3.1 and 4.3.3.2) stretching the chain re-
gion, as depicted in Figure 4.22 C, whereas this effect is limited in the case of
the J5-20 monolayer. The activity of the peptide LFb is probably concentrated
mostly on the headgroup region of the monolayers Eh-20 and J5-20. This evidence
is in agreement with previous observation of LFb ’s interfacial activity described in
Section 1.3.1. The effect of CAPs on monolayers containing EH100 LPS is greater
than in the presence of the J5 LPS as observed before in the experiment of Section
4.3.3.2. The reduction of the chain thickness induced to the Eh-20 monolayer may
be due to a lateral expansion of the interface by the intercalation of the peptide,
followed by the expansion of the tail region (Figure 4.22 B).
The peptide LL37 penetrates more than LFb the chain region of the Eh-20 mono-
layer reducing the density and expanding the width of the peak as revealed by the
profile in ACMW of Figure 4.16. Both peptides insert into the headgroup region
(inner + outer region) of the Eh-20 monolayer with the formation of an elongated
shoulder on the SLD profile (Figure 4.16). Both LL37 and LFb peptides do not
modify the density of the chain region of the J5-20 monolayer (Figure4.17) and
induce limited modifications on its headgroup region as well. This evidence are
the confirmation of the higher sensitivity of models containing EH100 LPS to the
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Figure 4.22: Possible effects of a generic CAP on the structure of a mixed
lipid-LPS monolayer at the air/liquid interface.
The mathematical model used for the analysis of the NR data reported in this
Section is clearly not the ideal model which could be applied, but it was the best
amongst the models tried (data not shown). A simplified model which consists
of two layers, tail region and chain region, reported a headgroup thickness of the
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monolayer J5-20 greater than the Eh-20 monolayer which is not possible in con-
sideration of the molecular dimensions of the LPS core regions. Another attempt
was made using a model which consisted of three layers, such as the one reported
in this Section, with a single SLD value for each layer without considering the two
contrasts applied (D2O and ACMW). As a result of the fitting with such model, the
roughness of the monolayers was sometimes exceeding the thickness of the bilayer
itself, especially in the case of the J5-20 monolayer (∼20 A˚). That would suggest
a disruption of the monolayer which was not the case in consideration of the fact
that stable monolayers were always formed. The constraint of the parameters such
as the monolayer roughness would have forced the fitting program to compensate,
generating the modification of other parameters into unreasonable numbers. The
analysis of such a complex system certainly requires further investigation in order
to optimise the models used in its analysis.
4.4.5 Neutron reflectivity of asymmetric bilayers of DPPC
and LPS and interaction with antimicrobial peptides.
The lower values for the inner headgroup thickness obtained in this experiment
for both the Ra EH100 and Rc J5 bilayers compared to the data of Clifton et al.
[265] may be due to a reduced exchange of lipids and LPS between the two leaflets
of the bilayers. The data presented in the previous study reported a considerable
amount of LPS flipping into the inner leaflet which resulted in an increased inner
headgroup thickness. The methodology for the formation of the bilayers used in
this study utilised the compression of the DPPC and LPS monolayers at 4◦C in
the presence of a solution of 1 mM MgCl2 in the subphase. Both conditions may
have aided the stability of the outer LPS leaflet reducing the exchange of material
between the two layers. This may also explain the lower hydration of the oxide
layer because of a thinner inner headgroup which would reduce the water content
in this layer. The higher SLD value in D2O and the lower SLD values in SMW
and H2O of the outer headgroup for the EH100 bilayer in respect to the values for
the J5 bilayer may be due to a greater extent of hydration of the former bilayer,
as could be expected from the bulkier and wetter headgroup of the Ra EH100
LPS chemotype. The bigger headgroup of the EH100 LPS produced a thicker
outer headgroup layer compared to the J5 LPS, in agreement with the molecular
dimensions of the relative core region of the LPSs.
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The peptide LL37 increases the thicknesses of the outer headgroup and the chain
region of the EH100 bilayer whereas it does not modify the J5 bilayer, suggest-
ing a stronger interaction with the Ra EH100 LPS as observed in the experi-
ments reported above and previously in this thesis (Section 4.3.1, Section 4.3.3.2
and Section 4.3.4).The peptide LFb modifies exclusively the thickness of the outer
headgroup of the EH100 bilayer suggesting a limited activity confined in the head-
group of Ra EH100 LPS as reported in previous experiments (Section 4.3.1). No
NR data are available for the interaction with J5 bilayer but in consideration of
earlier evidence (Section 4.3.1, Section 4.3.3.2) it is possible to assume a limited
interaction with bilayers consisting of Rc J5 LPS. The interaction of both peptides
did not modified the SLD parameters of the tail and the outer headgroup region
of the bilayers. This result is unexpected in the light of the fact that the pres-
ence of a peptide (which SLDs are reported in Table B.2) in either layers would
have modified the density of the layers with consequent modification of the SLD.
A qualitative observation of the SLD profiles in the D2O contrast of the bilayers
EH100 in the presence of either LL37 or LFb , and for the bilayer J5 in the pres-
ence of LL37 (respectively Figure 4.20 and Figure 4.21), show a clear increase in
density of the acyl chain region upon addition of the peptides. The magnitude
of the increase in density and expansion of the trough of the chain region of the
EH100 bilayer is greater for LL37 than LFb , indicating a possible insertion of the
peptide LL37 into the bilayer. The SLD profiles in H2O and SMW (Figure F.1 and
F.3) indicate a similar effect of the peptides on the headgroup region of the EH100
bilayer. The modification induced by LL37 on the chain region density of the J5
bilayer in D2O (Figure 4.21) are of smaller magnitude compared to the ones of the
EH100 bilayer. Similar results occur for the H2O and SMW contrasts (Appendix
F) indicating a lesser activity of the peptide on the J5 bilayer. Such changes of
density could not be completely detected by the model fitting applied, as a result
of which the parameters reported above may be an underestimation of the real
density changes; this limitation may be due to the restricted number of contrasts
which reduced the sensitivity of the measurements to SLD changes.
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4.5 Conclusion
The experiments presented in this chapter aimed to assess the interactive capac-
ity of LL37 anf LFb antimicrobial peptides with models of the outer membrane
of Gram negative bacteria composed of DPPC and different rough chemotypes
of LPS. Some data have been difficult to interpret and further investigations are
required to elucidate better the mechanism of interaction. Nevertheless some con-
clusions can be drawn. Both the amphiphilic, cationic peptides are interacting
with the membrane models by electrostatic interaction with the negative charge
of LPS. Models containing the Ra EH100 chemotype of LPS are more susceptible
to the activity of CAPs than models containing the Rc J5 chemotype, hence a
bigger core region of the LPS does not provide any shielding effect but actually
favors the peptide interaction. The α-helical peptide LL37 possesses a greater rate
of binding and penetration activity than the β-sheet peptide LFb ; due to its con-
formation, LL37 binds to the negative charges at the interface of the membrane
and penetrates the chain region via its hydrophobic side, disrupting the bilayer
(Section 1.3.2). As speculated in Section 1.3.1, the activity of LFb is concentrated
at the interface of the models and it exerts a limited penetration of the hydrophobic
region, hence its microbicidal activity may not be the result of membrane disrup-
tion [130]. The results presented in this study show benefits of the application of
the Gram negative bacteria OM model which includes the presence of lipopolysac-
charide; such a realistic model may expand the knowledge of the mechanism of
action of CAP. These investigations can lead to fruitful evidence thanks to the
application of powerful techniques such a solid state NMR and neutron scattering.
More studies using neutron techniques are desirable, implementing the model with
a greater range of solvent and lipid component contrasts which would increase the
sensitivity of the experiment.
Chapter 5
General discussion.
The study of lipopolysaccharide physicochemical characteristics began more than
three decades ago with the discovery of its endotoxic principle, the lipid A molecule
[211]. The interest in this bacterial membrane component resulted in the detailed
determination of its molecular structure and its high degree of structural variability
[29, 44, 283]. Since then many biophysical studies have revealed the close connec-
tion between the structure of the LPS and its toxicity, leading to the development
of the “conformational concept of endotoxicity” [84]. According to this theory a
conical molecular shape of LPS which favors aggregates of a non-lamellar form is
highly toxic, whereas LPS in a cylindrical conformation forms lamellar aggregates
which are less toxic [84, 91, 92]. The molecular conformation of LPS is determined
by its structure, hence different chemotypes of LPS exhibiting different toxicities
[199].
The toxic effect of LPS takes place after the release of monomers of LPS (in a con-
ical shape) from aggregates released from the OM of the bacteria, and their sub-
sequent recognition by specific lipopolysaccharide binding proteins (LBPs) which
present the molecules to membrane receptors (mCD14 and TLR4 ) of the immune
system cells such as macrophages and neutrophils [61]. This exceptionally sensi-
tive immune response results in a cascade of inflammatory signals (prostaglandins,
chemokines, cytokines, reactive oxygen species) aimed at eradicating the stimu-
lating infection, however in the eventuality of an elevated quantity of LPS in
the body, the over-stimulated immune system provokes the pathological condition
called septic shock [62]. Amongst the various inflammatory mediators produced
by immune cells, nitric oxide (NO) produced by cultured macrophages can be di-
rectly correlated to the inflammatory stimulation induced by LPS [201, 203]. This
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relationship was used to evaluate the inflammatory activation of cultured murine
J774.1 cells stimulated by nanograms/mL quantities of several chemotypes of LPS
through the measurement of the level of NO produced by the cells. The prelimi-
nary study presented in this thesis has some statistical limitations, nevertheless it
shows that the smooth 0111B4, the Ra EH100 and the Rc J5 rough chemotypes of
LPS from E. coli are more potent immunostimulators than the Re LPS (the lipid
A-2Kdo). Amongst the three most potent chemotypes the most toxic chemotype
seems to be the Ra EH100, whereas no significant differences have been observed
between the smooth 0111B4 and the Rc J5 chemotypes. In order to improve the
accuracy of the toxicity test, it would be desirable to study the LPS-induced in-
flammatory stimulation of whole blood, which provides a more sensitive test and
would compensate for the limitations of the NO assay such as the lack of LFb.
Nevertheless as result of the toxicity test performed, the question arises as to
whether the differences in the inflammatory stimulation are correlated with the
diversity of the structures of aggregates formed by the different LPS chemotypes.
Previous studies on the morphology of LPS aggregates have been conducted us-
ing X-ray radiation in non-physiological conditions with a high concentration of
LPS [84, 85, 87]. The use of small-angle neutron scattering (SANS) and cryo-
transmission electron microscopy (cryo-TEM) has allowed us to reduce the con-
centration of lipopolysaccharide considerably, thus resulting in a more biomimetic
model system. In the experiments presented here the structures of smooth 0111B4,
Ra D21 and Rc E7 LPSs were determined in solution at 6 mg/mL in the presence of
MgCl2 . The smooth LPS forms elongated micellar particles, sometimes branched
and interconnected, whereas rough Ra D21 and Rc E7 chemotypes formed com-
plex lamellar structures. According to the “conformational concept of endotoxic-
ity” introduced above, those structures should not have elicited an inflammatory
activation of the macrophages, which actually happened in the biological assay
performed in this study. Still the absence of LBP in the culture medium poses
a limitation to the possible speculations on the different toxic activities of LPS,
restrictions which need to be explored with further biological studies as suggested
above.
Based on the knowledge built up so far on the mechanism of lipopolysaccharide
toxicity, few studies have focused on the investigation of anti-endotoxic molecules
which could reduce the activation of the immune system induced by the LPS. Some
studies have, however, tried to develop small molecules able to bind and sequester
LPS to reduce the activation of the immune system [284]. A different approach
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based on the rationale of the “conformational concept of endotxicity” consists of
the study of molecules which would modify the supramolecular structure of LPS
aggregates from a more toxic (non-lamellar) to a less toxic (lamellar) form. These
studies focus on the anti-endotoxic activity of natural and synthetic antimicrobial
peptides [114–116]. Following the latter idea, the studies presented in this thesis
have concentrated on the assessment of the putative anti-endotoxic role of the two
amphphilic cationic antimicrobial peptides (CAPs) LL37 and LFb .
The NO assay performed on J774.1 macrophage cells described above, was car-
ried out on the same smooth 0111B4, Ra EH100, Rc J5 and Re lipid A-2Kdo
rough LPS chemotypes in the presence of different concentrations of either LL37 or
LFb in the cell culture medium to assess any anti-endotoxic activity of the CAPs.
Unfortunately the data were not conclusive due to the high degree of error of the
measurements and a definite conclusion can not be formed. It is clear though that
LL37 and LFb have different effects on the LPS-induced inflammatory stimulation
of macrophages cells.
The structural modifications induced by the peptides LL37 and LFb on aggregates
of smooth and rough LPS were investigated by SANS and cryo-TEM. Neither pep-
tide was able to modify the morphology of aggregates consisting of smooth 0111B4
LPS probably due to the shielding effect of the very large O-antigen moiety which
would hinder the interaction of the amphiphilic peptides. The removal of the
O-antigen, as for the case of the rough chemotypes, resulted in a stronger electro-
static interaction of the peptides with the aggregates due to the exposure of the
negative charges of the LPS core oligosaccharide and lipid A regions. LB experi-
ments on monolayers at the air/liquid interface and static fluorescence experiments
on model membranes containing mixtures of hDPPC and rough LPS chemotypes
revealed the essential role of the electrostatic interaction for the CAPs’ binding
activity.
The lamellar structures formed by the Ra D21 LPS were challenged by the LL37
peptide which induces the formation of elongated micelles closing up into irregu-
lar toroids and a significant modification of the innermost hydrophobic region of
the LPS aggregates. The peptide LFb , on the other hand, induces lesser changes
in the structure of the lamellar aggregates of D21 LPS resulting in the forma-
tion of tightly packed, regular toroidal structures which resemble pores spanning
a bilayer. The SANS data revealed that LFb acts more at the interface of the
aggregates, where the core oligosaccharide of LPS is located, rather than deeply
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into the hydrophobic region, inducing a curling effect on the bilayer [130]. The dif-
ferent mechanism of action of the LL37 and LFb peptides is corroborated by solid
state NMR experiments and neutron reflectivity (NR) experiments on monolayers
of mixed DPPC/Ra EH100 LPS and on supported asymmetric bilayers composed
of an outer leaflet of pure EH100 LPS; the experiments show that LL37 is more
likely to interact with the hydrophobic region of the LPS whereas LFb has an
interfacial activity on the core oligosaccharide region.The complex lamellar ag-
gregates formed by the Rc E7 LPS, which lacks part of the core oligosaccharide
region and its negative charges, are modified upon the addition of the peptides,
either LL37 or LFb . Both peptides induce the formation of a mixed population of
aggregate morphologies which comprise complex lamellae, toroids and worm-like
micelles, generating SANS data which is difficult to interpret. The effect of the
peptides on the E7 LPS aggregates is not as evident as for the Rc D21 LPS case.
This apparent inhomogeneity of the population of aggregate morphologies may be
due to the higher number of E7 LPS molecules compared to the experiments car-
ried out with the smooth and the Ra chemotypes, resulting in the sequestration of
the peptides in area of high lipoplysaccharide concentration. The absence of nega-
tive charges in the core region may allow the peptides to interact directly with the
negative charges of the lipid A region of the E7 LPS inducing strong modification
of the aggregates. Whereas static tryptophan fluorescence and NR experiments on
membrane models composed of Rc J5 LPS chemotype, which retains the negative
charges in the core region, suggest a reduced interaction of the peptides with these
models. The negative charges of this chemotype may help to stabilize the mono-
layers and bilayers containing J5 LPS reducing the activity of the peptides due to
a stronger cross-linking between adjacent molecules with a Mg2+ ion which is not
so readily displaced because of the lower lateral pressure created by the smaller
headgroup of J5 compared to the EH100 LPS.
The action of the peptides on rough chemotypes of LPS aggregates suggests that
both LL37 and LFb act in opposition to the conformational concept of endotox-
icity, leading to a theoretically more toxic form of LPS. It has to be taken into
consideration that the conditions in which these investigations are performed dif-
fer substantially from the experimental conditions used during the development
of the theory. The structural information which sustain the theory have been ob-
tained from experiments where condition are unlike those encountered in biology.
The neutron scattering technique is undoubtedly a potential tool which can be
used to study this system at very low LPS concentrations, closer to a biological
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conditions. This technique provides a better insight into the mechanism of action
of CAPs focusing at the molecular level on the localization of the peptide inter-
acting with membrane models. The evidence presented in this thesis point out the
necessity to verify and further investigate the basis of the conformational concept
of endotoxicity and the mechanism of interaction of CAPs with membrane mod-
els by the use of experiments which mimic more closely the biological conditions.
Our experiments indicate that there may be a more complex relationship between
aggregate structure, peptide interaction and toxicity of LPS.
5.1 Future works
The data presented in this thesis showed a greater bio-activity of the peptide LL37
compared to LFB, in both the biological and the biophysical experiments. There-
fore, future experiments will focus mainly on the LPS/LL37 interactions. In order
to obtain more realistic and conclusive biological data regarding the anti-endotoxic
role of antimicrobial peptides, whole-blood experiments could be carried out using
antibodies specific for different inflammatory markers (TNF-α and IFN-γ), which
would help to reduce the error of the measurement. Using a high-throughput
screening methodology such as the fluorescence-activated cell sorting (FACS) tech-
nique, will allow sensitive and accurate assessment of the inflammatory response
of the blood’s immune cells (neutrophils and macrophages), increasing the number
of experimental repetitions and reducing measurement error.
The growth of Gram negative bacteria in specialized media allows the production
and purification of deuterated LPS, which would be very useful in all the neutron
scattering techniques used in this thesis. In order to obtain such a compound, it
would be necessary to collaborate with institutions such as ISIS or ILL, which pos-
sess the facilities required for the production of deuterated biomolecules. The use
of isotopically labelled LPS would increase the number of contrasts which could be
applied in both SANS and NR experiments, allowing for a better understanding
at the molecular level of the peptide/LPS interaction.
Depending on the results obtained from the biological studies in whole-blood,
it may be interesting to carry out further SANS and cryo-TEM experiments to
clearly determine if the anti-endotoxic role of CAPs is due to LPS sequestration or
modification of the LPS aggregate morphologies. The use of asymmetric bilayers
composed of smooth LPS would be initially tested because they represent a very
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realistic model for the interaction studies with CAPs. In addition, the use of solid
state NMR and infrared spectroscopy should enable a deeper understanding of the
chain order of LPS in aggregates and bilayers, aiding the elucidation of the effect
of CAPs on the molecular packing of the endotoxin within the model.
Appendix A
Protein identification in LPS
extracts by SDS gel
electrophoresis.
Figure A.1 reports a SDS gel electophoresis of several of extracted and purchased
LPS chemotypes. The LPS chemotypes smooth 055B5, Rd F583 and Ra EH100
were purchased from Sigma-Aldrich Ltd. (Dorset, UK) and analysed without
further purification. The LPS chemotypes Ra D21, Rb e19, Rc e7, Rd f1, and Re f2
from E. coli K12 were cultured as described in Section 3.2.2 and purified according
to the original PCP method of Galanos et al. [230]. The Figure A.1 shows the
bands relative to each LPS chemotype and, in the upper part of the gel, the
stripes produced by the contaminants in the preparation. A Biorad Mini Protean 3
electrophoresis casting chamber (Biorad, Hercules, USA) was used to run a 1.0 mm
thick SDS gel according to methods described elsewhere [231, 285, 286]. Briefly,
the gel was composed of a 4% acrylamide in 1 M Tris HCl, pH 6.8, stacking layer
and a 15% acrylamide in 1 M Tris HCl pH 8.8 running layer, both obtained from
a Biorad 30% Acrylamide/Bis stock solution (Biorad, Hercules, USA). The LPS
samples were prepared by dissolving the LPSs in water and mixing with loading
buffer at a sample/buffer ratio of 1:1, in order to obtain approximately 12 µg
weight of LPS in each well. The gel was run through a Tris-tricine-SDS running
buffer (Sigma-Aldrich Ltd., Dorset, UK) in order to achieve a better resolution
[287] than the standard glycine buffer. The gel was run for one hour at constant
voltage of 200 mV. The gel was fixed and developed using the silver staining
technique of Tsai and Frasch [288] by the use of a Proteosilver kit (Sigma-Aldrich
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Stripes due to protein contamination 
Figure A.1: Picture of a 4%/15% SDS gel electrophoresis run in tris-glycine
running buffer. From the left the bands correspond to the separation of
purschased LPS chemotypes 055B5, Rd F583, Ra Eh100 and the extracted
LPS chemotypes Ra D21, Rb e19, Rc e7, Rd f1, and Re f2 from E. coli K12.
Ltd., Dorset, UK) and picture of the gel was taken using an Alpha imager EP
system (Aplha Innothec, San Leandro, USA).
Appendix B
Details of the peptides LL37 and
LFb.
The peptide here referred to as LL37 used in this thesis is a modification of the
wild-type peptide cathelicidin LL37 (see Table B.1) . The modified LL37 presents
a substitution of the original 17th residue phenylalanine (F) with a tryptophan
residue (W). The modified LL37 was purchased from GenScript USA Inc. (Pis-
cataway, USA) with a purity higher than 94%. The cyclic bovine lactoferricin
peptide LFb used in this thesis is the fragment of the bovine lactoferrin protein
from residue 17 to residue 41 and was purchased from Alpha Diagnostic Interna-
tional Inc. (Sant Antonio, USA).The peptide presents one disulfide bridge formed
by the two cysteins residues in position 3 and 21 of the peptide’s sequence. The
peptides were analysed by RP-HPLC and ESI-MS (see spectra below). The pro-
tein data bank (PDB) code for the wild type LL37 and the LFb peptides are re-
spectively “2k6o” and “1lfc” and details of the structures are reported elsewhere
[119, 138, 139]. The peptides LL37 and LFb were assessed by electrospray ioniza-
tion mass spectrometry (ESI-ms) at King’s College centre for mass spectrometry
and examples of the the spectra are reported. The entire ESI-ms spectra for the
peptides LL37 and LFb are shown in Figure B.1 and Figure B.4 respectively. The
details of the ESI-MS spectra of the different fragment ions are reported in Figures
B.2 and B.3 for LL37 and in Figure B.5 for LFb .
The SLD values of the hydrogenated peptides in different solvents are reported in
161
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Table B.1: Primary structure and molecular weight of the LL37 and LFb
peptides used in the thesis. Details of the wild type LL37 are reported.
Peptide Number of Peptide Molecular weight
acronym amino acid s Sequence (g/mol)
LL37 37 LLGDFFRKSKEKIGKE-W 4532.4
KRIVQRIKDFLRNLVPRTES
w.t.i LL37 37 LLGDFFRKSKEKIGKEF 4493.3
KRIVQRIKDFLRNLVPRTES
LFb ii 25 FKCRR-W-Q-W-R 3123.9
MKKLGAPSITCVRRAF
i wild type ii cyclic peptide
Table B.2
 
E:\LTQ Data\Harvey\M7662 14 Mar 13 16:29:35 Peptide 1 MW: 4493
in 0.1% FA in 50% MeOH
M7662 #33-224 RT: 0.12-0.81 AV: 192 NL: 5.27E6
F: ITMS + p ESI Full ms [50.00-2000.00]








































919.00656.67 1498.42178.92 816.33 1283.83997.33318.75 1797.67531.08 1583.50 1865.92
Figure B.1: ESI-ms of the peptide LL37 in methanol/water 1:1 with 0.1%
trifluoroacetic acid.
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E:\LTQ Data\Harvey\M7662 14 Mar 13 16:29:35 Peptide 1 MW: 4493
in 0.1% FA in 50% MeOH
M7662 #270-288 RT: 1.10-1.49 AV: 19 NL: 8.28E5
F: ITMS + p ESI u Z ms [896.00-904.00, 1120.00-1128.00, 1494.00-1502.00]
896 898 900 902 904
m/z
1120 1122 1124 1126 1128
m/z











































































Figure B.2: ESI-ms of the peptide LL37 in methanol/water 1:1 with 0.1%
trifluoroacetic acid. From the left the details show the peaks for the 5th, 4th
and 3th charged ions.
 
E:\LTQ Data\Harvey\M7662 14 Mar 13 16:29:35 Peptide 1 MW: 4493
in 0.1% FA in 50% MeOH
M7662 #336-363 RT: 2.42-2.81 AV: 28 NL: 6.38E5
F: ITMS + p ESI u Z ms [561.00-565.00, 641.00-645.00, 748.00-752.00]
561 562 563 564 565
m/z
641 642 643 644 645
m/z







































































Figure B.3: ESI-ms of the peptide LL37 in methanol/water 1:1 with 0.1%
trifluoroacetic acid. From the left the details show the peaks for the 8th, 7th
and 6th charged ions.
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E:\LTQ Data\Harvey\M7651 06 Mar 13 10:05:54 Peptide MW 3124  7 S-S bridge
100uL/mL in 0.1% FA in 50% MeOH
M7651 #220-824 RT: 0.79-2.98 AV: 605 NL: 1.95E6
T: ITMS + p ESI Full ms [50.00-2000.00]












































1247.67 1676.331563.421361.58 1759.08 1888.50
Figure B.4: ESI-ms of the peptide LFb in methanol/water 1:1 with 0.1%
trifluoroacetic acid.
 
E:\LTQ Data\Harvey\M7651 06 Mar 13 10:05:54 Peptide MW 3124  7 S-S bridge
100uL/mL in 0.1% FA in 50% MeOH
M7651 #2698-2766 RT: 10.71-11.69 AV: 69 NL: 5.29E5
F: ITMS + p ESI u Z ms [520.00-524.00, 624.00-628.00, 780.00-784.00]
520 521 522 523 524
m/z
624 625 626 627 628
m/z

















































































Figure B.5: ESI-ms of the peptide LFb in methanol/water 1:1 with 0.1%
trifluoroacetic acid. From the left the details show the peaks for the 6th, 5th
and 4th charged ions.
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Table B.2: SLD of the hydrogenated peptides calculated from the online tool
[289]. All the SLD values are expressed as ×10−6 A˚−2 .
in D2O in H2O in SMW in ACMW
6.38 -0.55 2.08 0.00
LL37 3.27 1.68 2.29 1.81
LFb 3.50 1.73 2.40 1.87
Appendix C
2H NMR supplementary data.
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Figure C.1: 2H NMR analysis at 45◦C of DPPC vesicle in the presence or
absence of the peptide LFb at a lipid/peptide molar ratio of 50/1. (A) De-paked
powder spectra of D62DPPC signal. (B) Smoothed order parameter (SCD ) plot




The SLD values of the lipids and LPS chemotypes used in this thesis are reported
in Table D.1 below. The SLDs were calculated with the use of the SLD calculator
provided by the Sansview software in consideration of the chemical formula of the
different parts of each molecule. The SLD of hDPPC and D62DPPC were obtained
from previously published data [161]. The structures of the LPSs are reported in

































Table D.1: SLD values of molecules and solvents used in this thesis.
Molecule Description formula SLD x10-6 (A˚−2 )
Water H2O -0.56
Deuterium oxide D2O 6.36
ACMW solution 8% D2O in water 0.00
SMW solution 38% D2O in water 2.07
Silicon Si 2.07
Silicon oxide SiO2 3.41
hDPPC Tails C32H62O2 -0.39
headgroup C8H18NO6P 1.98
D62DPPC Tails C32H2D62O2 7.45
headgroup C8H18NO6P 1.98
lipid A-2Kdo
tails Tails C78H160O6 -0.39
inner core 2GlcN-2P-2Kdo C32H48N2O33P2(-2) 1.60
LPS Rc J5
inner core 2GlcN-2Kdo-1PEtn C32H48N2O33P2(2-) 1.56
outer core 3Hep-2Glc-1P-1PPEtn C33H58NO30P2(-2) 1.26
LPS Rc- E7
inner core 2GlcN-2P-2Kdo C32H48N2O33P2(-2) 1.60
outer core 2Hep-1Glc C20H36O17 1.17
LPS Ra D21
inner core 2GlcN-2Kdo-1Rha C38H56N2O37P2(-2) 1.55
outer core 3Hep-3Glc-1Gal-1P-1PEtn C56H99N2O47P2(-1) 1.25
LPS Ra Eh100
inner core 2GlcN-2Kdo-1Gal-1PEtn C40H64N3O41P3(-2) 1.53
outer core 3Hep-3Glc-1Gal-1GlcNac-1P-1PEtn C55H97N2O50P2(-1) 1.29
Appendix E
Neutron reflectivity of mixed




Comparison of the reflectivity and SLD profiles of the mixed monolayers con-
taining hDPPC (Eh-20 and J5-20 monolayers) or D62DPPC (d-Eh-20 and d-J5-20
monolayers) in D2O subphase in the presence or absence in the subphase of the
peptides, either LL37 or LFb .
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Figure E.1: NR fitted data of Eh-20 monolayer on D2O subphase containing
1 mM MgCl2 solution at 22
◦C before and after the subphase injection of the
peptides LL37 and LFb. Upper plot: reflectivity profile. Lower plot: SLD
profile
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Figure E.2: NR fitted data of d-Eh-20 monolayer on D2O subphase containing
1 mM MgCl2 solution at 22
◦C before and after the subphase injection of the
peptides LL37 and LFb Upper plot: reflectivity profile. Lower plot: SLD profile
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Figure E.3: NR fitted data of J5-20 monolayer on D2O subphase containing
1 mM MgCl2 solution at 22
◦C before and after the subphase injection of the
peptides LL37 and LFb Upper plot: reflectivity profile. Lower plot: SLD profile
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Figure E.4: NR fitted data of d-J5-20 monolayer on D2O subphase containing
1 mM MgCl2 solution at 22
◦C before and after the subphase injection of the
peptides LL37 and LFb Upper plot: reflectivity profile. Lower plot: SLD profile
Appendix F
Neutron reflectivity data of
asymmetric bilayers of DPPC and
LPS and interaction with
antimicrobial peptides.
Figures F.1 and F.3 show the comparison of the neutron reflectivity profiles of the
bilayer Eh100 in H2O and SMW contrasts, in the absence and in the presence of
the peptides, either LL37 or LFb . Figures F.2 and F.2 show the comparison of
the neutron reflectivity profiles of the bilayer J5 in H2O and SMW contrasts, in
the absence and in the presence of the peptide LL37 . The discussion of the plots
is reported in Section 4.3.5.
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Figure F.1: Reflectivity (upper plot) and SLD (lower plot) profiles of the
EH100 bilayer in H2O solution containing 1 mM MgCl2 at 37
◦C in the absence
or presence of the peptides, either LL37 or LFb.
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Figure F.2: Reflectivity (upper plot) and SLD (lower plot) profiles of the
J5 bilayer in H2O solution containing 1 mM MgCl2 at 37
◦C in the absence or
presence of the peptide LL37.
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Figure F.3: Reflectivity (upper plot) and SLD (lower plot) profiles of the
EH100 bilayer in SMW solution containing 1 mM MgCl2 at 37
◦C in the absence
or presence of the peptides, either LL37 or LFb.
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Figure F.4: Reflectivity (upper plot) and SLD (lower plot) profiles of the J5
bilayer in SMW solution containing 1 mM MgCl2 at 37
◦C in the absence or
presence of the peptide LL37.
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